
<html lang="en"     class="pb-page"  data-request-id="fcd9c0c0-5607-42d5-b49f-4312f5151ff9"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2019.62.issue-2;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.8b01590;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Quinazolin-2,4-dione-Based Hydroxamic Acids as Selective Histone Deacetylase-6 Inhibitors for Treatment of Non-Small Cell Lung Cancer" /></meta><meta name="dc.Creator" content="Chao-Wu  Yu" /></meta><meta name="dc.Creator" content="Pei-Yun  Hung" /></meta><meta name="dc.Creator" content="Hui-Ting  Yang" /></meta><meta name="dc.Creator" content="Yi-Hsun  Ho" /></meta><meta name="dc.Creator" content="Hsing-Yi  Lai" /></meta><meta name="dc.Creator" content="Yi-Sheng  Cheng" /></meta><meta name="dc.Creator" content="Ji-Wang  Chern" /></meta><meta name="dc.Description" content="We designed and synthesized quinazolin-2,4-dione-based hydroxamic acids to serve as selective competitive inhibitors of histone deacetylase-6 (HDAC6). The most potent and selective compound, 3d (IC..." /></meta><meta name="Description" content="We designed and synthesized quinazolin-2,4-dione-based hydroxamic acids to serve as selective competitive inhibitors of histone deacetylase-6 (HDAC6). The most potent and selective compound, 3d (IC..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 10, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01590" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01590" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01590" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01590" /></link>
        
    
    

<title>Quinazolin-2,4-dione-Based Hydroxamic Acids as Selective Histone Deacetylase-6 Inhibitors for Treatment of Non-Small Cell Lung Cancer | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01590" /></meta><meta property="og:title" content="Quinazolin-2,4-dione-Based Hydroxamic Acids as Selective Histone Deacetylase-6 Inhibitors for Treatment of Non-Small Cell Lung Cancer" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0021.jpeg" /></meta><meta property="og:description" content="We designed and synthesized quinazolin-2,4-dione-based hydroxamic acids to serve as selective competitive inhibitors of histone deacetylase-6 (HDAC6). The most potent and selective compound, 3d (IC50, 4 nM, HDAC6; IC50 &gt; 10 μM, HDAC1), substantially increased acetylation of α-tubulin instead of histones in the lung cancer cell line, LL2. Paclitaxel in combination with 3d had a synergistic anticancer effect on reduction of programmed death-ligand 1 expression in LL/2 cells. When given orally, 3d was mainly found to locate in the liver and lungs, at a concentration 18- to 70-fold greater, respectively, than in plasma. As an orally active HDAC6 inhibitor, 3d (20 mg/kg) potentiated paclitaxel antitumor activity (percentage tumor growth inhibition, 67.5%) in a xenograft syngeneic non-small cell lung cancer mouse model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01590"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01590">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01590&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01590&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01590&amp;href=/doi/10.1021/acs.jmedchem.8b01590" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 2</span><span class="cit-fg-pageRange">, 857-874</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/2" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01550" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01594" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Quinazolin-2,4-dione-Based Hydroxamic Acids as Selective Histone Deacetylase-6 Inhibitors for Treatment of Non-Small Cell Lung Cancer</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Chao-Wu Yu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chao-Wu Yu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, College of Medicine, National Taiwan University, Taipei 10607, Taiwan</div><div class="loa-info-affiliations-info">AnnJi Pharmaceutical Co., Ltd., 18, Siyuan Street, Taipei 10087, Taiwan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chao-Wu++Yu">Chao-Wu Yu</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5176-4225" title="Orcid link">http://orcid.org/0000-0002-5176-4225</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pei-Yun Hung</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pei-Yun Hung</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">AnnJi Pharmaceutical Co., Ltd., 18, Siyuan Street, Taipei 10087, Taiwan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pei-Yun++Hung">Pei-Yun Hung</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hui-Ting Yang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hui-Ting Yang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">AnnJi Pharmaceutical Co., Ltd., 18, Siyuan Street, Taipei 10087, Taiwan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hui-Ting++Yang">Hui-Ting Yang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yi-Hsun Ho</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yi-Hsun Ho</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">AnnJi Pharmaceutical Co., Ltd., 18, Siyuan Street, Taipei 10087, Taiwan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yi-Hsun++Ho">Yi-Hsun Ho</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hsing-Yi Lai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hsing-Yi Lai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Life Science, Institute of Plant Biology, and Genome and Systems Biology Degree Program, National Taiwan University, Taipei 10617, Taiwan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hsing-Yi++Lai">Hsing-Yi Lai</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yi-Sheng Cheng</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yi-Sheng Cheng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Life Science, Institute of Plant Biology, and Genome and Systems Biology Degree Program, National Taiwan University, Taipei 10617, Taiwan</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#98fbf0fdf6ffe1ebd8f6ecedb6fdfcedb6ecef"><span class="__cf_email__" data-cfemail="412229242f263832012f35346f2425346f3536">[email protected]</span></a> (Y.-S.C.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yi-Sheng++Cheng">Yi-Sheng Cheng</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Ji-Wang Chern</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ji-Wang Chern</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, College of Medicine,  Center for Innovative Therapeutics Discovery, National Taiwan University, Taipei 10607, Taiwan</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#1a706d79727f68745a746e6f347f7e6f346e6d"><span class="__cf_email__" data-cfemail="deb4a9bdb6bbacb09eb0aaabf0bbbaabf0aaa9">[email protected]</span></a> (J.-W.C.).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ji-Wang++Chern">Ji-Wang Chern</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4310-8834" title="Orcid link">http://orcid.org/0000-0002-4310-8834</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01590&amp;href=/doi/10.1021%2Facs.jmedchem.8b01590" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 2</span><span class="cit-pageRange">, 857–874</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 10, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 October 2018</li><li><span class="item_label"><b>Published</b> online</span>10 December 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 January 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01590" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01590</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D857%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChao-Wu%2BYu%252C%2BPei-Yun%2BHung%252C%2BHui-Ting%2BYang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D2%26contentID%3Dacs.jmedchem.8b01590%26title%3DQuinazolin-2%252C4-dione-Based%2BHydroxamic%2BAcids%2Bas%2BSelective%2BHistone%2BDeacetylase-6%2BInhibitors%2Bfor%2BTreatment%2Bof%2BNon-Small%2BCell%2BLung%2BCancer%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D874%26publicationDate%3DJanuary%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01590"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1886</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">12</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01590" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Quinazolin-2,4-dione-Based Hydroxamic Acids as Selective Histone Deacetylase-6 Inhibitors for Treatment of Non-Small Cell Lung Cancer&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Chao-Wu&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Pei-Yun&quot;,&quot;last_name&quot;:&quot;Hung&quot;},{&quot;first_name&quot;:&quot;Hui-Ting&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Yi-Hsun&quot;,&quot;last_name&quot;:&quot;Ho&quot;},{&quot;first_name&quot;:&quot;Hsing-Yi&quot;,&quot;last_name&quot;:&quot;Lai&quot;},{&quot;first_name&quot;:&quot;Yi-Sheng&quot;,&quot;last_name&quot;:&quot;Cheng&quot;},{&quot;first_name&quot;:&quot;Ji-Wang&quot;,&quot;last_name&quot;:&quot;Chern&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;857-874&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01590&quot;},&quot;abstract&quot;:&quot;We designed and synthesized quinazolin-2,4-dione-based hydroxamic acids to serve as selective competitive inhibitors of histone deacetylase-6 (HDAC6). The most potent and selective compound, 3d (IC50, 4 nM, HDAC6; IC50 &gt; 10 μM, HDAC1), substantially increased acetylation of α-tubulin instead of histones in the lung cancer cell line, LL2. Paclitaxel in combination with 3d had a synergistic anticancer effect on reduction of programmed death-ligand 1 expression in LL/2 cells. When given orally, 3d was mainly found to locate in the liver and lungs, at a concentration 18- to 70-fold greater, respectively, than in plasma. As an orally active HDAC6 inhibitor, 3d (20 mg/kg) potentiated paclitaxel antitumor activity (percentage tumor growth inhibition, 67.5%) in a xenograft syngeneic non-small cell lung cancer mouse model.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01590&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01590" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01590&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01590" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01590&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01590" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01590&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01590&amp;href=/doi/10.1021/acs.jmedchem.8b01590" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01590" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01590" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01590%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DYu%26date%3D2019%26atitle%3DQuinazolin-2%252C4-dione-Based%2BHydroxamic%2BAcids%2Bas%2BSelective%2BHistone%2BDeacetylase-6%2BInhibitors%2Bfor%2BTreatment%2Bof%2BNon-Small%2BCell%2BLung%2BCancer%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D2%26spage%3D857%26epage%3D874%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/2" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/jmcmar.2019.62.issue-2/20190124/jmcmar.2019.62.issue-2.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We designed and synthesized quinazolin-2,4-dione-based hydroxamic acids to serve as selective competitive inhibitors of histone deacetylase-6 (HDAC6). The most potent and selective compound, <b>3d</b> (IC<sub>50</sub>, 4 nM, HDAC6; IC<sub>50</sub> > 10 μM, HDAC1), substantially increased acetylation of α-tubulin instead of histones in the lung cancer cell line, LL2. Paclitaxel in combination with <b>3d</b> had a synergistic anticancer effect on reduction of programmed death-ligand 1 expression in LL/2 cells. When given orally, <b>3d</b> was mainly found to locate in the liver and lungs, at a concentration 18- to 70-fold greater, respectively, than in plasma. As an orally active HDAC6 inhibitor, <b>3d</b> (20 mg/kg) potentiated paclitaxel antitumor activity (percentage tumor growth inhibition, 67.5%) in a xenograft syngeneic non-small cell lung cancer mouse model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span></span> Note</h4><p class="last">This paper was published ASAP on December 20, 2018, with an error in Figure 12. The corrected version was reposted December 24, 2018.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23580" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23580" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Histone deacetylase-6 (HDAC6) is the most studied member of the HDAC family, but, unlike what its name implies, HDAC6 deacetylates α-tubulin, HSP90, cortactin, and peroxiredoxin, and not histones.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> A HDAC6 knockout mouse develops normally with no obvious phenotype aberrations, whereas other types of HDAC knockout mice display severe defects.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Consequently, inhibitors of HDAC6 have been proposed to be more appropriate targets for drug development because the pan-HDAC inhibitors that have been developed to date have proven to possess undesirable side effects.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> Compounds that inhibit HDAC6 have been shown to decrease the negative effects associated with disease models including autoimmune disorders, Alzheimer’s disease, and cancer.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6−8)</a></div><div class="NLM_p">Selective positive effects on HDAC6 by siRNA or HDAC6 inhibitors include inhibition of tumorigenesis, inhibition of metastasis, and increased sensitivity of tumors to other anticancer agents.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9−11)</a> Several inhibitors selective for HDAC6 have been developed to treat cancers including an inhibitor that bears a substituted urea linker with antimelanoma activity.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Another inhibitor, ACY-1215, is being tested clinically in combination with bortezomib, a proteasome inhibitor, for multiple myeloma.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In addition, data have accumulated suggesting that prostate cancer may be treated with the HDAC6 inhibitor, tubacin, alone or in combination with a cytotoxic agent.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Although LBH589 is a pan-HDAC inhibitor, it is therapeutically responsive to LNCap and PC-3 prostate cancer cells by inhibiting HDAC6.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> HDAC6, as a microtubule deacetylase, is crucial to the regulation of epidermal growth factor receptor (EGFR) trafficking and EGFR degradation in lung cancer cells.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Combined treatment of ACY-1215 and sorafenib, a tyrosine kinase inhibitor, overcomes HDAC6-mediated resistance in non-small cell lung cancer cells.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Remarkably, Nexturastat A, a potent inhibitor of HDAC6 having an immunotherapeutic activity, downregulated protein programmed death-ligand 1 (PD-L1) expression by deactivating the STAT3 pathway.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> These studies highlight how HDAC6 inhibitors can regulate multiple pathways involved in carcinogenesis, tumor growth, and metastases.</div><div class="NLM_p">We have reported a series of quinazolin-4-one-based inhibitors selective for HDAC6.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> For the study reported herein, we designed and synthesized a new set of quinazoline-2,4-dione-based HDAC6 inhibitors with scaffold hopping of substituents on our previously developed quinazoline-4-one derivatives (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). The hydroxamic acid and benzyl groups in the previously constructed derivatives maintained their original positions as a zinc-binding group and a linker, respectively. The benzyl-containing linker was moved to the <i>N</i>-1 position of the quinazoline-2,4-dione core, which is a more central location. In addition, the phenyl rings of the quinazoline-2,4-dione core were substituted, one at a time, with various functional groups to explore the HDAC inhibitory profiles of the resultant compounds. Selected compounds, which showed a good inhibitory activity, were then tested for cytotoxicity against lung cancer cells.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of HDAC6-selective inhibitors by scaffold hopping.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33430" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33430" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemistry</h3><div class="NLM_p">The syntheses of <b>3a</b>–<b>c</b> began with the substituted anthranilic acids <b>1a</b>–<b>c</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Compounds <b>1a</b>–<b>c</b> were first coupled with phenyl chloroformate; then, amide was coupled with phenethylamine and cyclized under basic conditions to afford the intermediates <b>2a</b>–<b>c</b>, which were alkylated with ethyl 4-(bromomethyl)benzoate using NaH in an ice bath to obtain the corresponding ester intermediates. These esters were transformed into hydroxamic acids via hydrolysis, amide coupling, and reductive deprotection (<b>3c</b>) or via deprotection by BBr<sub>3</sub> (<b>3a</b> and <b>3b</b>). The synthesis of <b>3d</b> and <b>3f</b> began with a ring opening of isatoic anhydride with a phenethylamine at the C-4 position. Then, the product was coupled with phenyl chloroformate and cyclized under basic conditions to obtain <b>2d</b>, which was then alkylated with ethyl 4-(bromomethyl)benzoate or ethyl 3-(bromomethyl)benzoate to afford the corresponding esters. These esters were transformed into the hydroxamic acid derivatives <b>3d</b> and <b>3f</b>. 3-Methoxy aniline was coupled with phenyl chloroformate and then transformed into the disubstituted urea, which was ortho-carbonylated through palladium-catalyzed C–H activation<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and cyclized under basic conditions to afford <b>2e</b>. Compound <b>3e</b> was synthesized from <b>2e</b> in a similar way as mentioned above.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Syntheses of Compounds <b>3a</b>–<b>3h</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) PhOCOCl, 1 N NaOH, dioxane, ice bath, 1 h; (b) EDCI, HOBt, PhCH<sub>2</sub>CH<sub>2</sub>NH<sub>2</sub>, DMF, rt, 4.5 h; (c) TEA, DMF, μW 150 W, 20 min; (d) PhCH<sub>2</sub>CH<sub>2</sub>NH<sub>2</sub>, TEA, DMF/MeOH (1:1), μW 100 W, 20 min; (e) Pd(MeCN)<sub>2</sub>(OTf)<sub>2</sub>, BQ, <i>p</i>-TSA·H<sub>2</sub>O, CO (1 atm), THF/MeOH (1:1), rt, 5 h; (f) NaOH (2 N), THF, 80 °C, 2 h; (g) PhCH<sub>2</sub>CH<sub>2</sub>NH<sub>2</sub>, DMAC, μW 250 W, reflux, 6 min; (h) EtOCOCl, THF, reflux, 3.5 h; (i) NaOH (2 N), EtOH, 100 °C, 1 h; (j) (i) NaH, DMF, ice bath, 1.5 h and (ii) 4-COOEtC<sub>6</sub>H<sub>4</sub>CH<sub>2</sub>Br or 3-COOEtC<sub>6</sub>H<sub>4</sub>CH<sub>2</sub>Br, 15 h; (k) LiOH (2.5 N), THF/MeOH (5:1), rt, 4 h; (l) NH<sub>2</sub>OBn·HCl, EDCI, HOBt, TEA, DMF, 4 h; (m) Pd/C, (10% w/w), H<sub>2</sub> (1 atm), MeOH/THF (3:1), rt, 5 h; and (n) BBr<sub>3</sub> (1 M in DCM), DCM, ice bath 1 h.</p></p></figure><div class="NLM_p">In addition, we individually modified positions 6 and 7 of the quinazolin-di-one or replaced the phenyl group with a pyridine of the quinazolin-di-one core (<a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, respectively). Compounds <b>1d</b>, <b>1e</b>, and <b>1f</b> were each coupled with phenethylamine and then cyclized with ethyl chloroformate under basic conditions to give <b>2f</b>, <b>2g</b>, and <b>2h</b>, respectively. These intermediates were then subjected to conditions similar to those shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> to afford <b>3g</b>, <b>3h</b>, and <b>3i</b>, respectively.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>3i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) PhCH<sub>2</sub>CH<sub>2</sub>NH<sub>2</sub>, EDCI, HOBt, DMF, rt, 4.5 h; (b) EtOCOCl, THF, reflux 3.5 h; (c) NaOH (2 N), EtOH, 100 °C, 1 h; (d) (i) NaH, DMF, ice bath, 1.5 h; (ii) 4-COOEtC<sub>6</sub>H<sub>4</sub>CH<sub>2</sub>Br, 15 h; (e) LiOH (2.5 N), THF/MeOH (5:1), rt, 4 h; (f) NH<sub>2</sub>OBn·HCl, EDCI, HOBt, TEA, DMF, 4 h; and (g) Pd/C, (10% w/w), H<sub>2</sub> (1 atm), MeOH/THF (3:1), rt, 5 h.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Syntheses of Compounds <b>3j</b>–<b>3l</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) NaH, DMF, ice bath, 1.5 h and (ii) 4-COOEtC<sub>6</sub>H<sub>4</sub>CH<sub>2</sub>Br, 15 h; (b) Pd(OAc)<sub>2</sub>, XPhos, Cs<sub>2</sub>CO<sub>3</sub>, DMF/H<sub>2</sub>O (10:1), μW, reflux, 30 min; (c) (CH<sub>3</sub>)<sub>2</sub>Zn, Pd<sub>2</sub>(dba)<sub>3</sub>, [(<i>t</i>-Bu)<sub>3</sub>PH]BF<sub>4</sub>, THF, μW, 120 °C, 30 min; (d) (CH<sub>2</sub>)<sub>2</sub>CHBF<sub>3</sub>K, Pd(OAc)<sub>2</sub>, XPhos, Cs<sub>2</sub>CO<sub>3</sub>, THF/H<sub>2</sub>O (10:1), 80 °C, 24 h; (e) LiOH (2.5 N), THF/MeOH (5:1), rt, 4 h; (f) NH<sub>2</sub>OBn·HCl, EDCI, HOBt, TEA, DMF, 4 h; and (g) Pd/C, (10% w/w), H<sub>2</sub> (1 atm), MeOH/THF (3:1), rt, 5–8 h.</p></p></figure><div class="NLM_p">Intermediate <b>2b</b> was alkylated with ethyl 4-(bromomethyl)benzoate to give the ester <b>4</b>. The chloro group of <b>4</b> was converted into a hydroxyl, methyl, or cyclopropyl by palladium catalysis under Buchwald–Hartwig condition, Negishi, or Suzuki reaction to afford <b>5a</b>, <b>5b</b>, or <b>5c</b>, respectively,<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a> and these derivatives were then converted into the hydroxamic acids <b>3j</b>, <b>3k</b>, or <b>3l</b>, respectively (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><div class="NLM_p">To explore the structure–activity relationship of substituents on the phenyl ring of the phenethyl group, the fluoro or methoxy-substituted compounds <b>3m</b>–<b>3r</b> were synthesized under conditions similar to those of <b>3d</b> and <b>3a</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). The phenyl group of the linker or cap was also replaced with thiophene to generate <b>3s</b>, <b>3t</b>, or <b>3u</b>, respectively (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). The benzyl group was removed by BBr<sub>3</sub> as the final step because a Pd-catalyzed reduction did not give the desired product and might have been caused by thiophene poisoning.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Syntheses of Compounds <b>3m</b>–<b>3r</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) PhCH<sub>2</sub>CH<sub>2</sub>NH<sub>2</sub>, DMAC, μW 250 W, reflux, 6 min; (b) EtOCOCl, THF, reflux 3.5 h; (c) NaOH (2 N), EtOH, 100 °C, 1 h; (d) (i) NaH, DMF, ice bath, 1.5 h and (ii) 4-COOEtC<sub>6</sub>H<sub>4</sub>CH<sub>2</sub>Br, 15 h; (e) LiOH (2.5 N), THF/MeOH (5:1), rt, 4 h; (f) NH<sub>2</sub>OBn·HCl, EDCI, HOBt, TEA, DMF, 4 h; (g) Pd/C, (10% w/w), H<sub>2</sub> (1 atm), MeOH/THF (3:1), rt, 5 h; and (h) BBr<sub>3</sub> (1 M in DCM), DCM, ice bath 1 h.</p></p></figure><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Syntheses of Compounds <b>3s</b>–<b>3u</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) NaH, DMF, ice bath, 0.5 h and (ii) methyl 5-(bromomethyl)thiophene-2-carboxylate or methyl 4-(bromomethyl)thiophene-2-carboxylate or 4-COOEtCH<sub>6</sub>H<sub>4</sub>CH<sub>2</sub>Br, 5 h; (b) LiOH (2.5 N), THF/MeOH (5:1), rt, 4 h; (c) NH<sub>2</sub>OBn·HCl, EDCI, HOBt, TEA, DMF, 4 h; (d) BBr<sub>3</sub> (1 M in DCM), DCM, ice bath 1 h; (e) PhOCOCl, THF, μW, 200 W, reflux, 10 min; (f) PhCH<sub>2</sub>CH<sub>2</sub>NH<sub>2</sub>, TEA, MeOH, μW 100 W, 10 min; and (g) NaOH (2 N), EtOH, 100 °C, 8 h.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> HDAC Inhibition Profile</h3><div class="NLM_p">We first screened the compounds that contained substitutions on the phenyl of the quinazolin-di-one core (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Compound <b>3d</b>, with a nonfunctionalized quinazolin-di-one core, was the best inhibitor of HDAC6 (4 nM) and had the most selectivity over HDAC1 (2790-fold). Introduction of a chloro (<b>3a</b>) or fluoro (<b>3g</b>) at the C-6 position was detrimental to HDAC6 inhibition. Compared with <b>3g</b>, shifting the fluoro to C-7, which afforded <b>3c</b>, significantly increased the inhibition of HDAC6 and HDAC8. However, the enlargement of the C-7 group in <b>3e</b>, <b>3h</b>, <b>3k</b>, and <b>3l</b> did not improve HDAC6 inhibitory activity. Regarding the electronic effect, the electron-withdrawing group in <b>3h</b> substantially reduced HDAC6 inhibition to 636 nM and selectivity over HDAC1 (13-fold) compared with the electron-donating substituents in <b>3e</b> and <b>3j</b>. Compounds <b>3k</b> and <b>3l</b>, containing a methyl and a cyclopropyl, respectively, had generally comparable HDAC-inhibition profiles. The data shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> indicated that the core size of the quinazolinone cap determined if it could properly be accommodated at the rim of the HDAC6 active site, with an increase in bulkiness being harmful for HDAC6 inhibition. Consequently, <b>3d</b> was used as the lead compound for further modification.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. HDAC-Inhibition Profiles of <b>3a</b>–<b>3e</b>, <b>3g</b>, <b>3h</b>, and <b>3j</b>–<b>3l</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0018.gif" alt="" id="GRAPHIC-d7e893-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">HDAC inhibition, IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Cpd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">HDAC1</th><th class="colsep0 rowsep0" align="center">HDAC6</th><th class="colsep0 rowsep0" align="center">HDAC8</th><th class="colsep0 rowsep0" align="center">HDAC11</th><th class="colsep0 rowsep0" align="center">selectivity, HDAC1/HDAC6</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3a</b></td><td class="colsep0 rowsep0" align="left">6-Cl</td><td class="colsep0 rowsep0" align="left">18 860</td><td class="colsep0 rowsep0" align="left">35</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">539</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3b</b></td><td class="colsep0 rowsep0" align="left">7-Cl</td><td class="colsep0 rowsep0" align="left">9540</td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">1640</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">434</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3c</b></td><td class="colsep0 rowsep0" align="left">7-F</td><td class="colsep0 rowsep0" align="left">9410</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">95</td><td class="colsep0 rowsep0" align="left">15 400</td><td class="colsep0 rowsep0" align="left">1176</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">11 160</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">309</td><td class="colsep0 rowsep0" align="left">13 900</td><td class="colsep0 rowsep0" align="left">2790</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3e</b></td><td class="colsep0 rowsep0" align="left">7-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">12 000</td><td class="colsep0 rowsep0" align="left">51</td><td class="colsep0 rowsep0" align="left">731</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">235</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3g</b></td><td class="colsep0 rowsep0" align="left">6-F</td><td class="colsep0 rowsep0" align="left">13 410</td><td class="colsep0 rowsep0" align="left">57</td><td class="colsep0 rowsep0" align="left">1155</td><td class="colsep0 rowsep0" align="left">16 740</td><td class="colsep0 rowsep0" align="left">235</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3h</b></td><td class="colsep0 rowsep0" align="left">7-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">8021</td><td class="colsep0 rowsep0" align="left">636</td><td class="colsep0 rowsep0" align="left">1442</td><td class="colsep0 rowsep0" align="left">7392</td><td class="colsep0 rowsep0" align="left">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3j</b></td><td class="colsep0 rowsep0" align="left">7-OH</td><td class="colsep0 rowsep0" align="left">8275</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">2751</td><td class="colsep0 rowsep0" align="left">5501</td><td class="colsep0 rowsep0" align="left">259</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3k</b></td><td class="colsep0 rowsep0" align="left">7-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">10 870</td><td class="colsep0 rowsep0" align="left">170</td><td class="colsep0 rowsep0" align="left">2521</td><td class="colsep0 rowsep0" align="left">52 050</td><td class="colsep0 rowsep0" align="left">64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3l</b></td><td class="colsep0 rowsep0" align="left">7-CH(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">14 500</td><td class="colsep0 rowsep0" align="left">168</td><td class="colsep0 rowsep0" align="left">3060</td><td class="colsep0 rowsep0" align="left">10 500</td><td class="colsep0 rowsep0" align="left">86</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">The assays were conducted by the Reaction Biology Corporation, Malvern, PA. Compounds were tested in the 10-dose IC<sub>50</sub> mode with threefold serial dilutions starting at 30 μM.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">ND, not determined.</p></div></div></div><div class="NLM_p">We next synthesized <b>3m</b>–<b>3r</b> to examine how substituents on the phenyl ring of the phenethyl group affected the activity (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Introduction of fluoro at the para (<b>3m</b>) or meta (<b>3n</b>) position did not increase potency or selectivity. Adding a methoxy group at the para (<b>3o</b>) or ortho (<b>3p</b>) position also did not improve activity. However, substitutions at the C-7-position more negatively affected potency and selectivity. We assumed that the flexible phenethyl appendage might protrude into the solvent away from the HDAC6 active site. Compound <b>3q</b>, with a para hydroxyl group, was more selective for HDAC6 compared with HDAC1 (1816-fold) and HDAC8 (169-fold).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. HDAC-Inhibition Profiles of <b>3d</b> and <b>3m</b>–<b>3q</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0019.gif" alt="" id="GRAPHIC-d7e1250-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">HDAC inhibition, IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Cpd</th><th class="colsep0 rowsep0" align="center">R′</th><th class="colsep0 rowsep0" align="center">HDAC1</th><th class="colsep0 rowsep0" align="center">HDAC6</th><th class="colsep0 rowsep0" align="center">HDAC8</th><th class="colsep0 rowsep0" align="center">HDAC11</th><th class="colsep0 rowsep0" align="center">selectivity, HDAC1/HDAC6</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">11 160</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">309</td><td class="colsep0 rowsep0" align="left">13 900</td><td class="colsep0 rowsep0" align="left">2790</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3m</b></td><td class="colsep0 rowsep0" align="left"><i>p</i>-F</td><td class="colsep0 rowsep0" align="left">10 810</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">1049</td><td class="colsep0 rowsep0" align="left">14 730</td><td class="colsep0 rowsep0" align="left">470</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3n</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>-F</td><td class="colsep0 rowsep0" align="left">13 170</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">429</td><td class="colsep0 rowsep0" align="left">10 660</td><td class="colsep0 rowsep0" align="left">1317</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3o</b></td><td class="colsep0 rowsep0" align="left"><i>p</i>-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">7374</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">1150</td><td class="colsep0 rowsep0" align="left">13 850</td><td class="colsep0 rowsep0" align="left">369</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3p</b></td><td class="colsep0 rowsep0" align="left"><i>o</i>-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">10 430</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">525</td><td class="colsep0 rowsep0" align="left">34 370</td><td class="colsep0 rowsep0" align="left">869</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3q</b></td><td class="colsep0 rowsep0" align="left"><i>p</i>-OH</td><td class="colsep0 rowsep0" align="left">9080</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">845</td><td class="colsep0 rowsep0" align="left">11 290</td><td class="colsep0 rowsep0" align="left">1816</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3r</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">12 700</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">1760</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">529</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">The assays were conducted by the Reaction Biology Corporation, Malvern, PA. Compounds were tested in 10-dose IC<sub>50</sub> mode with threefold serial dilutions starting at 30 μM.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">ND, not determined.</p></div></div></div><div class="NLM_p">In addition to SAR on the phenyl group, the orientation of the zinc binding group and the introduction of heterocycles on <b>3d</b> was further investigated (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). First, we moved the hydroxamic acid group from the para position to the meta position of the phenyl to give <b>3f</b>. Intriguingly, the meta-oriented hydroxamic acid abolished the inhibition of HDAC6 inhibition and gave an inhibition profile slightly selective for HDAC8, which suggested that the catalytic site of HDAC6 is not as flexible as that of HDAC8 and does not allow for a conformational change.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Second, replacing the phenyl ring of the core structure with a pyridine to produced <b>3i</b> reduced the activity toward HDAC6 around sevenfold but did not affect the activity against HDAC1. However, <b>3u</b> with a thiophene ring strengthens its interaction with HDAC8 compared to <b>3i</b>. Finally, by replacing the phenyl linker with 2,4-disubstituted thiophene to give <b>3t</b> which possesses a similar inhibitory profile as <b>3f</b>, that might be because of their comparable orientation of hydroxamic acid group. Remarkably, <b>3s</b> with 2,5-disubstituted thiophene linker reduced the selectivity for HDAC6 over HDAC1 and HDAC8 (1147- and ∼fivefold, respectively) provided a dual HDAC6/8 inhibitor.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. HDAC-Inhibition Profiles of <b>3d</b>, <b>3f</b>, <b>3i</b>, and <b>3r</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0020.gif" alt="" id="GRAPHIC-d7e1550-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">HDAC inhibition, IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Cpd</th><th class="colsep0 rowsep0" align="center">HDAC1</th><th class="colsep0 rowsep0" align="center">HDAC6</th><th class="colsep0 rowsep0" align="center">HDAC8</th><th class="colsep0 rowsep0" align="center">HDAC11</th><th class="colsep0 rowsep0" align="center">selectivity, HDAC1/HDAC6</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3d</b></td><td class="colsep0 rowsep0" align="left">11 160</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">309</td><td class="colsep0 rowsep0" align="left">13 900</td><td class="colsep0 rowsep0" align="left">2790</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3f</b></td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">4630</td><td class="colsep0 rowsep0" align="left">653</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">>2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3i</b></td><td class="colsep0 rowsep0" align="left">11 150</td><td class="colsep0 rowsep0" align="left">29</td><td class="colsep0 rowsep0" align="left">1068</td><td class="colsep0 rowsep0" align="left">25 050</td><td class="colsep0 rowsep0" align="left">384</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3s</b></td><td class="colsep0 rowsep0" align="left">22 940</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">97</td><td class="colsep0 rowsep0" align="left">19 800</td><td class="colsep0 rowsep0" align="left">1147</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3t</b></td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">1194</td><td class="colsep0 rowsep0" align="left">1191</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">>8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3u</b></td><td class="colsep0 rowsep0" align="left">6655</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">169</td><td class="colsep0 rowsep0" align="left">5686</td><td class="colsep0 rowsep0" align="left">443</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">The assays were conducted by the Reaction Biology Corporation, Malvern, PA. Compounds were tested in the 10-dose IC<sub>50</sub> mode with threefold serial dilutions starting at 30 μM.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> HDAC6 Kinetic Activity Study</h3><div class="NLM_p">To delineate the interaction between some of our synthesized compounds and HDAC6, the enzymatic activity of HDAC6 was measured in the presence of a substrate at different concentrations and with different concentrations of the inhibitors. In addition to full-length HDAC6, the activity of the catalytic domain 2 (CD2) from HDAC6 was studied (CD1 does not have catalytic active).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The <i>K</i><sub>i</sub> values of the potential inhibitors were similar to that of tubastatin A, with <b>3d</b> being the most potent (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). The inhibition data were consistent with a competitive inhibition model for full-length HDAC6 and for CD2. The <i>v</i> values for CD2 were ∼50% those of full-length HDAC6 for all inhibitors. The <i>K</i><sub>m</sub> values for the substrate were of the same order of magnitude as were the <i>K</i><sub>i</sub> values for the quinazolinone derivatives.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. HDAC6 and CD2 Kinetic Parameters in the Presence of <b>3d</b>, <b>3i</b>, and <b>3p</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Cpd</th><th class="colsep0 rowsep0" align="center">enzyme</th><th class="colsep0 rowsep0" align="center" char="±"><i>v</i> (μM·s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="±"><i>K</i><sub>m</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="±"><i>K</i><sub>i</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3d</b></td><td class="colsep0 rowsep0" align="left">full-length HDAC6</td><td class="colsep0 rowsep0" align="char" char="±">0.70 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">16.7 ± 1.20</td><td class="colsep0 rowsep0" align="char" char="±">1.60 ± 0.40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3i</b></td><td class="colsep0 rowsep0" align="left">full-length HDAC6</td><td class="colsep0 rowsep0" align="char" char="±">0.77 ± 0.42</td><td class="colsep0 rowsep0" align="char" char="±">21.8 ± 8.30</td><td class="colsep0 rowsep0" align="char" char="±">3.89 ± 1.64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3p</b></td><td class="colsep0 rowsep0" align="left">full-length HDAC6</td><td class="colsep0 rowsep0" align="char" char="±">1.19 ± 0.22</td><td class="colsep0 rowsep0" align="char" char="±">34.6 ± 4.20</td><td class="colsep0 rowsep0" align="char" char="±">2.10 ± 0.44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tubastatin A</td><td class="colsep0 rowsep0" align="left">full-length HDAC6</td><td class="colsep0 rowsep0" align="char" char="±">1.04 ± 0.35</td><td class="colsep0 rowsep0" align="char" char="±">29.1 ± 16.4</td><td class="colsep0 rowsep0" align="char" char="±">3.43 ± 1.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3d</b></td><td class="colsep0 rowsep0" align="left">CD2</td><td class="colsep0 rowsep0" align="char" char="±">0.45 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">29.8 ± 5.50</td><td class="colsep0 rowsep0" align="char" char="±">3.70 ± 0.50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3i</b></td><td class="colsep0 rowsep0" align="left">CD2</td><td class="colsep0 rowsep0" align="char" char="±">0.43 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">35.3 ± 5.00</td><td class="colsep0 rowsep0" align="char" char="±">4.50 ± 0.50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3p</b></td><td class="colsep0 rowsep0" align="left">CD2</td><td class="colsep0 rowsep0" align="char" char="±">0.45 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">32.5 ± 8.60</td><td class="colsep0 rowsep0" align="char" char="±">2.60 ± 0.50</td></tr></tbody></table></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> More Potent Inhibitors of Recombinant HDAC6 also Decreased Lung Cancer Cell Viability in Vitro</h3><div class="NLM_p">A 3-(4,5-cimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay was used to characterize the cytotoxicities and IC<sub>50</sub> values of some of the HDAC6-selective inhibitors (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Human lung cancer A549 cells were treated with serial dilutions of the HDAC6 inhibitors at 37 °C for 72 h. Compound <b>3i</b> had the greatest activity against the cells with an IC<sub>50</sub> value of 2.8 μM. Although, the cytotoxicities of the HDAC6 inhibitors were not as potent as that of the pan-HDAC inhibitor, suberanilohydroxamic acid (SAHA), it showed better safety without severe adverse effects than pan-HDAC inhibitors.<a onclick="showRef(event, 'ref12 ref22'); return false;" href="javascript:void(0);" class="ref ref12 ref22">(12,22)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Cytotoxicities of (IC<sub>50</sub>) of Selected Potential and Known HDAC6 Inhibitors Against A549 Lung Cancer Cells</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Cpd</th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50</sub><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3c</b></td><td class="colsep0 rowsep0" align="char" char="±">3.92 ± 0.61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3d</b></td><td class="colsep0 rowsep0" align="char" char="±">7.87 ± 0.70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3g</b></td><td class="colsep0 rowsep0" align="char" char="±">12.19 ± 0.39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3i</b></td><td class="colsep0 rowsep0" align="char" char="±">2.84 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3m</b></td><td class="colsep0 rowsep0" align="char" char="±">3.65 ± 0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3p</b></td><td class="colsep0 rowsep0" align="char" char="±">11.78 ± 0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3r</b></td><td class="colsep0 rowsep0" align="char" char="±">6.03 ± 0.43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3s</b></td><td class="colsep0 rowsep0" align="char" char="±">13.5 ± 0.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SAHA</td><td class="colsep0 rowsep0" align="char" char="±">2.24 ± 0.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ACY1215</td><td class="colsep0 rowsep0" align="char" char="±">7.7 ± 0.12</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">The IC<sub>50</sub> values were the concentrations of the compounds that had a 50% cytotoxic effect on the A549 cells.</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Combined Cytotoxic Effect of Paclitaxel and <b>3d</b> on Cultured Mouse Lung Cancer LL/2 Cells</h3><div class="NLM_p">As described above, our data indicated that the HDAC6-selective inhibitors potentially had a useful anti-lung cancer activity. To analyze the combined effect of paclitaxel (PAX) and <b>3d</b>, we employed the MTT assay for cell viability. Because the IC<sub>50</sub> values for PAX and <b>3d</b> were 10 nM and 7.87 μM, respectively, we performed the combination experiments with 10 nM PAX and 4 μM of <b>3d</b>. Compound <b>3d</b> (4 μM) or PAX (10 nM) when used separately killed between 10 and 20% of the LL/2 cells by day 3, whereas when used together, they killed 80–90% of the cells by day 3. To assess the combined efficacies of <b>3d</b> or <b>3r</b> with PAX, LL/2 cells were treated with <b>3d</b> or <b>3r</b> separately and in combination with PAX for 3 days. The combined treatment of PAX and <b>3d</b> or <b>3r</b> resulted in a significantly greater inhibition of LL/2 cell viability when compared with the treatment of either inhibitor alone (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B,C). Further, increasing concentrations of <b>3d</b> (0–10 μM) and PAX were cultured in LL/2 cells for 72 h, and the viability was analyzed by MTT to determinate the combination effect. When <b>3d</b> was combined with PAX, the IC<sub>50</sub> of <b>3d</b> and PAX in LL/2 cells was found to decrease significantly. Synergism was evaluated by Chou–Talalay method and showed the combination index (CI) < 1.0 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>D). Taken together, the data show that the selective HDAC6 inhibitor, <b>3d</b> and <b>3r</b> in combination with PAX, had a synergistic effect on the viability of LL/2 cells.</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Combined treatment of <b>3d</b> or <b>3r</b> and PAX reduced LL/2 cell viability. (A) LL/2 cells were incubated with <b>3d</b> (4 μM) and/or PAX (10 nM) for 3 days after which the relative number of viable cells were determined by the MTT assay. (B) LL/2 cells were exposed to <b>3d</b> or PAX for up to 3 days, and the relative number of viable cells were determined by the MTT assay. (C) At the end of the 3 day period, the cells were fixed with formaldehyde and then stained with 0.02% (w/v) crystal violet. (D) LL/2 cells were treated with PAX in the presence or absence of <b>3d</b> at different concentrations (0–10 μM) for 72 h, and the cytotoxicity was assayed by MTT. The isobologram analysis confirms the synergistic effect.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Selective HDAC6 Inhibitor, <b>3d</b>, Increased α-Tubulin Acetylation</h3><div class="NLM_p">To further confirm the specific inhibitory effect of <b>3d</b> on HDAC6 activity, acetylation of α-tubulin in the human lung cancer cell, A549, was accessed. A dose-dependent increase in α-tubulin acetylation was observed when the cells were treated with <b>3d</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). Besides <b>3d</b>, another HDAC6 selective inhibitor, ACY1215, was also analyzed. In addition, <b>3d</b> also increased α-tubulin acetylation in a time-dependent manner (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). A substantial increase in α-tubulin acetylation was seen when the cells were treated with compound <b>3d</b> for only 1 h. Conversely, <b>3d</b> had no effect on the acetylation of histone H3 and histone H4, which suggested that it is a selective HDAC6 inhibitor.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>3d</b> increased α-tubulin acetylation in the human lung cancer cell line, A549. (A) Cells were treated with the indicated concentrations of <b>3d</b> or ACY-1215 for 24 h, and the expression of acetylated α-tubulin (Ac-tubulin) was assessed by Western blotting. (B) Cells were treated with 1 μM of <b>3d</b> for different periods of time, and the expression of Ac-tubulin was assessed by Western blotting. Ctrl, control. The intensities of each bands were calculated with Image J.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Combination Treatment of <b>3d</b> and PAX Enhanced α-Tubulin Acetylation</h3><div class="NLM_p">Because previous studies indicated that <b>3d</b> and PAX induced α-tubulin acetylation, we investigated the effects of <b>3d</b> and PAX alone and when combined on the microtubule system in LL/2 cells. Little tubulin acetylation was observed when the cells were treated separately with 10 nM PAX or 0.8 μM <b>3d</b> as α-tubulin acetylation was increased only 7.28- and 42.66-fold, respectively, in comparison with the control. However, α-tubulin acetylation was increased to 74.72-fold when the cell was treated with both PAX and 0.8 μM <b>3d</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). There is a similar phenomenon that was observed when the cell was treated with the both PAX and 4 μM <b>3d</b>. Our data, therefore, suggested that treatment with <b>3d</b> and PAX had a synergistic effect on the acetylation of α-tubulin in LL/2 cells.</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Combined treatment with <b>3d</b> and PAX enhanced acetylation of α-tubulin in LL/2 cells. The cells were treated with <b>3d</b> and/or PAX for 24 h, and the expression of acetylated-α-tubulin and actin was assessed by Western blotting. The intensities of each bands were calculated with Image J.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Combined Treatment of <b>3d</b> and PAX Increased the Number of Abnormal Nuclei in LL/2 Cells</h3><div class="NLM_p">A relatively small concentration of PAX induces mitotic block at the metaphase/anaphase stage and results in abnormal cell division and formation of multiple nuclei.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> To test whether the combined treatment of <b>3d</b> and PAX had a synergistic effect on aberrant cell division and cell viability, LL/2 cells were treated for 24 h with 10 nM PAX or with 0.8 μM <b>3d</b> alone or in combination, and the morphology of their nuclei was visualized by 4′,6-diamidino-2-phenylindole staining. An increase in the number of multinucleated cells was observed when the cells were treated with <b>3d</b> and PAX (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Combination of <b>3d</b> and PAX induced development of abnormal nuclei in LL/2 cells. LL/2 cells were treated with <b>3d</b> and/or PAX for 24 h prior to fixation. Nuclei were visualized by staining with 4′,6-diamidino-2-phenylindole (blue).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Combined Treatment of <b>3d</b> and PAX Induced a Synergetic Apoptotic Response in A549 and LL/2 Cells</h3><div class="NLM_p">Human and mouse lung cancer cells (A549 and LL/2, respectively) were incubated with indicated concentrations of <b>3d</b> and/or PAX for 24 h (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). The relative proliferation of each cell sample was analyzed daily using the MTT assay. Apoptotic and dead cells were identified by flow cytometry with propidium iodide and annexin V staining. Treatment with 4 μM of <b>3d</b> did not cause apoptosis, and treatment with 10 nM PAX induced apoptosis in 4 and 2.9% of the LL/2 and A549 cells, respectively. However, the combined treatment with 4 μM of <b>3d</b> and 10 nM of PAX induced apoptosis in 8.8 and 5.4% of the LL/2 and A549 cells, respectively. In addition to inducing apoptosis, the combined treatment of <b>3d</b> and PAX also resulted in more dead cells.</div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Combined treatment of <b>3d</b> and PAX synergistically induced apoptosis in A549 and LL/2 cells. The cells were treated for 24 h. The extent of apoptosis in each group of cells was detected using flow cytometry.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Combined Treatment of <b>3d</b> and PAX Decreased PD-L1 Expression</h3><div class="NLM_p">LL/2 cells were incubated with <b>3d</b>, tubastatin A, which is also selective for HDAC6, or the pan-HDAC inhibitor, SAHA for 24 h (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>, top panel). Expression of PD-L1 was then assessed by Western blotting. Tubastatin A and <b>3d</b> inhibited PD-L1 expression, whereas SAHA did not. To determinate the effect of PAX and <b>3d</b> on PD-L1 expression in LL/2 cells, the cells were incubated with <b>3d</b> and/or PAX for 24 h, and PD-L1 levels were determined by Western blotting (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>, lower panel). Interestingly, when the cells were treated with PAX alone, PD-L1 expression increased, suggesting that PAX may be the cause of immune-resistance seen in patients who receive chemotherapy.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Conversely, PD-L1 expression decreased when the cells were treated with PAX and <b>3d</b>, suggesting that <b>3d</b> may decrease PAX-induced PD-L1 expression and thereby avoid inducing immune-resistance and improving the antitumor response.</div><figure id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0010.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>3d</b> decreased PD-L1 expression in LL/2 cells. The cells were treated with <b>3d</b> and/or PAX for 24 h, and then expression of PD-L1 was assessed by Western blotting. Tub A, tubastatin A.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Effects of Combined Treatment of <b>3d</b> and PAX on LL/2 Tumors in an in Vivo Syngeneic Xenograft Mouse Model</h3><div class="NLM_p">Given the promising results of the in vitro experiments reported herein, the combined use of <b>3d</b> and PAX was assessed in an LL/2-tumor syngeneic subcutaneous xenograft C57BL/6 mouse model. Tumor growth in the mice was not inhibited by 20 mg/kg of <b>3d</b> or 10 mg/kg of PAX when the compounds were given singly. However, in combination and at the same doses, PAX and <b>3d</b> decreased tumor growth by 67.5%. In addition, a single dose of 80 or 40 mg/kg of <b>3d</b> showed LL/2 cell tumor growth inhibition (TGI) of 63.4% in the mice, suggesting that <b>3d</b> has an antitumor activity (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).</div><figure id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0011.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Antitumor activity of <b>3d</b> alone or in combination with PAX on LL/2 tumors in [B6 OR C57BL/6] mice. Tumor growth was defined as an increase in tumor volume (TV) (mm<sup>3</sup> = 1/2 × length × width) and measured using a caliper. Percentage TGI was defined as the relationship between the TV of a test group and the control group, using the formula: % TGI = [(TV<sub>control</sub> – TV<sub>treated</sub>)/TV<sub>control</sub>] × 100.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> In Vivo Tissue Distribution of ACY-1215 and <b>3d</b> in Mice</h3><div class="NLM_p">The tissue distribution of <b>3d</b> and ACY-1215 administrated orally to mice was assessed. The concentration of <b>3d</b> in the liver was greater than in any other tissue, including the lung and kidney, however, the concentration of <b>3d</b> in the lung was 18.8-fold greater than in the plasma. Comparing the AUC<sub>0–24</sub> of ACY-1215 with that of <b>3d</b> (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a> and <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>) in mice, the AUC<sub>0–24</sub> of <b>3d</b> was greater than that of ACY-1215 in all organs except for the kidney. The AUC<sub>0–24</sub> ratio of <b>3d</b> to ACY-1215 in the lung was 2.1-fold and 4.4-fold in the liver (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). Even though <b>3d</b> had poor exposure levels in the plasma and decreased dramatically within 24 h after an oral administration, the results informed that <b>3d</b> may tend to distribute into the peripheral tissues instead of staying in the plasma.</div><figure id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0012.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Tissue distribution of ACY-1215 in mice after applying a 40 mg/kg oral gavage (data are the mean ± SE).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig10" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0002.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Tissue distribution of <b>3d</b> in mice after applying a 40 mg/kg oral gavage (data are the mean ± SE).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. AUC<sub>0–24</sub> Values in Various Tissues after a 40 mg/kg Oral Gavage of ACY-1215 or <b>3d</b> in Mice (Data are the Mean ± Standard Error)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">AUC<sub>0–24</sub> (h·ng/g)</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">tissue</th><th class="colsep0 rowsep0" align="center" char="±">ACY-1215</th><th class="colsep0 rowsep0" align="center" char="±"><b>3d</b></th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub><b>3d</b></sub>/AUC<sub>ACY-1215</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="char" char="±">622 ± 131</td><td class="colsep0 rowsep0" align="char" char="±">1335 ± 46</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="char" char="±">1442 ± 368</td><td class="colsep0 rowsep0" align="char" char="±">6395 ± 2974</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kidney</td><td class="colsep0 rowsep0" align="char" char="±">2493 ± 939</td><td class="colsep0 rowsep0" align="char" char="±">1903 ± 844</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="char" char="±">308 ± 86</td><td class="colsep0 rowsep0" align="char" char="±">71 ± 19</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td></tr></tbody></table></div></div></div><div id="sec2_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> In Vivo Metabolism of <b>3d</b></h3><div class="NLM_p">Because the unsubstituted phenyl ring of <b>3d</b> may undergo hydroxylation or the hydroxamic acid may be hydrolyzed into carboxylic acid in vivo, the biological samples after <b>3d</b> orally 40 mg/kg in mice were used to assess the possible metabolites of <b>3d</b>. The hydrolysis metabolite of <b>3d</b> had been measured in various tissues; however, the hydroxylated metabolite could not be found. The concentration of hydrolysis metabolite in every tissue was significantly higher than the parent form, especially the liver, which plays an important role for xenobiotic metabolism (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a> and <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>). The results suggested that a large amount of <b>3d</b> may experience a first-pass metabolism and be biotransformed into hydrolysis form by the hepatic isozymes.</div><figure id="fig11" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0003.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Tissue distribution of <b>3d</b> metabolite in mice after applying a 40 mg/kg oral gavage of <b>3d</b> (data are the mean ± SE).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> In Vivo Tissue Distribution of Combined Treatment of <b>3d</b> and PAX in Mice</h3><div class="NLM_p">The tissue distribution was assessed at 1 h after dosing 40 mg/kg of <b>3d</b> orally combined with or without PAX intraperitoneal injection 10 mg/kg administrated to mice. Compared with single oral dosing, combined treatment increased the concentration of <b>3d</b> in the tissues from 1.6- to 12-fold, except for the liver, at 1 h after dosing (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). This phenomena was also observed in one phase I study of vorinostat. The AUC and half-life of vorinostat in the plasma were increased when coadministered with PAX, but PAX pharmacokinetics was not affected by vorinostat.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><figure id="fig12" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0004.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Tissue distribution of <b>3d</b> in mice after applying a 40 mg/kg oral gavage combined with or without 10 mg/kg intraperitoneal injection of PAX (data are the mean ± SE).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Concentration and Amounts of <b>3d</b> in Various Tissues after a Combined Use of 40 mg/kg Oral Gavage of <b>3d</b> and 10 mg/kg Intraperitoneal Injection of PAX in Mice (Data are the Mean ± Standard Error)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">concentration or amounts of <b>3d</b> (ng/mL for plasma or ng/g for tissues)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">tissue</th><th class="colsep0 rowsep0" align="center" char="±">single</th><th class="colsep0 rowsep0" align="center" char="±">combine</th><th class="colsep0 rowsep0" align="center" char=".">[<i>C</i><sub>combinel</sub>]/[<i>C</i><sub>single</sub>]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="char" char="±">212 ± 106</td><td class="colsep0 rowsep0" align="char" char="±">331 ± 72</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="char" char="±">782 ± 119</td><td class="colsep0 rowsep0" align="char" char="±">719 ± 217</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kidney</td><td class="colsep0 rowsep0" align="char" char="±">130 ± 38</td><td class="colsep0 rowsep0" align="char" char="±">392 ± 56</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="char" char="±">13 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">160 ± 44</td><td class="colsep0 rowsep0" align="char" char=".">12.3</td></tr></tbody></table></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67533" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67533" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We designed and synthesized quinazolin-2,4-dione derivatives to determine if they could act as potent and competitive HDAC6-selective inhibitors. Compound <b>3d</b> (IC<sub>50</sub>, 4 nM; <i>K</i><sub>i</sub>, 1.58 nM) showed the greatest selectivity for HDAC6 compared with that for HDAC1 (2790-fold) among the derivatives. In vitro studies of using <b>3d</b> revealed that it had a modest cytotoxicity against non-small cell lung cancer cells; however, <b>3d</b> in combination with PAX had a synergistically increased anticancer activity. Time-course and dose-dependent Western blot studies demonstrated that <b>3d</b> increased Ac-tubulin within 1 h of treatment in LL/2 cells and with only 1 μM dose. Remarkably, PD-L1 expression in LL/2 cells was also reduced after incubation with <b>3d</b>. Tumor growth in a syngeneic mice model was substantially suppressed by a single oral treatment of <b>3d</b>, and in combination with PAX, its anticancer activity was synergistically increased. As an orally active HDAC6 inhibitor, <b>3d</b> had better penetration in the mouse lung than it did ACY-1215. In summary, this study suggested that the quinazolin-2,4-dione derivative, <b>3d</b>, may be an orally active and safe therapeutic agent for the treatment of non-small cell lung cancer.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70475" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70475" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> General Information for Synthetic Methods</h3><div class="NLM_p last"><sup>1</sup>H and <sup>13</sup>C NMR spectra of the compounds in DMSO-<i>d</i><sub>6</sub> were recorded on a DPX200 or AV400 Bruker spectrometer. Mass spectra were recorded on a Bruker spectrometer (Esquire2000) with an electrospray ionization mode. Column chromatography was performed using Merck silica gel (40–60 μm). Melting points were measured on a BOX-6420 melting point apparatus (Laboratory Devices Inc.) without calibration. Elemental analysis of C, H, and N was carried out on a HERAEUS VarioEL-III or Thermo Flash 2000 analyzer, and, in all cases, the experimental values were within ±0.4% of the corresponding theoretical values. Microwave reactions were carried out in Discover (CEM Corp.). Final compound purity (≥95%) was determined by analytical HPLC using a Shimadzu HPLC system equipped with an SPD-M20A UV-VIS Detector and a Kinetex XB-C18 column (5 μm pore size, 100 × 4.60 mm column dimensions). The HPLC flow rate was 1.5 mL/min, and the absorbance of the eluates were monitored at 254 nm. The elution solvents were 0.1% (v/v) TFA<sub>(aq)</sub> in MeOH (solvent A) and 0.1% (v/v) TFA<sub>(aq)</sub> (solvent B). The elution gradient was 10% B, 0–0.7 min; 10–100% B, 0.7–11 min; 100% B, 11–16 min; 100–10% B, 16–17 min; and 10% B, 17–25 min.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 6-Chloro-3-phenethylquinazoline-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>2a</b>)</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> General Procedure A for Quinazolinedione Synthesis</h4><div class="NLM_p last">NaOH (1 N, 120 mL) was added dropwise into 5-chloro anthranilic acid (10 g, 57.12 mmol) mixed with phenyl chloroformate (8.7 mL, 68.43 mmol) in dioxane (120 mL) with stirring in an ice bath for 1 h. The resultant solution was poured into ice water (200 mL), and then the resultant solid (14.2 g) was filtered and vacuum dried overnight. The dried solid (6 g, 20.57 mmol) was mixed with EDCI (4.33 g, 22.61 mmol) and HOBt (3.12 g, 22.63 mmol) in DCM (100 mL), and the mixture was stirred at rt for 0.5 h. Then, phenethylamine (2.75 mL, 21.61 mmol) was injected into the mixture, which was stirred for an additional 4 h. The resultant solution was evaporated to dryness, and TEA (2.85 mL, 20.56 mmol) and DMF (50 mL) were then added into the residue. The mixture was refluxed under microwave irradiation (100 W) for 20 min. The resultant solution was poured into ice water (250 mL) and filtered to obtain <b>2a</b> as a beige solid (2 g, 32% yield, two steps). <i>R</i><sub>f</sub> = 0.25 (EtOAc/hexane = 1:2); mp = 233–235 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.53 (br s, 1H), 7.76 (d, <i>J</i> = 2.0 Hz, 1H), 7.61 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 7.28–7.12 (m, 6H), 4.05 (t, <i>J</i> = 7.8 Hz, 2H), 2.83 (t, <i>J</i> = 7.8 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 160.6, 149.6, 138.5, 138.1, 134.6, 128.5, 128.3, 126.38, 126.30, 126.1, 117.2, 115.0, 41.4, 33.1; ESIMS(−) <i>m</i>/<i>z</i>: 298.9 [M – H]<sup>−</sup>; Anal. Calcd for (C<sub>16</sub>H<sub>13</sub>ClN<sub>2</sub>O<sub>2</sub>): C, 63.90; H, 4.36; N, 9.31. Found: C, 64.02; H, 4.34; N, 9.28.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 7-Chloro-3-phenethyl-1<i>H</i>-quinazoline-2,4-dione (<b>2b</b>)</h3><div class="NLM_p last">General procedure A was followed (79% yield, three steps). <i>R</i><sub>f</sub> = 0.38 (EtOAc/hexane = 1:2); mp = 255–257 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.52 (br s, 1H), 7.89 (d, <i>J</i> = 8.8 Hz, 1H), 7.30–7.16 (m, 7H), 4.06 (t, <i>J</i> = 8.0 Hz, 1H), 2.85 (t, <i>J</i> = 8.0 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 161.0, 149.8, 140.3, 139.2, 138.5, 129.3, 128.5, 128.3, 126.2, 122.6, 114.4, 112.6, 41.3, 33.1; Anal. Calcd for (C<sub>16</sub>H<sub>13</sub>ClN<sub>2</sub>O<sub>2</sub>): C, 63.90; H, 4.36; N, 9.31. Found: C, 64.01; H, 4.33; N, 9.35.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 7-Fluoro-3-phenethylquinazoline-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>2c</b>)</h3><div class="NLM_p last">General procedure A was followed (38% yield, three steps). <i>R</i><sub>f</sub> = 0.37 (EtOAc/hexane = 1:2); mp = 224–226 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.51 (br s, 1H), 7.94 (dd, <i>J</i> = 8.8, 6.4 Hz, 1H), 7.29–7.16 (m, 5H), 7.00 (td, <i>J</i> = 8.4, 2.4 Hz, 1H), 6.86 (dd, <i>J</i> = 9.6, 2.4 Hz, 1H), 4.05 (t, <i>J</i> = 8.0 Hz, 2H), 2.83 (t, <i>J</i> = 8.0, Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 165.7 (d, <i>J</i> = 250.0 Hz), 160.8, 149.9, 141.2 (d, <i>J</i> = 13.0 Hz), 138.5, 130.5 (d, <i>J</i> = 11.0 Hz), 128.5, 128.4, 126.3, 110.7 (d, <i>J</i> = 2.0 Hz), 110.4 (d, <i>J</i> = 23.0 Hz), 101.2 (d, <i>J</i> = 26.0 Hz), 41.2, 31.2; Anal. Calcd for (C<sub>16</sub>H<sub>13</sub>FN<sub>2</sub>O<sub>2</sub>): C, 67.60; H, 4.61; N, 9.85. Found: C, 67.73; H, 4.78; N, 10.09.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 3-Phenethylquinazoline-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>2d</b>)</h3><div class="NLM_p">A mixture of isatoic anhydride (2 g, 12.26 mmol) and phenethylamine (2 mL, 15.72 mmol) in DMAC (20 mL) was refluxed under microwave irradiation (250 W) for 6 min. The resultant mixture was poured into ice water (50 mL) to obtain a beige solid. The solution was filtered, washed with H<sub>2</sub>O (300 mL), and dried under vacuum to produce a white solid (2.15 g, 73.0% yield).</div><div class="NLM_p last">The solid (6 g, 24.97 mmol) was dissolved in THF (50 mL) to which ethyl chloroformate (7.2 mL, 74.88 mmol) was added, and the mixture was refluxed for 8 h. After cooling to rt, H<sub>2</sub>O (5 mL) was added into the mixture, and the solution was evaporated to obtain a white solid. The solid was mixed with 2 N NaOH (30 mL) in EtOH (30 mL), and the resultant solution was stirred at 100 °C for 1 h. The resulting slurry was suspended in excess H<sub>2</sub>O, and then the mixture was filtered. The filtered cake was washed with EtOH to obtain <b>2d</b> as white cottonlike crystal (6.31 g, 94% yield). <i>R</i><sub>f</sub> = 0.22 (EtOAc/hexane = 1:2); mp = 217–219 °C (lit 215–216 °C); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.42 (br s, 1H), 7.91 (d, <i>J</i> = 7.6 Hz, 1H), 7.63 (td, <i>J</i> = 8.0, 1.0 Hz, 1H), 7.30–7.16 (m, 7H), 4.09 (t, <i>J</i> = 7.8 Hz, 2H), 2.86 (t, <i>J</i> = 8.0 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 161.7, 149.9, 139.4, 138.6, 134.9, 128.5, 128.4, 127.3, 126.2, 122.4, 115.1, 113.7, 41.2, 33.3.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 7-Methoxy-3-phenethylquinazoline-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>2e</b>)</h3><div class="NLM_p last">Into a mixture of 3-methoxy aniline (63.17 mmol) and phenyl chloroformate (9.6 mL, 75.51 mmol) in dioxane (120 mL) was added dropwise 1 N NaOH (126 mL) with stirring at an ice-bath temperature for 1 h. The resultant solution was poured into ice water (200 mL) and extracted with EtOAc (3 × 50 mL). The EtOAc solution was dried over MgSO<sub>4</sub> and then evaporated to obtain crude phenyl 3-methoxyphenylcarbamate as an oil residue, and then 1 mL of the residue (4.11 mmol) was mixed with phenethylamine (0.52 mL, 4.08 mmol) and TEA (0.6 mL, 4.33 mmol) in DMF (5 mL) MeOH (5 mL). This mixture was microwave irradiated (100 W) for 20 min. The resultant solution was poured into excess H<sub>2</sub>O, and the mixture was filtered to obtain a crude beige solid (0.84 g, 75.8% yield). The solid (1 g, 3.70 mmol) was mixed with Pd(MeCN)<sub>2</sub>(OTs)<sub>2</sub> (0.1 g, 0.018 mmol), benzoquinone (0.82 g, 7.43 mmol), and <i>p</i>-TSA·H<sub>2</sub>O (0.36 g, 1.85 mmol) in THF–MeOH (5 mL each) under Ar. The flask was evacuated and then filled with CO three times. Then, the mixture was stirred at rt under CO for 5 h. The resultant mixture was evaporated and suspended in DCM (30 mL). The DCM solution was washed with 1 N HCl (3 × 20 mL) and H<sub>2</sub>O (3 × 20 mL); then, the DCM layer was dried over MgSO<sub>4</sub>, concentrated, and purified by column chromatography to obtain the ester product as a light orange residue. The residue was mixed with 2 N NaOH (6 mL) in THF (8 mL), and the resultant solution was stirred at 80 °C for 2 h. Next, the solution was suspended in an excess of H<sub>2</sub>O and filtered to obtain <b>2e</b> as a white solid (0.28 g, 25% yield). <i>R</i><sub>f</sub> = 0.13 (EtOAc/hexane = 1:2); mp = 229–231 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.30 (br s, 1H), 7.81 (d, <i>J</i> = 8.8 Hz, 1H), 7.29–7.19 (m, 5H), 6.76 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 4.05 (t, <i>J</i> = 7.8 Hz, 2H), 3.80 (s, 3H), 2.84 (t, <i>J</i> = 7.8 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.3, 161.2, 150.2, 141.2, 138.6, 129.2, 128.5, 128.3, 126.2, 110.7, 107.1, 97.9, 55.5, 41.0, 33.4; Anal. Calcd for (C<sub>17</sub>H<sub>16</sub>N<sub>2</sub>O<sub>3</sub>): C, 68.91; H, 5.44; N, 9.45. Found: C, 69.09; H, 5.35; N, 9.47.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 6-Fluoro-3-phenethylquinazoline-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>2f</b>)</h3><div id="sec4_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> General Procedure B for Quinazolinedione Synthesis</h4><div class="NLM_p last">5-Fluoroanthranilic acid (5 g, 32.23 mmol) was mixed with EDCI (6.36 g, 33.21 mmol) and HOBt (4.57 g, 33.15 mmol) in DMF (30 mL), and the mixture was stirred at rt for 0.5 h. Next, phenethylamine (4.1 mL, 32.22 mmol) was added into the mixture, which was then stirred at rt for 3.5 h. The resultant solution was poured into H<sub>2</sub>O (150 mL), and the mixture was filtered to obtain a crude solid. The solid was suspended in THF (30 mL). Ethyl chloroformate (9.24 mL, 96.09 mmol) was injected into the THF mixture, and it was then refluxed for 4 h. The resultant solution was diluted with H<sub>2</sub>O (10 mL) and concentrated to remove THF. The concentrated solution was added into 2 N NaOH (20 mL) and EtOH (20 mL), and the resulting mixture was stirred at 100 °C for 1 h. The resultant solution was poured into excess H<sub>2</sub>O, the mixture was filtered, and the filtered cake was washed with excess EtOH to obtain <b>2f</b> as a white solid (7.39 g, 81% yield). <i>R</i><sub>f</sub> = 0.26 (EtOAc/hexane = 1:2); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.58 (dd, <i>J</i> = 8.8, 2.8 Hz, 1H), 7.52 (td, <i>J</i> = 8.8, 2.8 Hz, 1H), 7.29–7.17 (m, 6H), 4.07 (t, <i>J</i> = 7.8 Hz, 2H), 2.84 (t, <i>J</i> = 7.8 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 161.0 (d, <i>J</i> = 2.9 Hz), 157.2 (d, <i>J</i> = 239 Hz), 149.7, 138.5, 136.1, 128.5, 128.4, 126.3, 123.0 (d, <i>J</i> = 42 Hz), 117.4 (d, <i>J</i> = 7 Hz), 114.6 (d, <i>J</i> = 8 Hz), 112.1 (d, <i>J</i> = 23 Hz), 41.4, 33.2.</div></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 3-Phenethyl-7-(trifluoromethyl)quinazoline-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>2g</b>)</h3><div class="NLM_p last">General procedure B was followed to give <b>2g</b> as a white solid (89% yield). <i>R</i><sub>f</sub> = 0.57 (EtOAc/hexane = 1:2); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.00 (d, <i>J</i> = 8.0 Hz, 1H), 7.39–7.13 (m, 7H), 4.02 (t, <i>J</i> = 7.8 Hz, 2H), 2.81 (t, <i>J</i> = 7.8 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 161.4, 150.2, 140.0, 138.9, 134.8, 134.5, 129.4, 129.0, 128.9, 126.8, 125.0, 122.3, 118.8, 117.0, 112.5, 41.9, 33.5.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 3-Phenethylpyrido[2,3-<i>d</i>]pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>2h</b>)</h3><div class="NLM_p last">General procedure B was followed to give <b>2h</b> as a white solid (56% yield). <i>R</i><sub>f</sub> = 0.39 (EtOAc/hexane = 1:2); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.96 (br s), 8.60 (br d, <i>J</i> = 4.4 Hz, 1H), 8.27 (br d, <i>J</i> = 7.6 Hz, 1H), 7.30–7.17 (m, 6H), 4.07 (t, <i>J</i> = 7.8 Hz, 2H), 2.85 (t, <i>J</i> = 7.6 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 161.4, 154.6, 150.9, 150.2, 138.5, 136.7, 128.5, 128.4, 126.3, 119.0, 109.3, 41.4, 33.1.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 3-(4-Fluorophenethyl)quinazoline-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>2i</b>)</h3><div id="sec4_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> General procedure C for Quinazolinedione Construction</h4><div class="NLM_p last">Isatoic anhydride (6 g, 36.78 mmol) in DMAC (50 mL) and 4-fluorophenylethylamine (6.24 g, 44.38 mmol) were added, and the resultant solution was microwave irradiated (250 W) for 6 min. The resultant solution was poured into H<sub>2</sub>O (250 mL) and filtered to obtain a crude solid. The solid was suspended in THF (40 mL); ethylchloroformate (10.5 mL, 109.19 mmol) was injected into THF solution; and the solution was refluxed for 11 h. Next, the solution was diluted with H<sub>2</sub>O (10 mL) and concentrated to remove THF. Next, 2 N NaOH (25 mL) and EtOH (25 mL) were added into the concentrated solution, which was then stirred at 100 °C for 3 h. The resultant solution was poured into excess of H<sub>2</sub>O and filtered. The filtered cake was washed with excess EtOH to obtain <b>2i</b> as a beige solid (7.9 g, 76% yield). <i>R</i><sub>f</sub> = 0.34 (EtOAc/hexane = 1:1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.41 (br s), 7.90 (dd, <i>J</i> = 8.0, 1.2 Hz, 1H), 7.62 (td, <i>J</i> = 8.0, 1.2 Hz, 1H), 7.25–7.06 (m, 6H), 4.07 (t, <i>J</i> = 7.8 Hz, 2H), 2.85 (t, <i>J</i> = 7.6 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 161.7, 159.6, 149.9, 139.3, 134.9, 134.7 (d, <i>J</i> = 2.0 Hz), 130.4 (d, <i>J</i> = 7.0 Hz), 127.3, 122.4, 115.1 (d, <i>J</i> = 19 Hz), 115.0, 113.6, 41.2, 32.4.</div></div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 3-(3-Fluorophenethyl)quinazoline-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>2j</b>)</h3><div class="NLM_p last">General procedure C was followed to give <b>2j</b> as a beige solid (38% yield). <i>R</i><sub>f</sub> = 0.46 (EtOAc/hexane = 1:1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.90 (br d, <i>J</i> = 8.0 Hz, 1H), 7.63 (dd, <i>J</i> = 8.0, 7.2 Hz, 1H), 7.33–6.99 (m, 6H), 4.11 (t, <i>J</i> = 7.6 Hz, 2H), 2.89 (t, <i>J</i> = 7.6 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.1 (d, <i>J</i> = 242 Hz), 161.7, 150.0, 141.6 (d, <i>J</i> = 7 Hz), 139.4, 134.9, 130.2 (d, <i>J</i> = 7 Hz), 127.3, 124.7 (d, <i>J</i> = 2 Hz), 122.4, 115.3 (d, <i>J</i> = 20 Hz), 115.1, 113.6, 113.1 (d, <i>J</i> = 20 Hz).</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 3-(4-Methoxyphenethyl)quinazoline-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>2k</b>)</h3><div class="NLM_p last">General procedure C was followed to give <b>2k</b> as a beige solid (38% yield). <i>R</i><sub>f</sub> = 0.43 (EtOAc/hexane 1:1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.4 (br s, 1H), 7.89 (br d, <i>J</i> = 7.6 Hz, 1H), 7.61 (td, <i>J</i> = 7.6, 1.2 Hz, 1H), 7.18–7.10 (m, 4H), 6.82 (d, <i>J</i> = 8.4 Hz, 2H), 4.02 (t, <i>J</i> = 7.8 Hz, 2H), 3.68 (s, 3H), 2.77 (t, <i>J</i> = 8.0, 7.6 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 161.8, 157.8, 150.0, 139.4, 135.0, 130.5, 129.6, 127.4, 122.5, 115.1, 113.9, 113.8, 55.0, 41.5, 32.5.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 3-(2-Methoxyphenethyl)quinazoline-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>2l</b>)</h3><div class="NLM_p last">General procedure C was followed to give <b>2l</b> as a beige solid (89% yield). <i>R</i><sub>f</sub> = 0.42 (EtOAc/hexane = 1:1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.94 (br s, 1H), 8.61 (dd, <i>J</i> = 4.8, 1.6 Hz, 1H), 8.28 (dd, <i>J</i> = 7.6, 2.0 Hz, 1H), 7.30–7.17 (m, 6H), 4.07 (t, <i>J</i> = 7.8 Hz, 2H), 2.86 (t, <i>J</i> = 8.0 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 161.4, 154.6, 150.9, 150.2, 138.5, 136.8, 128.6, 128.4, 126.3, 119.0, 109.3, 41.4, 33.1.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 3-(3-(Trifluoromethyl)phenethyl)quinazoline-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>2m</b>)</h3><div class="NLM_p last">General procedure C was followed to give <b>2m</b> as a beige solid (38% yield). <i>R</i><sub>f</sub> = 0.46 (EtOAc/hexane = 1:1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.44 (s, 1H), 7.90 (dd, <i>J</i> = 7.9, 1.3 Hz, 1H), 7.66–7.60 (m, 1H), 7.57–7.48 (m, 4 H), 7.21–7.13 (m, 2H), 4.13 (t, <i>J</i> = 7.5 Hz, 2H), 2.98 (t, <i>J</i> = 7.5 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 161.8, 150.0, 140.1, 139.4, 135.0, 132.9, 129.6, 129.1 (q, <i>J</i> = 31 Hz), 127.4, 125.2 (q, <i>J</i> = 3.7 Hz), 124.2 (q, <i>J</i> = 272 Hz), 123.1 (q, <i>J</i> = 3.8 Hz), 122.5, 115.1, 113.7, 40.9, 32.9; ESIMS(−) <i>m</i>/<i>z</i>: 333.2 [M – H]<sup>−</sup>.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 3-Phenethylthieno[2,3-<i>d</i>]pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>2n</b>)</h3><div class="NLM_p last">A solution of <b>1g</b> (10 g, 61.7 mmol) that had been mixed with phenyl chloroformate (23.5 mL, 184.8 mmol) in THF (30 mL) was refluxed under microwave irradiation (200 W) for 10 min. The resultant solution was poured into ice water (250 mL), which was then filtered to obtain a brown solid. After mixing the solid with phenethylamine (8.6 mL, 67.5 mmol) and triethylamine (8.6 mL, 62.0 mmol) in MeOH (40 mL), the mixture was microwave irradiated (100 W) for 10 min. The resultant solution was poured into ice water (100 mL) and extracted with EtOAc (5 × 50 mL). The organic layer was evaporated to dryness. The dried residue was suspended in NaOH (2 N, 60 mL) and EtOH (60 mL) and stirred at 100 °C for 8 h. Next, the solution was poured into ice water (300 mL), neutralized with HCl (1 N, 60 mL), and filtered to obtain <b>2n</b> as a beige solid (5.2 g, 31% yield). <i>R</i><sub>f</sub> = 0.17 (EtOAc/hexane = 1:2); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.19 (br s, 1H), 7.30–7.07 (m, 7H), 4.03 (t, <i>J</i> = 8.0 Hz, 2H), 2.82 (t, <i>J</i> = 8.0 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 158.2, 150.5, 150.2, 138.6, 128.5, 128.3, 126.2, 122.1, 117.1, 114.6, 41.1, 33.2.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 4-((6-Chloro-2,4-dioxo-3-phenethyl-3,4-dihydroquinazolin-1(2<i>H</i>)-yl)methyl)-<i>N</i>-hydroxybenzamide (<b>3a</b>)</h3><div id="sec4_16_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> General procedure D for Benzylation and Protected Hydroxamic Acid Synthesis</h4><div class="NLM_p last">NaH (60% (w/v); 0.96 g, 24 mmol) was added in portions into DMF (70 mL) containing <b>2a</b> (6 g, 19.95 mmol) at an ice-bath temperature and stirred for 1.5 h. Next, ethyl 4-(bromomethyl)benzoate (5.3 g, 20.93 mmol) was added into the solution, which was stirred with an increase in temperature from that of an ice bath to rt over 7 h. Next, the solution was poured into water (350 mL) and extracted with EtOAc (5 × 50 mL). The EtOAc layer was dried over MgSO<sub>4</sub>, concentrated, and filtered to obtain a beige solid (4.85 g, 52% yield). The solid (3.9 g, 8.42 mmol), in 48 mL of THF/MeOH (5:1), was then added into LiOH<sub>aq</sub> (2.5 M, 14 mL), and the mixture was stirred at rt for 3 h. Next, the solution was acidified with 3 N HCl (12 mL) and filtered to obtain a crude solid. The solid with EDCI (1.61 g, 8.41 mmol) and HOBt (1.16 g, 8.41 mmol) in DMF (30 mL) was stirred at rt for 0.5 h, then NH<sub>2</sub>OBn·HCl (1.34 g, 8.4 mmol) and triethylamine (1.2 mL, 8.66 mmol) were added, and the solution was stirred at rt for 20 h. The resultant solution was poured into ice water (180 mL) and filtered to obtain the benzyl-protected solid (4.12 g, 90% yield).</div></div><div id="sec4_16_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> General Procedure E for Deprotection of the Hydroxamic Acid by BBr<sub>3</sub></h4><div class="NLM_p last">The benzyl-protected solid (1.5 g, 2.78 mmol), after mixing with pentamethylbenzene (2.5 g, 16.69 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (30 mL), was added dropwise with BBr<sub>3</sub> (1 M in CH<sub>2</sub>Cl<sub>2</sub>; 13.9 mL, 13.9 mmol)] over a 15 min period. The mixture was stirred at an ice-bath temperature for 45 min. Then, the reaction was quenched with an excess of MeOH and CH<sub>2</sub>Cl<sub>2</sub> at the same temperature, and the solution was evaporated to obtain an orange residue. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (30 mL), which was washed with saturated NaHCO<sub>3aq</sub> (2 × 20 mL), and then the CH<sub>2</sub>Cl<sub>2</sub> layer was dried over MgSO<sub>4</sub> and purified by flash column chromatography with MeOH/CH<sub>2</sub>Cl<sub>2</sub> (2:98) as the eluent to obtain <b>3a</b> as a white solid (0.72 g, 57% yield). <i>R</i><sub>f</sub> = 0.27 (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 1:19); mp = 190–192 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.18 (br s, 1H), 9.02 (br s, 1H), 7.98 (d, <i>J</i> = 2.4 Hz, 1H), 7.72–7.65 (m, 3H), 7.31–7.19 (m, 8H), 5.37 (s, 2H), 4.21 (t, <i>J</i> = 7.5 Hz, 2H), 2.94 (t, <i>J</i> = 7.5 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.8, 159.9, 150.3, 139.1, 138.3 (2C), 134.8, 131.8, 128.7, 128.4, 127.2 (2C), 126.8, 126.3 (2C), 117.1, 116.6, 46.2, 42.6, 32.9; ESIMS(−) <i>m</i>/<i>z</i>: 447.9 [M – H]<sup>−</sup>; Anal. Calcd for (C<sub>24</sub>H<sub>20</sub>ClN<sub>3</sub>O<sub>4</sub>): C, 64.07; H, 4.48; N, 9.34. Found: C, 63.75; H, 4.40; N, 9.18.</div></div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 4-((7-Chloro-2,4-dioxo-3-phenethyl-3,4-dihydroquinazolin-1(2<i>H</i>)-yl)methyl)-<i>N</i>-hydroxybenzamide (<b>3b</b>)</h3><div class="NLM_p last">The general procedures D and E were followed to give <b>3b</b> as a beige solid (27% yield, four steps). <i>R</i><sub>f</sub> = 0.45 (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 1: 19); mp = 185–187 °C (dec.); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.05 (d, <i>J</i> = 8.4 Hz, 1H), 7.76–7.64 (m, 2H), 7.34–7.18 (m, 9H), 5.39 (s, 2H), 4.20 (t, <i>J</i> = 7.3 Hz, 2H), 2.93 (t, <i>J</i> = 7.3 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.7, 160.2, 150.5, 140.5, 139.8, 138.9, 138.4, 132.0, 129.9, 128.7, 128.4, 127.2, 126.3 (2C), 123.1, 114.5, 114.0, 46.0, 42.5, 33.0; ESIMS(−) <i>m</i>/<i>z</i>: 447.9 [M – H]<sup>−</sup>. Anal. Calcd for (C<sub>24</sub>H<sub>20</sub>ClN<sub>3</sub>O<sub>4</sub>): C, 64.07; H, 4.48; N, 9.34. Found: C, 64.12; H, 4.52; N, 9.31.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 4-((7-Fluoro-2,4-dioxo-3-phenethyl-3,4-dihydroquinazolin-1(2<i>H</i>)-yl)methyl)-<i>N</i>-hydroxybenzamide (<b>3c</b>)</h3><div class="NLM_p">Compound <b>2c</b> was converted into protected <b>3c</b> according to the general procedure D to give protected <b>3c</b> as a beige solid (34%, yield; three steps).</div><div id="sec4_18_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> General Procedure F for Deprotection of a Protected Hydroxamic Acid Derivative by Hydrogenation</h4><div class="NLM_p last">The protected solid (0.9 g, 1.72 mmol) was mixed with 10% (w/w) Pd/C (70 mg) in MeOH/THF (3:1, 32 mL), and the mixture was then stirred under H<sub>2</sub> (1 atm) at rt for 3 h. Next, the solution was filtered through Celite, and the filtrate was purified by flash column chromatography with MeOH/CH<sub>2</sub>Cl<sub>2</sub> (2:98) as the eluent to give <b>3c</b> as a beige solid (0.59 g, 79% yield); <i>R</i><sub>f</sub> = 0.47 (MeOH/CH<sub>2</sub>Cl<sub>2</sub>, 1:19); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.17 (br s, 1H), 9.01 (br s, 1H), 8.12 (dd, <i>J</i> = 9.2, 6.4 Hz, 1H), 7.73–7.65 (m, 2H), 7.31–7.19 (m, 7H), 7.15–7.07 (m, 2H), 5.36 (s, 2H), 4.20 (t, <i>J</i> = 7.5 Hz, 2H), 2.93 (t, <i>J</i> = 7.5 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 166.0 (d, <i>J</i> = 250.0 Hz), 163.9, 160.1, 150.6, 141.6 (d, <i>J</i> = 12.0 Hz), 139.1, 138.4, 131.9, 131.2 (d, <i>J</i> = 11.0 Hz) 128.7, 128.4, 127.2, 126.4, 126.3, 112.0 (br s), 110.8 (d, <i>J</i> = 23.0 Hz), 101.9 (d, <i>J</i> = 28.0 Hz), 46.2, 42.5, 33.0; ESIMS(−) <i>m</i>/<i>z</i>: 431.9 [M – H]<sup>−</sup>. Anal. Calcd for (C<sub>24</sub>H<sub>20</sub>FN<sub>3</sub>O<sub>4</sub>·1/2H<sub>2</sub>O): C, 65.15; H, 4.78; N, 9.50. Found: C, 65.24; H, 4.68; N, 9.53.</div></div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 4-((2,4-Dioxo-3-phenethyl-3,4-dihydroquinazolin-1(2<i>H</i>)-yl)methyl)-<i>N</i>-hydroxybenzamide (<b>3d</b>)</h3><div class="NLM_p last">By following general procedures D and F, <b>2d</b> was converted into <b>3d</b> as a white solid (50% yield, four steps). <i>R</i><sub>f</sub> = 0.20 (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 2:98); mp = 99–101 °C (dec.); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.19 (br s, 1H), 9.04 (s, 1H), 8.07 (dd, <i>J</i> = 7.8, 1.3 Hz, 1H), 7.71–7.66 (m, 2H), 7.65–7.60 (m, 1H), 7.32–7.17 (m, 9H), 5.37 (s, 2H), 4.23 (t, <i>J</i> = 7.5 Hz, 2H), 2.94 (t, <i>J</i> = 7.5 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.9, 160.9, 150.6, 139.5, 139.4, 138.5, 135.2, 131.8, 128.7, 128.4, 128.0, 127.2, 126.4, 126.3, 122.9, 115.1, 114.8, 46.0, 42.4, 33.1; ESIMS(−) <i>m</i>/<i>z</i>: 413.9 [M – H]<sup>−</sup>. Anal. Calcd for (C<sub>24</sub>H<sub>21</sub>N<sub>3</sub>O<sub>4</sub>·1/10H<sub>2</sub>O): C, 69.09; H, 5.12; N, 10.07. Found: C, 68.91; H, 5.13; N, 9.93.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 4-((3,4-Dihydro-7-methoxy-2,4-dioxo-3-phenethylquinazolin-1(2<i>H</i>)-yl)methyl)-<i>N</i>-hydroxybenzamide (<b>3e</b>)</h3><div class="NLM_p last">By following general procedures D and F, <b>2e</b> was converted into <b>3e</b> as a white solid (29% yield; four steps). <i>R</i><sub>f</sub> = 0.43 (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 1:19); mp = 198–200 °C (dec.); <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.20 (br s, 1H), 9.04 (br s, 1H), 7.98 (d, <i>J</i> = 8.8 Hz, 1H), 7.68 (d, <i>J</i> = 8.2 Hz, 1H), 7.31–7.24 (m, 4H), 7.24–7.19 (m, 3H), 6.85 (dd, <i>J</i> = 8.8, 2.1 Hz, 1H), 6.61 (d, <i>J</i> = 2.1 Hz, 1H), 5.37 (s, 2H), 4.20 (t, <i>J</i> = 7.6 Hz, 2H), 3.73 (s, 3H), 2.93 (t, <i>J</i> = 7.5 Hz, 2H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.4, 163.9, 160.3, 150.9, 141.1, 139.5, 138.5, 131.8, 130.1, 128.7, 128.3, 127.2, 126.4, 126.2, 109.8, 108.4, 99.5, 55.7, 45.9, 42.2, 33.1; ESIMS(−) <i>m</i>/<i>z</i>: 444.0 [M – H]<sup>−</sup>. Anal. Calcd for (C<sub>25</sub>H<sub>23</sub>N<sub>3</sub>O<sub>5</sub>): C, 67.41; H, 5.20; N, 9.43. Found: C, 67.17; H, 5.30; N, 9.24.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 3-((3,4-Dihydro-2,4-dioxo-3-phenethylquinazolin-1(2<i>H</i>)-yl)methyl)-<i>N</i>-hydroxybenzamide (<b>3f</b>)</h3><div class="NLM_p last">By following general procedures D and F, <b>2d</b> was converted into <b>3f</b> as a white solid (57% yield; four steps). <i>R</i><sub>f</sub> = 0.19 (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 2: 98); mp = 188–90 °C (dec.); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.24 (br s, 1H), 9.06 (s, 1H), 8.07 (d, <i>J</i> = 7.2, 1H), 7.78–7.53 (m, 3H), 7.44–7.15 (m, 9H), 5.39 (s, 2H), 4.24 (t, <i>J</i> = 7.6 Hz, 2H), 2.95 (t, <i>J</i> = 7.6 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.9, 160.9, 150.6, 139.5, 138.5, 136.6, 135.2, 133.2, 129.1, 128.8, 128.6, 128.4, 128.0, 126.3, 125.8, 125.0, 122.9, 115.1, 114.8, 46.2, 42.5, 33.2; ESIMS(−) <i>m</i>/<i>z</i>: 413.9 [M – H]<sup>−</sup>. Anal. Calcd for (C<sub>24</sub>H<sub>21</sub>N<sub>3</sub>O<sub>4</sub>·0.6H<sub>2</sub>O): C, 67.63; H, 5.25; N, 9.86. Found: C, 67.56; H, 4.86; N, 9.61.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 4-((6-Fluoro-2,4-dioxo-3-phenethyl-3,4-dihydroquinazolin-1(2<i>H</i>)-yl)methyl)-<i>N</i>-hydroxybenzamide (<b>3g</b>)</h3><div class="NLM_p last">By following general procedures D and F, <b>2f</b> was converted into <b>3g</b> as a white solid (28% yield; four steps). <i>R</i><sub>f</sub> = 0.23 (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 2: 98); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.21 (br s, 1H), 9.05 (br s, 1H), 7.82–7.63 (m, 3H), 7.54 (s, 1H), 7.32–7.18 (m, 8H), 5.37 (s, 2H), 4.21 (t, <i>J</i> = 6.8 Hz, 2H), 2.94 (t, <i>J</i> = 6.8 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.8, 160.1, 158.7, 156.3, 150.3, 139.3, 138.4, 136.2, 131.8, 128.7, 128.4, 127.2, 126.4 (<i>J</i> = 4.3 Hz), 122.8 (<i>J</i> = 23.9 Hz), 117.4 (<i>J</i> = 7.3 Hz), 116.5 (<i>J</i> = 7.7 Hz), 113.1 (<i>J</i> = 23.7 Hz), 46.3, 42.7, 33.0; ESIMS(−) <i>m</i>/<i>z</i>: 432 [M – H]<sup>−</sup>. Anal. Calcd for (C<sub>24</sub>H<sub>20</sub>FN<sub>3</sub>O<sub>4</sub>·0.1H<sub>2</sub>O): C, 66.23; H, 4.68; N, 9.65. Found: C, 66.07; H, 4.77; N, 9.32.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 4-((2,4-Dioxo-3-phenethyl-7-(trifluoromethyl)-3,4-dihydroquinazolin-1(2<i>H</i>)-yl)methyl)-<i>N</i>-hydroxybenzamide (<b>3h</b>)</h3><div class="NLM_p last">By following general procedures D and F, <b>2g</b> was converted into <b>3h</b> as a white solid (36% yield; four steps). <i>R</i><sub>f</sub> = 0.25 (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 2:98); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.18 (br s, 1H), 9.03 (br s, 1H), 8.26 (d, <i>J</i> = 8.2 Hz, 1H), 7.69 (d, <i>J</i> = 8.2 Hz, 2H), 7.58 (d, <i>J</i> = 8.2 Hz, 1H), 7.50 (s, 1H), 7.32–7.19 (m, 7H), 5.47 (s, 2H), 4.23 (t, <i>J</i> = 7.6 Hz, 2H), 2.95 (t, <i>J</i> = 7.5 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.5, 160.7, 150.9, 140.1, 139.5, 138.7, 134.9 (<i>J</i> = 32.2 Hz), 132.0, 130.1, 129.1, 128.8, 127.7, 126.8, 123.5 (<i>J</i> = 273.4 Hz), 119.6, 118.5, 112.1, 46.6, 43.1, 33.2; ESIMS(−) <i>m</i>/<i>z</i>: 482 [M – H]<sup>−</sup>. Anal. Calcd for (C<sub>25</sub>H<sub>20</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub>): C, 62.11; H, 4.17; N, 8.69. Found: C, 62.13; H, 4.13; N, 8.64.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 4-((2,4-Dioxo-3-phenethyl-3,4-dihydropyrido[2,3-<i>d</i>]pyrimidin-1(2<i>H</i>)-yl)methyl)-<i>N</i>-hydroxybenzamide (<b>3i</b>)</h3><div class="NLM_p last">By following general procedures D and F, <b>2g</b> was converted into <b>3i</b> as a white solid (22%, four steps); <i>R</i><sub>f</sub> = 0.37 (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 5: 95); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.66 (dd, <i>J</i> = 4.6, 1.3 Hz, 1H), 8.39 (dd, <i>J</i> = 7.7, 1.3 Hz, 1H), 7.66 (d, <i>J</i> = 8.0 Hz, 2H), 7.36–7.30 (m, 1H), 7.29–7.16 (m, 7H), 5.43 (s, 2H), 4.16 (t, <i>J</i> = 7.6 Hz, 2H), 2.90 (t, <i>J</i> = 7.6 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.7, 160.5, 154.2, 150.6, 150.2, 139.2, 138.4, 137.4, 133.0, 128.7, 128.4, 126.7, 126.6, 126.4, 119.5, 110.5, 48.6, 44.7, 42.5, 33.0; ESIMS(−) <i>m</i>/<i>z</i>: 415 [M – H]<sup>−</sup>. Anal. Calcd for (C<sub>23</sub>H<sub>20</sub>N<sub>4</sub>O<sub>4</sub>·1.2H<sub>2</sub>O): C, 63.06; H, 5.15; N, 12.79. Found: C, 62.97; H, 4.90; N, 12.47.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> <i>N</i>-Hydroxy-4-((7-hydroxy-2,4-dioxo-3-phenethyl-3,4-dihydroquinazolin-1(2<i>H</i>)-yl)methyl)benzamide (<b>3j</b>)</h3><div class="NLM_p last">By following general procedures D and F, <b>5a</b> was converted into <b>3j</b> as a white solid (15% yield, three steps); <i>R</i><sub>f</sub> = 0.18 (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 5:95); mp 205–207 °C (dec.); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.83 (d, <i>J</i> = 8.6 Hz, 1H), 7.73–7.65 (m, 2H), 7.31–7.18 (m, 7H), 6.58 (d, <i>J</i> = 8.6 Hz, 1H), 6.34 (s, 1H), 5.24 (s, 2H), 4.19 (t, <i>J</i> = 7.5 Hz, 2H), 2.92 (t, <i>J</i> = 7.5 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 165.7, 163.8, 160.5, 151.1, 141.5, 139.5, 138.6, 131.9, 130.0, 128.7, 128.4, 127.2, 126.3 (2C), 112.6, 105.6, 100.5, 46.1, 42.1, 33.4; ESIMS(−) <i>m</i>/<i>z</i>: 430 [M – H]<sup>−</sup>. Anal. Calcd for (C<sub>24</sub>H<sub>21</sub>N<sub>3</sub>O<sub>5</sub>·H<sub>2</sub>O): C, 64.13; H, 5.16; N, 9.35. Found: C, 64.24; H, 4.88; N, 9.11.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> <i>N</i>-Hydroxy-4-((7-methyl-2,4-dioxo-3-phenethyl-3,4-dihydroquinazolin-1(2<i>H</i>)-yl)methyl)benzamide (<b>3k</b>)</h3><div class="NLM_p last">By following general procedures D and F, <b>5b</b> was converted into <b>3k</b> as a white solid (56% yield; three steps). <i>R</i><sub>f</sub> = 0.2 (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 4: 96); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.16 (br s, 1H), 8.99 (br s, 1H), 7.95 (d, <i>J</i> = 8.1 Hz, 1H), 7.68 (d, <i>J</i> = 8.0 Hz, 2H), 7.30–7.19 (m, 7H), 7.10–7.06 (m, 2H), 5.35 (s, 2H), 4.21 (t, <i>J</i> = 7.6 Hz, 2H), 2.93 (t, <i>J</i> = 7.5 Hz, 2H), 2.30 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.8, 160.7, 150.7, 146.0, 139.5 (2C), 138.4, 131.7, 128.7, 128.3, 127.9, 127.2, 126.3 (2C), 124.1, 114.6, 112.7, 45.9, 42.3, 33.1, 21.6; ESIMS(+) <i>m</i>/<i>z</i>: 430 [M + H]<sup>+</sup>. Anal. Calcd for (C<sub>25</sub>H<sub>23</sub>N<sub>3</sub>O<sub>4</sub>): C, 69.92; H, 5.40; N, 9.78. Found: C, 69.70; H, 5.23; N, 9.74.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 4-((7-Cyclopropyl-2,4-dioxo-3-phenethyl-3,4-dihydroquinazolin-1(2<i>H</i>)-yl)methyl)-<i>N</i>-hydroxybenzamide (<b>3l</b>)</h3><div class="NLM_p last">By following general procedures D and F, <b>5c</b> was converted into <b>3l</b> as a white solid (32% yield, three steps). <i>R</i><sub>f</sub> = 0.36 (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 5:95); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.18 (br s, 1H), 9.02 (br s, 1H), 7.90 (d, <i>J</i> = 8.1 Hz, 1H), 7.69 (d, <i>J</i> = 8.0 Hz, 1H), 7.30–7.25 (m, 4H), 7.23–7.19 (m, 3H), 6.92–6.85 (m, 2H), 5.38 (s, 2H), 4.21 (t, <i>J</i> = 7.5 Hz, 2H), 2.93 (t, <i>J</i> = 7.4 Hz, 2H), 1.96–1.85 (m, 1H), 0.98 (br d, <i>J</i> = 8.0 Hz, 2H), 0.65 (br d, <i>J</i> = 4.8 Hz 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.8, 160.6, 152.6, 150.7, 139.7, 139.4, 138.5, 131.7, 128.7, 128.3, 128.0, 127.2, 126.4, 126.3, 119.8, 112.5, 111.2, 45.8, 42.3, 33.1, 15.7, 10.8; ESIMS(+) <i>m</i>/<i>z</i>: 456.1 [M + H]<sup>+</sup>. Anal. Calcd for (C<sub>27</sub>H<sub>25</sub>N<sub>3</sub>O<sub>4</sub>·0.5H<sub>2</sub>O): C, 69.81; H, 5.64; N, 9.05. Found: C, 69.80; H, 5.71; N, 8.96.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 4-((3-(4-Fluorophenethyl)-2,4-dioxo-3,4-dihydroquinazolin-1(2<i>H</i>)-yl)methyl)-<i>N</i>-hydroxybenzamide (<b>3m</b>)</h3><div class="NLM_p last">By following general procedures D and F, <b>2i</b> was converted into <b>3m</b> as a white solid (72% yield; four steps); <i>R</i><sub>f</sub> = 0.34 (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 2:98); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.15 (br s, 1H), 9.01 (br s, 1H), 8.06 (dd, <i>J</i> = 8.0, 1.2 Hz, 1H), 7.69 (d, <i>J</i> = 8.2 Hz, 1H), 7.62 (dd, <i>J</i> = 8.4, 7.6 Hz, 1H), 7.28–7.20 (m, 6H), 7.09 (dd, <i>J</i> = 9.2, 8.4 Hz, 2H), 5.37 (s, 2H), 4.22 (t, <i>J</i> = 7.4 Hz, 2H), 2.94 (t, <i>J</i> = 7.4 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.9, 162.1, 160.9, 159.7, 150.6, 139.4, 135.2, 134.7 (<i>J</i> = 3.0 Hz), 131.8, 130.5 (<i>J</i> = 7.9 Hz), 128.0, 127.2, 126.4, 122.9, 115.1, 115.0 (<i>J</i> = 21.1 Hz), 114.8, 46.0, 42.4, 32.2; ESIMS(−) <i>m</i>/<i>z</i>: 432 [M – H]<sup>−</sup>. Anal. Calcd for (C<sub>24</sub>H<sub>20</sub>FN<sub>3</sub>O<sub>4</sub>): C, 66.51; H, 4.65; N, 9.69. Found: C, 66.20; H, 4.46; N, 9.48.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 4-((3-(3-Fluorophenethyl)-2,4-dioxo-3,4-dihydroquinazolin-1(2<i>H</i>)-yl)methyl)-<i>N</i>-hydroxybenzamide (<b>3n</b>)</h3><div class="NLM_p last">By following general procedures D and F, <b>2j</b> was converted into <b>3n</b> as a white solid (38% yield, four steps). <i>R</i><sub>f</sub> = 0.21 (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 5:95); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.17 (br s, 1H), 9.01 (br s, 1H), 8.06 (dd, <i>J</i> = 8.0, 1.2 Hz, 1H), 7.73–7.59 (m, 3H), 7.34–7.19 (m, 5H), 7.11–7.00 (m, 3H), 5.37 (s, 2H), 4.25 (t, <i>J</i> = 7.4 Hz, 2H), 2.98 (t, <i>J</i> = 7.3 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.9, 163.3, 160.9, 150.6, 141.5 (<i>J</i> = 7.4 Hz), 139.4, 135.2, 131.8, 130.2 (<i>J</i> = 8.4 Hz), 128.0, 127.2, 126.4, 124.9 (<i>J</i> = 2.3 Hz), 123.0, 115.5 (<i>J</i> = 20.8 Hz), 115.1, 114.8, 113.1 (<i>J</i> = 20.8 Hz), 46.0, 42.1, 32.7; ESIMS(+) <i>m</i>/<i>z</i>: 434.1 [M + H]<sup>+</sup>. Anal. Calcd for (C<sub>24</sub>H<sub>20</sub>FN<sub>3</sub>O<sub>4</sub>): C, 66.51; H, 4.65; N, 9.69. Found: C, 66.85; H, 4.69; N, 9.76.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> <i>N</i>-Hydroxy-4-((3-(4-methoxyphenethyl)-2,4-dioxo-3,4-dihydroquinazolin-1(2<i>H</i>)-yl)methyl)benzamide (<b>3o</b>)</h3><div class="NLM_p last">By following general procedures D and F, <b>2k</b> was converted into <b>3o</b> as a white solid (19% yield; four steps). <i>R</i><sub>f</sub> = 0.31 (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 2:98); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.14 (br s, 1H), 8.99 (br s, 1H), 8.07 (d, <i>J</i> = 7.8 Hz, 1H), 7.71–7.60 (m, 3H), 7.30–7.19 (m, 4H), 7.14 (d, <i>J</i> = 8.4 Hz, 2H), 6.84 (d, <i>J</i> = 8.5 Hz, 2H), 5.38 (s, 2H), 4.19 (t, <i>J</i> = 7.6 Hz, 2H), 3.70 (s, 3H), 2.87 (t, <i>J</i> = 7.6 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 160.8, 157.8, 150.6, 139.4, 135.1, 131.8, 130.3, 129.6, 128.0, 127.2, 126.3, 122.9, 115.1, 114.8, 113.8, 54.9, 46.0, 42.6, 32.2; ESIMS(−) <i>m</i>/<i>z</i>: 444.1 [M – H]<sup>−</sup>. Anal. Calcd for (C<sub>25</sub>H<sub>23</sub>N<sub>3</sub>O<sub>5</sub>): C, 67.41; H, 5.20; N, 9.43. Found: C, 67.27; H, 5.23; N, 9.49.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> <i>N</i>-Hydroxy-4-((3-(2-methoxyphenethyl)-2,4-dioxo-3,4-dihydroquinazolin-1(2<i>H</i>)-yl)methyl)benzamide (<b>3p</b>)</h3><div class="NLM_p last">By following general procedures D and F, <b>2l</b> was converted into <b>3p</b> as a white solid (14% yield; four steps). <i>R</i><sub>f</sub> = 0.23 (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 2:98); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.16 (br s, 1H), 8.99 (br s, 1H), 8.04 (dd, <i>J</i> = 8.0, 1.2 Hz, 1H), 7.68 (d, <i>J</i> = 8.2 Hz, 2H), 7.61 (dd, <i>J</i> = 7.6, 7.2 Hz, 1H), 7.26–7.17 (m, 5H), 7.06 (d, <i>J</i> = 7.2 Hz, 1H), 6.90 (d, <i>J</i> = 8.1 Hz, 1H), 6.83 (dd, <i>J</i> = 7.6, 7.2 Hz, 1H), 5.33 (s, 2H), 4.26 (t, <i>J</i> = 6.9 Hz, 2H), 3.64 (s, 3H), 2.94 (t, <i>J</i> = 6.9 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.0, 161.0, 157.5, 150.8, 139.6, 139.5, 135.2, 131.8, 130.3, 128.1, 127.9, 127.3, 126.6, 126.5, 123.0, 120.3, 115.2, 114.7, 110.7, 55.2, 46.1, 41.3, 27.9; ESIMS(−) <i>m</i>/<i>z</i>: 444 [M – H]<sup>−</sup>. Anal. Calcd for (C<sub>25</sub>H<sub>23</sub>N<sub>3</sub>O<sub>5</sub>·0.5H<sub>2</sub>O): C, 66.07; H, 5.32; N, 9.25. Found: C, 66.12; H, 5.33; N, 9.17.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> <i>N</i>-Hydroxy-4-((3-(4-hydroxyphenethyl)-2,4-dioxo-3,4-dihydroquinazolin-1(2<i>H</i>)-yl)methyl)benzamide (<b>3q</b>)</h3><div class="NLM_p last">By following general procedures D and E, <b>2k</b> was converted into <b>3q</b> as a white solid (19% yield; four steps). <i>R</i><sub>f</sub> = 0.25 (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 1:9); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.15 (br s, 1H), 9.23 (br s, 1H), 9.02 (br s, 1H), 8.06 (d, <i>J</i> = 6.6 Hz, 1H), 7.70–7.60 (m, 3H), 7.30–7.19 (m, 4H), 7.01 (d, <i>J</i> = 8.2 Hz, 2H), 6.67 (d, <i>J</i> = 8.3 Hz, 2H), 5.38 (s, 2H), 4.15 (t, <i>J</i> = 7.5 Hz, 2H), 2.81 (t, <i>J</i> = 7.5 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.0, 160.9, 155.8, 150.6, 139.5, 139.4, 135.2, 131.8, 129.6, 128.5, 128.0, 127.2, 126.4, 123.0, 115.2, 115.1, 114.8, 46.0, 42.8, 32.3; ESIMS(−) <i>m</i>/<i>z</i>: 430 [M – H]<sup>−</sup>. HPLC 95.5% (retention time = 10.43).</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 4-((2,4-Dioxo-3-(3-(trifluoromethyl)phenethyl)-3,4-dihydroquinazolin-1(2<i>H</i>)-yl)methyl)-<i>N</i>-hydroxybenzamide (<b>3r</b>)</h3><div class="NLM_p last">By following general procedures D and F, <b>2m</b> was converted into <b>3r</b> as a white solid (25% yield; four steps). <i>R</i><sub>f</sub> = 0.36 (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 1:9); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.19 (s, 1H), 9.04 (s, 1H), 8.05 (dd, <i>J</i> = 7.8, 1.5 Hz, 1H), 7.68 (d, <i>J</i> = 8.3 Hz, 2H), 7.66–7.61 (m, 1H), 7.60–7.49 (m, 4H), 7.29–7.19 (m, 4H), 5.37 (s, 2H), 4.27 (t, <i>J</i> = 7.3 Hz, 2H), 3.07 (t, <i>J</i> = 7.2 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.9, 161.9, 150.6, 140.0, 139.5, 139.4, 135.3, 133.0, 131.8, 129.4, 129.2, 128.9, 128.0, 127.2, 126.4, 125.2 (q, <i>J</i> = 3.6 Hz), 123.1, 123.0, 115.0, 114.8, 46.1, 42.1, 32.7; ESIMS(+) <i>m</i>/<i>z</i>: 484.1 [M + H]<sup>+</sup>. HPLC 100% (retention time = 16.73).</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 5-((2,4-Dioxo-3-phenethyl-3,4-dihydroquinazolin-1(2<i>H</i>)-yl)methyl)-<i>N</i>-hydroxythiophene-2-carboxamide (<b>3s</b>)</h3><div class="NLM_p last">By following general procedures D and E, <b>2d</b> was converted into <b>3s</b> as a beige solid (19% yield; four steps). <i>R</i><sub>f</sub> = 0.14 (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 4:96); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.19 (br s, 1H), 9.10 (br s, 1H), 8.04 (dd, <i>J</i> = 7.8, 1.2 Hz, 1H), 7.72 (ddd, <i>J</i> = 8.8, 8.8, 1.6 Hz, 1H), 7.56 (d, <i>J</i> = 8.5 Hz, 1H), 7.45 (br s, 1H), 7.30–7.14 (m, 7H), 5.49 (s, 2H), 4.19 (t, <i>J</i> = 7.7 Hz, 2H), 2.91 (t, <i>J</i> = 7.7 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 160.7, 159.2, 150.1, 142.9, 139.0, 138.4, 136.9, 135.3, 128.6, 128.4, 128.1, 127.5, 127.0, 126.4, 123.1, 115.0, 114.6, 42.4, 41.9, 33.2; ESIMS(−) <i>m</i>/<i>z</i>: 420 [M – H]<sup>−</sup>. Anal. Calcd for (C<sub>22</sub>H<sub>19</sub>N<sub>3</sub>O<sub>4</sub>S): C, 62.69; H, 4.54; N, 9.97. Found: C, 62.86; H, 4.89; N, 9.61.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 4-((2,4-Dioxo-3-phenethyl-3,4-dihydroquinazolin-1(2<i>H</i>)-yl)methyl)-<i>N</i>-hydroxythiophene-2-carboxamide (<b>3t</b>)</h3><div class="NLM_p last">By following general procedures D and E, <b>2d</b> was converted into <b>3t</b> as a beige solid (12% yield; four steps). <i>R</i><sub>f</sub> = 0.21 (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 1:19); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.14 (br s, 1H), 9.06 (br s, 1H), 8.07 (dd, <i>J</i> = 7.8, 1.2 Hz, 1H), 7.69 (ddd, <i>J</i> = 8.8, 8.4, 0.8 Hz, 1H), 7.60 (br s, 1H), 7.50 (br s, 1H), 7.40 (d, <i>J</i> = 8.4 Hz, 1H), 7.31–7.17 (m, 6H), 5.30 (s, 2H), 4.23 (t, <i>J</i> = 7.8 Hz, 2H), 2.93 (t, <i>J</i> = 7.8 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 160.8, 159.2, 150.2, 139.3, 137.8, 137.5, 135.2, 128.6, 128.4, 128.0, 126.9, 126.8, 126.3, 122.9, 115.0, 114.7, 42.5, 42.3, 33.2; ESIMS(+) <i>m</i>/<i>z</i>: 444.1 [M + Na]<sup>+</sup>. Anal. Calcd for (C<sub>22</sub>H<sub>19</sub>N<sub>3</sub>O<sub>4</sub>S): C, 62.69; H, 4.54; N, 9.97. Found: C, 62.93; H, 4.60; N, 9.97.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 4-((2,4-Dioxo-3-phenethyl-3,4-dihydrothieno[2,3-<i>d</i>]pyrimidin-1(2<i>H</i>)-yl)methyl)-<i>N</i>-hydroxybenzamide (<b>3u</b>)</h3><div class="NLM_p last">By following general procedures D and E, <b>2m</b> was converted into <b>3u</b> as a beige solid (5% yield; four steps). <i>R</i><sub>f</sub> = 0.25 (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 4:96); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ11.20 (br s, 1H), 9.04 (br s, 1H), 7.71 (d, <i>J</i> = 7.9 Hz, 2H), 7.36–7.14 (m, 9H), 5.19 (s, 2H), 4.15 (t, <i>J</i> = 7.5 Hz, 2H), 2.90 (t, <i>J</i> = 7.5 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.8, 157.5, 152.3, 150.5, 138.4, 137.9, 132.3, 128.7, 128.4, 127.2, 127.1, 126.3, 123.1, 118.2, 115.2, 50.5, 42.2, 33.1; ESIMS(−) <i>m</i>/<i>z</i>: 420 [M – H]<sup>−</sup>. Anal. Calcd for (C<sub>22</sub>H<sub>19</sub>N<sub>3</sub>O<sub>4</sub>S·0.5H<sub>2</sub>O): C, 61.38; H, 4.68; N, 9.76. Found: C, 61.44; H, 4.60; N, 9.63.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Methyl 4-((7-Chloro-2,4-dioxo-3-phenethyl-3,4-dihydroquinazolin-1(2<i>H</i>)-yl)methyl)benzoate (<b>4</b>)</h3><div class="NLM_p last">NaH (60% (w/v) 0.63 g, 15.95 mmol) was added in portions into DMF (40 mL) containing <b>2b</b> (4 g, 13.3 mmol) at an ice bath temperature and stirred for 1.5 h. Next, ethyl 4-(bromomethyl)benzoate (3.26 g, 13.95 mmol) was added into the solution, which was stirred while increasing the temperature from that of an ice bath to rt over 3 h. Next, the solution was poured into ice water (250 mL) and filtered to obtain <b>4</b> as a beige solid (3.68 g, 60% yield). <i>R</i><sub>f</sub> = 0.21 (EtOAc/hexane = 1:3); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.06 (d, <i>J</i> = 8.9 Hz, 1H), 7.90 (d, <i>J</i> = 8.4 Hz, 2H), 7.36 (d, <i>J</i> = 8.3 Hz, 2H), 7.33–7.26 (m, 4H), 7.24–7.18 (m, 3H), 5.44 (s, 2H), 4.23–4.17 (m, 2H), 3.82 (s, 3H), 2.93 (t, <i>J</i> = 7.6 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 166.0, 160.3, 150.5, 141.6, 140.6, 140.0, 138.5, 130.0, 129.6, 128.7, 128.5, 126.7, 126.4, 123.3, 114.5, 114.1, 52.2, 46.2, 42.6, 33.1; ESIMS(+) <i>m</i>/<i>z</i>: 449.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Methyl 4-((7-Hydroxy-2,4-dioxo-3-phenethyl-3,4-dihydroquinazolin-1(2<i>H</i>)-yl)methyl)benzoate (<b>5a</b>)</h3><div class="NLM_p last">After mixing <b>4</b> (3.5 g, 7.56 mmol) with Herrmann’s palladacycle (0.14 g, 0.15 mmol), XPhos (0.29 g, 0.6 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (7.39 g, 22.68 mmol) in DMF (35 mL) and H<sub>2</sub>O (3.5 mL) under Ar, the mixture was microwave irradiated (200 W, 2 × 30 min) and then evaporated to dryness and suspended in EtOAc (50 mL). The EtOAc solution was washed with H<sub>2</sub>O (3 × 50 mL), dried over MgSO<sub>4</sub>, concentrated, and then filtered to obtain <b>5a</b> as a beige solid (3 g, 90% yield). <i>R</i><sub>f</sub> = 0.41 (EtOAc/hexane = 1:1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.67 (s, 1H), 7.94–7.87 (m, 3H), 7.32 (d, <i>J</i> = 8.3 Hz, 2H), 7.29–7.24 (m, 2H), 7.24–7.16 (m, 3H), 6.68 (dd, <i>J</i> = 8.7, 1.9 Hz, 1H), 6.44 (d, <i>J</i> = 1.9 Hz, 1H), 5.32 (s, 2H), 4.18 (t, <i>J</i> = 7.6 Hz, 2H), 3.81 (s, 3H), 2.91 (t, <i>J</i> = 7.6 Hz, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 166.0, 163.7, 160.5, 151.0, 142.0, 141.4, 138.7, 130.3, 129.6, 128.8, 128.7, 128.4, 126.7, 126.3, 111.8, 107.1, 100.3, 52.2, 46.4, 42.3, 33.4; ESIMS(+) <i>m</i>/<i>z</i>: 431.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Methyl 4-((7-Methyl-2,4-dioxo-3-phenethyl-3,4-dihydroquinazolin-1(2<i>H</i>)-yl)methyl)benzoate (<b>5b</b>)</h3><div class="NLM_p last">After mixing <b>4</b> (3 g, 6.68 mmol) with Pd<sub>2</sub>(dba)<sub>3</sub> (0.126 g, 0.13 mmol), [(<i>t</i>-Bu)<sub>3</sub>PH]BF<sub>4</sub> (0.16 g, 0.53 mmol) in THF (15 mL) under Ar and Me<sub>2</sub>Zn (1 M in heptane, 13.4 mL) were injected into the mixture, which was then microwave irradiated at 120 °C for 30 min. Next, the solution was evaporated to dryness and then suspended in CH<sub>2</sub>Cl<sub>2</sub> (50 mL), which was washed with H<sub>2</sub>O (3 × 50 mL). The CH<sub>2</sub>Cl<sub>2</sub> layer was dried over MgSO<sub>4</sub> and purified by flash column chromatography with EtOAc/hexane (1:3) as the eluent to obtain <b>5b</b> as a beige solid (1.75 g, 61% yield). <i>R</i><sub>f</sub> = 0.22 (EtOAc/hexane = 1:3); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.95 (d, <i>J</i> = 8.0 Hz, 1H), 7.90 (d, <i>J</i> = 8.3 Hz, 2H), 7.34 (d, <i>J</i> = 8.3 Hz, 2H), 7.31–7.25 (m, 2H), 7.23–7.18 (m, 3H), 7.11–7.05 (m, 2H), 5.40 (s, 2H), 4.21 (t, <i>J</i> = 7.6 Hz, 2H), 3.82 (s, 3H), 2.93 (t, <i>J</i> = 7.5 Hz, 2H), 2.30 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 166.0, 160.8, 150.7, 146.2, 142.1, 139.6, 138.5, 129.6, 128.8, 128.6, 128.4, 128.1, 126.7, 126.3, 124.3, 114.7, 112.8, 52.2, 46.1, 42.4, 33.2, 21.7; ESIMS(+) <i>m</i>/<i>z</i>: 451.2 [M + Na]<sup>+</sup>.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> Methyl 4-((7-Cyclopropyl-2,4-dioxo-3-phenethyl-3,4-dihydroquinazolin-1(2<i>H</i>)-yl)methyl)benzoate (<b>5c</b>)</h3><div class="NLM_p last">After mixing <b>4</b> (0.5 g, 1.08 mmol) with Pd(OAc)<sub>2</sub> (0.007 g, 0.03 mmol), XPhos (0.032 g, 0.06 mmol), C<sub>3</sub>H<sub>5</sub>BF<sub>3</sub>K (0.16 g, 1.08 mmol), and K<sub>2</sub>CO<sub>3</sub> (0.448 g, 3.24 mmol) in THF (3.5 mL) and H<sub>2</sub>O (0.35 mL) under Ar, the mixture was refluxed for 24 h. The resultant solution was diluted with MeOH (15 mL), and the solution was filtered through Celite. The filtrate was evaporated to dryness and purified by flash column chromatography with EtOAc/hexane (1:5) as the eluent to obtain <b>5c</b> as a beige solid (0.42 g, 84% yield). <i>R</i><sub>f</sub> = 0.33 (EtOAc/hexane = 1:5); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.92–7.88 (m, 3H), 7.35 (d, <i>J</i> = 8.1 Hz, 2H), 7.30–7.25 (m, 2H), 7.23–7.17 (m, 3H), 6.91 (d, <i>J</i> = 8.2 Hz, 1H), 6.84 (s, 1H), 5.42 (s, 2H), 4.20 (t, <i>J</i> = 7.5 Hz, 2H), 3.81 (s, 3H), 2.92 (t, <i>J</i> = 7.5 Hz, 2H), 1.95–1.85 (m, 1H), 1.02–0.91 (m, 2H), 0.70–0.59 (m, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 166.0, 160.7, 152.7, 150.8, 142.3, 139.5, 138.5, 129.6, 128.8, 128.6, 128.4, 128.1, 126.8, 126.3, 119.9, 112.5, 111.2, 52.2, 46.0, 42.4, 33.2, 15.8, 10.9; ESIMS(+) <i>m</i>/<i>z</i>: 455.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> HDAC Inhibition Assay</h3><div class="NLM_p last">HDAC inhibition assays were performed by the Reaction Biology Corp. (Malvern, PA) using full-length recombinant hHDAC 1, 6, 8, and 11 that had been expressed in Sf9 cells via baculovirus vectors. Substrate I, a fluorogenic peptide based on the p53 residues 379–382 (RHKKAc), was used for the HDAC 1, 6, and 11 assays, and substrate II, a fluorogenic diacyl peptide based on the p53 residues 379–382 (RHKAcKAc), was used for HDAC8. The reaction buffer was 50 mM Tris-HCl, pH 8.0, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl<sub>2</sub>, 1 mg/mL BSA, and 1% (v/v) DMSO (final concentration). The compounds and a substrate were delivered sequentially into the enzyme mixture, and each reaction was incubated for 2 h at 30 °C. IC<sub>50</sub> values were generated from the resulting 10-dose plots based on threefold serial dilutions starting at 30 μM.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> Plasmid Construction</h3><div class="NLM_p last">The nucleotide sequence of CD2 from hHDAC6 (amino acid residues 450–850) was PCR-amplified from the pcDNA-HDAC6 FLAG clone (product number 30482; Addgene), and the product was subcloned into a pET-28b vector (Novagen). An insert that included <i>EcoR</i>I and <i>Hind</i>III restriction sites was created and PCR-amplified by the polymerase chain reaction using primers 1 and 2, respectively, 5′-TGA ATT CAT GGA GGA GGA CAA TGT AGA GG-3′ and 5′-CGA CAA GCT TTT ACA ACT TAG AAC TGG AGG GTC C-3′. This vector and the PCR fragment were each digested with <i>EcoR</i>I and <i>Hind</i>III, purified by agarose gel electrophoresis, and joined by reaction with T4 ligase DNA ligase. The plasmid sequence was confirmed by Mission Biotech.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> Purification of CD2 of hHDAC6</h3><div class="NLM_p last">CD2 was expressed in <i>Escherichia coli</i> BL21 (RIL). Expression was induced with 1 mM isopropyl-1-thio-β-<span class="smallcaps smallerCapital">d</span>-galactose, after which the cells were incubated at 16 °C overnight. The cells were harvested by centrifugation at 6000<i>g</i> for 15 min at 4 °C, and the pellet was suspended in 20 mM Tris-HCl, pH 8.0, 250 mM NaCl, 5% (v/v) glycerol, and 2 μM β-mercaptoethanol (β-ME). The cells were sonicated, and the lysate was centrifuged at 12 500<i>g</i> and 4 °C for 30 min. The supernatant was passed through a Ni-NTA affinity column, which was washed with 20 mM Tris-HCl, pH 7.0, 250 mM NaCl, 2 μM β-ME, and 20 mM imidazole, and then CD2 was eluted with a step gradient of increasing imidazole concentration (20–500 mM imidazole in 20 mM Tris-HCl, pH 7.0, 30 mM NaCl, and 2 μM β-ME). The protein was stored in 20 mM Tris-HCl, pH 7.0, 100 mM NaCl, 5% (v/v) glycerol, and 2 μM β-ME (buffer was exchanged through a desalting column, GE Healthcare).</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> HDAC6 Enzyme Kinetic Studies</h3><div class="NLM_p last">For the HDAC6 inhibition assays, each inhibitor, after dilution, at various concentrations, into 120 μL of 15 mM Tris-HCl, pH 8.0, 250 μM EDTA, 250 mM NaCl, and 10% (v/v) glycerol, was mixed with 4 nM hHDAC6 (Merck Millipore) or 5 nM CD2 at rt for 10 min. Enzyme activity was then measured using the Fluor De Lys HDAC substrate (Boc-Lys (Ac)-AMC, Biovision; final concentrations: 5–35 μM) and incubated at 37 °C for 30 min. Reactions were stopped by adding 80 μL of 0.1 mg/mL trypsin, 50 mM Tris-HCl, pH 8.0, 100 mM NaCl, 4 mM of the HDAC-inhibitor TSA, and 30% (v/v) isopropanol. After a 30 min incubation at 37 °C, the release of AMC was monitored by measuring the fluorescence at λ<sub>ex</sub> = 350 nm and λ<sub>em</sub> = 440 nm using a Tecan microplate reader. Fluorescence intensity was calibrated using known concentrations of AMC. AMC signals were recorded against a blank containing buffer and substrate. The inhibition data were best fit to a competitive inhibition pattern, and all experiments were repeated three times.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> Assessment of Tissue Distribution of ACY-1215, <b>3d</b>, and Hydrolysis Metabolite in Mice</h3><div class="NLM_p last">All of the animals were performed in accordance with the guidelines of the Institutional Animal Care and Use Committee of the Institute (IACUC). Male C57BL/6 mice weighing 0.02–0.03 kg were purchased from LASCO (BioLasco Taiwan Co. Ltd., Taipei, Taiwan) and housed under a standard 12 h light/dark cycle. The mice were allowed access only to water for 12 h before experimentation. For ACY-1215 and <b>3d</b> tissue distribution study, the mice received an orally administered 40 mg/kg dose of ACY-1215 or one of <b>3d</b> (18 mice per group). At 0.25, 0.5, 1, 2, 6, and 24 h after dosing, three mice from each group were sacrificed. For <b>3d</b> combined with PAX treatment study, mice received an orally administered 40 mg/kg dose of <b>3d</b> combined with 10 mg/kg intraperitoneal injection of PAX (3 mice per group). At 1 h after dosing, the mice were sacrificed. In both studies, the mice were perfused with ice-cold normal saline for myocardial perfusion. Plasma, lung, liver, and kidney samples were collected and stored at −80 °C until analysis. Plasma was separated from blood by centrifugation (3000<i>g</i> for 15 min at 4 °C). To determine the ACY-1215, <b>3d</b>, and the hydrolysis metabolite of <b>3d</b> concentrations in the plasma, a 50 μL plasma sample was added into a fourfold volume of acetonitrile containing 200 ppb vorinostat supplied by TCI as an internal standard and vortexed for 1 min. After centrifugation at 12 000<i>g</i> for 6 min, the upper layer of the mixture was filtrated through a Minisart RC4 syringe filter (0.22 μm, Sartorius Stedim Lab Ltd, UK). A sample of each organ, lungs, livers, and kidneys, was weighed and added into deionized water (2 mL/g) and homogenized using an Active Motif Q120AM ultrasonicator at 30% power for two 20 s periods with a resting period of 10 s between two sonication periods. Vorinostat (2500 ppb, 10 μL) was added into each homogenate to serve as an internal standard; then, a threefold volume of EtOAc was added, and each mixture was vortexed for 1 min. After centrifugation at 3800<i>g</i> for 10 min, the organic layer of each sample was placed into a clean tube and evaporated under a stream of air at 40 °C. Each residue was suspended in 200 μL of acetonitrile. After centrifugation at 12 000<i>g</i> for 6 min, the upper layer of each solution was filtrated through a Minisart RC4 syringe filter. Each sample was subjected to LC/MS/MS to quantitate the concentrations of the drugs extracted from the plasma and tissues.</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> LC/MS/MS</h3><div class="NLM_p last">Compounds were separated through a Kinetex C18 column (50 mm × 3 mm i.d.; 2.6 μm particle size; Phenomenex, Torrance, CA, USA) protected by a Phenomenex Gemini C18 guard cartridge. The elution solvents were 0.5% (w/v) formic acid in acetonitrile (solvent A) and 0.5% (w/v) formic acid in deionized water (solvent B). The column was equilibrated in 90% B for 2 min. Between 2 and 3 min, the percentage of B was decreased to 0% and then held at 0% B for an additional 2 min. Between 5 and 5.5 min, B was increased to 90% and then maintained at 90% B for 1 min for a total time of 6.5 min. The flow rate was 0.8 mL/min; the column temperature was 40 °C; and the sample size was 10 μL. Multiple reaction monitoring mode via a positive ESI was applied to detect ACY-1215, <b>3d</b>, hydrolysis metabolite of <b>3d</b>, and vorinostat at the transitions <i>m</i>/<i>z</i> = 434.10 → 274.10, 416.05 → 150.05, 398.90 → 265.05, and 265.05 → 232.15, respectively.</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> Cell Lines and Culture Medium</h3><div class="NLM_p last">Mouse Lewis lung carcinoma cells (LL/2, ATCC CCL-81<sup>T</sup>) and human lung carcinoma cells (A549, ATCC CCL-185) were maintained in Dulbecco’s modified Eagle’s medium (DMEM) and RPMI-1640 medium, respectively, supplemented with 10% (v/v) fetal bovine serum (Gibco), 100 units/mL penicillin G, and 100 μg/mL streptomycin (Gibco). Cell cultures were maintained at 37 °C in a humidified atmosphere of 5% CO<sub>2</sub> and were subcultured one to three times a week.</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> MTT Assay</h3><div class="NLM_p last">Cell-doubling rates and viability were evaluated by the MTT assay. Briefly, cells were grown in wells of 96-well plates (initially, 5000 cells per well). Cells were allowed to attach for 24 h and then exposed to fivefold diluted compound or only to the vehicle (DMEM with 0.1% DMSO). After 72 h, 20 μL (5 mg/mL) of MTT was added into each cell culture. After a 5 h incubation at 37 °C, the supernatant of each culture was carefully aspirated, and the resulting formazan crystals were dissolved in 100 μL DMSO at 37 °C for 10 min with a gentle agitation. Absorbance of each solution was measured at 570 nm using a Molecular Devices I3 microplate reader. Results are presented as the mean of three independent experiments. IC<sub>50</sub> values were calculated from the relative viability values and concentrations of the compounds by regression analysis.</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> In Vitro Combination Assay</h3><div class="NLM_p last">The inhibitory effect of drug combinations on cell proliferation was assessed by crystal violet staining. Briefly, LL/2 cells were seeded into the wells of 24-well plates (5000 cells per well). Cells were allowed to attach for 24 h and were then exposed to HDAC6 inhibitor and/or PAX for up to 4 days. At the end of the 5 day period, the cells were fixed with 3.7% (w/v) formaldehyde at rt for 30 min and then stained with 0.02% (w/v) crystal violet. The cells were then washed with water, after which the plates were dried at rt. The CI was calculated by CompuSyn software (ComboSyn Inc, Paramus, NJ, USA) according to the Chou-Talalay method.</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> Western Blots</h3><div class="NLM_p last">Cells were lysed in 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% (v/v) Triton X-100, 0.1% (w/v) SDS, 1% (w/v) sodium deoxycholate, 1 mM phenylmethanesulfonylfluoride (Sigma-Aldrich), and a protease inhibitor cocktail (Sigma-Aldrich), and the protein concentration in each lysate was measured by the BCA protein assay (Bio-Rad). Proteins were resolved by SDS-PAGE [12.5% (w/v) acrylamide]; transferred onto a polyvinylidene difluoride membrane (Merck Millipore); blocked with 5% (v/v) skim milk in 20 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 0.5% (v/v) Tween-20; and reacted with anti-β-actin (1:2000 dilution; Cell Signaling, with β-actin serving as the internal control), anti-acetyl-α-tubulin (Lys40; 1:1000 dilution; Cell Signaling), and anti-acetyl-histone H3 (Lys9; 1:1000 dilution; Cell Signaling). The secondary antibody used was Europium-labeled goat antirabbit IgG (1:5000 dilution; Molecular Devices).</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> LL/2 Tumor Syngeneic Xenograft Mouse Model</h3><div class="NLM_p last">Seven-week-old C57BL/6 mice were subcutaneously injected with 100 μL of an LL/2 cell suspension (equivalent to 5 × 10<sup>6</sup> cells). PAX (10 mg/kg) was intraperitoneally injected once daily for 5 days (10 mg/kg IP QD × 5) (<i>n</i> = 8). Mice were orally dosed with 20, 40, or 80 mg/kg <b>3d</b> once daily for 21 consecutive days (20 or 40 or 80 mg/kg oral QD × 3 weeks) (<i>n</i> = 8). TVs were measured twice weekly throughout the duration of the experiment.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i90"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01590" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55802" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55802" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01590" class="ext-link">10.1021/acs.jmedchem.8b01590</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">SMILES (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01590/suppl_file/jm8b01590_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">HPLC purity results, <sup>1</sup>H, <sup>13</sup>C NMR spectra, and enzyme inhibition curves of target compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01590/suppl_file/jm8b01590_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01590/suppl_file/jm8b01590_si_001.csv">jm8b01590_si_001.csv (1.39 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01590/suppl_file/jm8b01590_si_002.pdf">jm8b01590_si_002.pdf (3.93 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01590" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25501" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25501" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yi-Sheng Cheng</span> - <span class="hlFld-Affiliation affiliation">Department
of Life Science, Institute of Plant Biology, and Genome and Systems
Biology Degree Program, National Taiwan
University, Taipei 10617, Taiwan</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#583b303d363f212b18362c2d763d3c2d762c2f"><span class="__cf_email__" data-cfemail="2a49424f444d53596a445e5f044f4e5f045e5d">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ji-Wang Chern</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, College of Medicine, 
    Center for Innovative Therapeutics
Discovery, 
    , and , National Taiwan University, Taipei 10607, Taiwan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4310-8834" title="Orcid link">http://orcid.org/0000-0002-4310-8834</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c5afb2a6ada0b7ab85abb1b0eba0a1b0ebb1b2"><span class="__cf_email__" data-cfemail="8be1fce8e3eef9e5cbe5fffea5eeeffea5fffc">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chao-Wu Yu</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, College of Medicine, 
    , and , National Taiwan University, Taipei 10607, Taiwan</span>; 
    <span class="hlFld-Affiliation affiliation">AnnJi
Pharmaceutical Co., Ltd., 18, Siyuan Street, Taipei 10087, Taiwan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5176-4225" title="Orcid link">http://orcid.org/0000-0002-5176-4225</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pei-Yun Hung</span> - <span class="hlFld-Affiliation affiliation">AnnJi
Pharmaceutical Co., Ltd., 18, Siyuan Street, Taipei 10087, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hui-Ting Yang</span> - <span class="hlFld-Affiliation affiliation">AnnJi
Pharmaceutical Co., Ltd., 18, Siyuan Street, Taipei 10087, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yi-Hsun Ho</span> - <span class="hlFld-Affiliation affiliation">AnnJi
Pharmaceutical Co., Ltd., 18, Siyuan Street, Taipei 10087, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hsing-Yi Lai</span> - <span class="hlFld-Affiliation affiliation">Department
of Life Science, Institute of Plant Biology, and Genome and Systems
Biology Degree Program, National Taiwan
University, Taipei 10617, Taiwan</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written with contributions from all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i92">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57061" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57061" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was supported by the Ministry of Science and Technology, Taiwan (107-2311-B-002-010 and 107-2313-B-002-003), National Taiwan University (108L893105), Aim for top university projects, and AnnJi new drug development grant.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">HDAC</td><td class="NLM_def"><p class="first last">histone deacetylase</p></td></tr><tr><td class="NLM_term">CD2</td><td class="NLM_def"><p class="first last">catalytic domain 2</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i94">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63375" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63375" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 25 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parmigiani, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venta-Perez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdjument-Bromage, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaneva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tempst, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, P. A.</span></span> <span> </span><span class="NLM_article-title">HDAC6 Is a Specific Deacetylase of Peroxiredoxins and Is Involved in Redox Regulation</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">9633</span>– <span class="NLM_lpage">9638</span>, <span class="refDoi"> DOI: 10.1073/pnas.0803749105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1073%2Fpnas.0803749105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=18606987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovVOjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=9633-9638&author=R.+B.+Parmigianiauthor=W.+S.+Xuauthor=G.+Venta-Perezauthor=H.+Erdjument-Bromageauthor=M.+Yanevaauthor=P.+Tempstauthor=P.+A.+Marks&title=HDAC6+Is+a+Specific+Deacetylase+of+Peroxiredoxins+and+Is+Involved+in+Redox+Regulation&doi=10.1073%2Fpnas.0803749105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation</span></div><div class="casAuthors">Parmigiani, R. B.; Xu, W. S.; Venta-Perez, G.; Erdjumen-Bromage, H.; Yaneva, M.; Tempst, P.; Marks, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">9633-9638</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Eighteen histone deacetylases (HDACs) are present in humans, categorized into 2 groups: (1) Zn-dependent enzymes (HDAC1-11) and (2) NAD-dependent enzymes (sirtuins 1-7).  Among Zn-dependent HDACs, HDAC6 is unique.  It has a cytoplasmic localization, 2 catalytic sites, a ubiquitin-binding site, and it selectively deacetylates α-tubulin and Hsp90.  Here, the authors report the discovery that the redox regulatory proteins, peroxiredoxins (Prxs) I and II are specific targets of HDAC6 in human prostate cancer cells.  Prxs are antioxidant enzymes whose main function is H2O2 redn.  Prxs are elevated in many cancers and neurodegenerative diseases.  The acetylated form of Prx accumulates in the absence of an active HDAC6.  Acetylation of Prx increases its reducing activity, its resistance to superoxidn., and its resistance to transition to high-mol.-wt. complexes.  Thus, HDAC6 and Prxs are targets for modulating intracellular redox status in therapeutic strategies for disorders as disparate as cancers and neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPhHinn-zsRbVg90H21EOLACvtfcHk0ljT7BtcTm631A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovVOjt7g%253D&md5=205d33a2f6c154d83b1d1cee59d29108</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0803749105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0803749105%26sid%3Dliteratum%253Aachs%26aulast%3DParmigiani%26aufirst%3DR.%2BB.%26aulast%3DXu%26aufirst%3DW.%2BS.%26aulast%3DVenta-Perez%26aufirst%3DG.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DYaneva%26aufirst%3DM.%26aulast%3DTempst%26aufirst%3DP.%26aulast%3DMarks%26aufirst%3DP.%2BA.%26atitle%3DHDAC6%2520Is%2520a%2520Specific%2520Deacetylase%2520of%2520Peroxiredoxins%2520and%2520Is%2520Involved%2520in%2520Redox%2520Regulation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D9633%26epage%3D9638%26doi%3D10.1073%2Fpnas.0803749105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valenzuela-Fernández, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrero, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrador, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Madrid, F.</span></span> <span> </span><span class="NLM_article-title">HDAC6: A Key Regulator of Cytoskeleton, Cell Migration and Cell-Cell Interactions</span>. <i>Trends Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">291</span>– <span class="NLM_lpage">297</span>, <span class="refDoi"> DOI: 10.1016/j.tcb.2008.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1016%2Fj.tcb.2008.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=18472263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvVymu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=291-297&author=A.+Valenzuela-Fern%C3%A1ndezauthor=J.+R.+Cabreroauthor=J.+M.+Serradorauthor=F.+S%C3%A1nchez-Madrid&title=HDAC6%3A+A+Key+Regulator+of+Cytoskeleton%2C+Cell+Migration+and+Cell-Cell+Interactions&doi=10.1016%2Fj.tcb.2008.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions</span></div><div class="casAuthors">Valenzuela-Fernandez, Agustin; Cabrero, J. Roman; Serrador, Juan M.; Sanchez-Madrid, Francisco</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">291-297</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase 6 (HDAC6) is a cytoplasmic enzyme that regulates many important biol. processes, including cell migration, immune synapse formation, viral infection, and the degrdn. of misfolded proteins.  HDAC6 deacetylates tubulin, Hsp90 and cortactin, and forms complexes with other partner proteins.  Although HDAC6 enzymic activity seems to be required for the regulation of cell morphol., the role of HDAC6 in lymphocyte chemotaxis is independent of its tubulin deacetylase activity.  The diverse functions of HDAC6 suggest that it is a potential therapeutic target for the treatment of a range of diseases.  This review examines the biol. actions of HDAC6, focusing on its deacetylase activity and its potential scaffold functions in the regulation of cell migration and other key biol. processes in which the cytoskeleton plays an important role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqds4gVWXQSw7Vg90H21EOLACvtfcHk0lj_CZo6EqFUkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvVymu7g%253D&md5=146b21482aa0828a1e7c1c9c24339199</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2008.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2008.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DValenzuela-Fern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DCabrero%26aufirst%3DJ.%2BR.%26aulast%3DSerrador%26aufirst%3DJ.%2BM.%26aulast%3DS%25C3%25A1nchez-Madrid%26aufirst%3DF.%26atitle%3DHDAC6%253A%2520A%2520Key%2520Regulator%2520of%2520Cytoskeleton%252C%2520Cell%2520Migration%2520and%2520Cell-Cell%2520Interactions%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2008%26volume%3D18%26spage%3D291%26epage%3D297%26doi%3D10.1016%2Fj.tcb.2008.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, S. C.</span></span> <span> </span><span class="NLM_article-title">Histone Deacetylase Inhibitors: Molecular Mechanisms of Action and Clinical Trials as Anti-Cancer Drugs</span>. <i>Am. J. Transl. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">166</span>– <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=21416059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtVSqur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=166-79&author=H.+J.+Kimauthor=S.+C.+Bae&title=Histone+Deacetylase+Inhibitors%3A+Molecular+Mechanisms+of+Action+and+Clinical+Trials+as+Anti-Cancer+Drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs</span></div><div class="casAuthors">Kim, Hyun-Jung; Bae, Suk-Chul</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Translational Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">166-179</span>CODEN:
                <span class="NLM_cas:coden">AJTRA7</span>;
        ISSN:<span class="NLM_cas:issn">1943-8141</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase (HDAC) inhibitors are a relatively new class of anti-cancer agents that play important roles in epigenetic or non-epigenetic regulation, inducing death, apoptosis, and cell cycle arrest in cancer cells.  Recently, their use has been clin. validated in cancer patients resulting in the approval of two HDAC inhibitors, vorinostat and depsipetide, by the FDA.  Also, clin. trials of several HDAC inhibitors for use as anti-cancer drugs (alone or in combination with other anti-cancer therapeutics) are ongoing.  However, the mol. mechanisms underlying the response to HDAC inhibitors in cancer patients are not fully understood.  In this review, we summarize our understanding of the mol. and biol. events that underpin the anti-cancer effects of HDAC inhibitors and the outcomes of recent clin. trials involving these drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6o4vH0OXL7bVg90H21EOLACvtfcHk0lj_CZo6EqFUkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtVSqur0%253D&md5=2f4388dec15ec9b517836f4f3b225641</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DBae%26aufirst%3DS.%2BC.%26atitle%3DHistone%2520Deacetylase%2520Inhibitors%253A%2520Molecular%2520Mechanisms%2520of%2520Action%2520and%2520Clinical%2520Trials%2520as%2520Anti-Cancer%2520Drugs%26jtitle%3DAm.%2520J.%2520Transl.%2520Res.%26date%3D2011%26volume%3D3%26spage%3D166%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">West, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, R. W.</span></span> <span> </span><span class="NLM_article-title">New and Emerging HDAC Inhibitors for Cancer Treatment</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1172/jci69738</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1172%2Fjci69738" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=24382387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntFejtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=30-39&author=A.+C.+Westauthor=R.+W.+Johnstone&title=New+and+Emerging+HDAC+Inhibitors+for+Cancer+Treatment&doi=10.1172%2Fjci69738"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">New and emerging HDAC inhibitors for cancer treatment</span></div><div class="casAuthors">West, Alison C.; Johnstone, Ricky W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">30-39</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review.  Epigenetic enzymes are often dysregulated in human tumors through mutation, altered expression, or inappropriate recruitment to certain loci.  The identification of these enzymes and their partner proteins has driven the rapid development of small-mol. inhibitors that target the cancer epigenome.  Herein, the authors discuss the influence of aberrantly regulated histone deacetylases (HDACs) in tumorigenesis.  The authors examine HDAC inhibitors (HDACis) targeting class I, II, and IV HDACs that are currently under development for use as anticancer agents following the FDA approval of two HDACis, vorinostat and romidepsin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpELUU7P0B_grVg90H21EOLACvtfcHk0lj_CZo6EqFUkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntFejtg%253D%253D&md5=ab59960223b33e89725f6539b031f531</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1172%2Fjci69738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252Fjci69738%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DA.%2BC.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26atitle%3DNew%2520and%2520Emerging%2520HDAC%2520Inhibitors%2520for%2520Cancer%2520Treatment%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2014%26volume%3D124%26spage%3D30%26epage%3D39%26doi%3D10.1172%2Fjci69738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raedler, L. A.</span></span> <span> </span><span class="NLM_article-title">Farydak (Panobinostat): First HDAC Inhibitor Approved for Patients with Relapsed Multiple Myeloma</span>. <i>Am. Heal. Drug Benefits</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">87</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=27668050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A280%3ADC%252BC2svjvFWrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=84-87&author=L.+A.+Raedler&title=Farydak+%28Panobinostat%29%3A+First+HDAC+Inhibitor+Approved+for+Patients+with+Relapsed+Multiple+Myeloma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Farydak (Panobinostat): First HDAC Inhibitor Approved for Patients with Relapsed Multiple Myeloma</span></div><div class="casAuthors">Raedler Lisa A</div><div class="citationInfo"><span class="NLM_cas:title">American health & drug benefits</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">Spec Feature</span>),
    <span class="NLM_cas:pages">84-7</span>
        ISSN:<span class="NLM_cas:issn">1942-2962</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAmJOZnkDiwS86Js-BCLiifW6udTcc2eZXazTYrevAG7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2svjvFWrtg%253D%253D&md5=683cd02a397160b722022cf3ac3fdfa9</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaedler%26aufirst%3DL.%2BA.%26atitle%3DFarydak%2520%2528Panobinostat%2529%253A%2520First%2520HDAC%2520Inhibitor%2520Approved%2520for%2520Patients%2520with%2520Relapsed%2520Multiple%2520Myeloma%26jtitle%3DAm.%2520Heal.%2520Drug%2520Benefits%26date%3D2016%26volume%3D9%26spage%3D84%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalin, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akimova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">Second-Generation Histone Deacetylase 6 Inhibitors Enhance the Immunosuppressive Effects of Foxp3+ T-Regulatory Cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">639</span>– <span class="NLM_lpage">651</span>, <span class="refDoi"> DOI: 10.1021/jm200773h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200773h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1SrtbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=639-651&author=J.+H.+Kalinauthor=K.+V.+Butlerauthor=T.+Akimovaauthor=W.+W.+Hancockauthor=A.+P.+Kozikowski&title=Second-Generation+Histone+Deacetylase+6+Inhibitors+Enhance+the+Immunosuppressive+Effects+of+Foxp3%2B+T-Regulatory+Cells&doi=10.1021%2Fjm200773h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Second-Generation Histone Deacetylase 6 Inhibitors Enhance the Immunosuppressive Effects of Foxp3+ T-Regulatory Cells</span></div><div class="casAuthors">Kalin, Jay H.; Butler, Kyle V.; Akimova, Tatiana; Hancock, Wayne W.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">639-651</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Second-generation Tubastatin A analogs were synthesized and evaluated for their ability to inhibit selectively histone deacetylase 6 (HDAC6).  Substitutions to the carboline cap group were well-tolerated with substitution at the 2-position of both β- and γ-carbolines being optimal for HDAC6 activity and selectivity.  Some compds. in this series were detd. to have subnanomolar activity at HDAC6 with more than 7000 fold selectivity for HDAC6 vs. HDAC1.  Selected compds. were then evaluated for their ability to augment the immunosuppressive effect of Foxp3+ regulatory T cells.  All compds. tested were found to enhance the ability of regulatory T cells to inhibit the mitotic division of effector T cells both in vitro and in vivo, suggesting that further investigation into the use of these compds. for the treatment of autoimmune disorders is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzt2Rz2tD6ibVg90H21EOLACvtfcHk0ljiRxTnzyyUdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1SrtbzM&md5=88a4f02045fdc5387970abe53ec00c7a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm200773h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200773h%26sid%3Dliteratum%253Aachs%26aulast%3DKalin%26aufirst%3DJ.%2BH.%26aulast%3DButler%26aufirst%3DK.%2BV.%26aulast%3DAkimova%26aufirst%3DT.%26aulast%3DHancock%26aufirst%3DW.%2BW.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DSecond-Generation%2520Histone%2520Deacetylase%25206%2520Inhibitors%2520Enhance%2520the%2520Immunosuppressive%2520Effects%2520of%2520Foxp3%252B%2520T-Regulatory%2520Cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D639%26epage%3D651%26doi%3D10.1021%2Fjm200773h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, P.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsin, L.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chern, J.-W.</span></span> <span> </span><span class="NLM_article-title">Quinazolin-4-One Derivatives as Selective Histone Deacetylase-6 Inhibitors for the Treatment of Alzheimer’s Disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">6775</span>– <span class="NLM_lpage">6791</span>, <span class="refDoi"> DOI: 10.1021/jm400564j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400564j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Slsb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6775-6791&author=C.-W.+Yuauthor=P.-T.+Changauthor=L.-W.+Hsinauthor=J.-W.+Chern&title=Quinazolin-4-One+Derivatives+as+Selective+Histone+Deacetylase-6+Inhibitors+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1021%2Fjm400564j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Quinazolin-4-one Derivatives as Selective Histone Deacetylase-6 Inhibitors for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Yu, Chao-Wu; Chang, Pei-Teh; Hsin, Ling-Wei; Chern, Ji-Wang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6775-6791</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel quinazolin-4-one derivs. contg. a hydroxamic acid moiety were designed and synthesized.  All compds. were subjected to histone deacetylase (HDAC) enzymic assays to identify selective HDAC6 inhibitors with nanomolar IC50 values.  (E)-3-(2-Ethyl-7-fluoro-4-oxo-3-phenethyl-3,4-dihydroquinazolin-6-yl)-N-hydroxyacrylamide (I) is the most potent HDAC6 inhibitor (IC50, 8 nM).  In vitro, these compds. induced neurite outgrowth accompanied by growth-assocd. protein 43 expression, and they enhanced the synaptic activities of PC12 and SH-SY5Y neuronal cells without producing toxic or mitogenic effects.  Several of the compds. dramatically increased nonhistone protein acetylation, specifically of α-tubulin.  Some of the more potent HDAC6 inhibitors decreased zinc-mediated β-amyloid aggregation in vitro.  N-Hydroxy-3-(2-methyl-4-oxo-3-phenethyl-3,4-dihydro-quinazolin-7-yl)-acrylamide (II) the most promising drug candidate, selectively inhibits HDAC6 (IC50, 29 nM), practically does not affect human ether-a-go-go-related membrane channel activity (IC50 >10 μM) or cytochrome P 450 activity (IC50 >6.5 μM) in vitro, and significantly improves learning-based performances of mice with β-amyloid-induced hippocampal lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9ZyFO0SBaDLVg90H21EOLACvtfcHk0ljiRxTnzyyUdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Slsb7J&md5=bcc20d956982b1e4e9a706327087f233</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm400564j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400564j%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DC.-W.%26aulast%3DChang%26aufirst%3DP.-T.%26aulast%3DHsin%26aufirst%3DL.-W.%26aulast%3DChern%26aufirst%3DJ.-W.%26atitle%3DQuinazolin-4-One%2520Derivatives%2520as%2520Selective%2520Histone%2520Deacetylase-6%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6775%26epage%3D6791%26doi%3D10.1021%2Fjm400564j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Villarroel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villagra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotomayor, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">Selective Histone Deacetylase 6 Inhibitors Bearing Substituted Urea Linkers Inhibit Melanoma Cell Growth</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9891</span>– <span class="NLM_lpage">9899</span>, <span class="refDoi"> DOI: 10.1021/jm301098e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301098e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9891-9899&author=J.+A.+Bergmanauthor=K.+Woanauthor=P.+Perez-Villarroelauthor=A.+Villagraauthor=E.+M.+Sotomayorauthor=A.+P.+Kozikowski&title=Selective+Histone+Deacetylase+6+Inhibitors+Bearing+Substituted+Urea+Linkers+Inhibit+Melanoma+Cell+Growth&doi=10.1021%2Fjm301098e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Histone Deacetylase 6 Inhibitors Bearing Substituted Urea Linkers Inhibit Melanoma Cell Growth</span></div><div class="casAuthors">Bergman, Joel A.; Woan, Karrune; Perez-Villarroel, Patricio; Villagra, Alejandro; Sotomayor, Eduardo M.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9891-9899</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The incidence of malignant melanoma has dramatically increased in recent years thus requiring the need for improved therapeutic strategies.  In our efforts to design selective histone deactylase inhibitors (HDACI), we discovered that the aryl urea 1 is a modestly potent yet nonselective inhibitor.  Structure-activity relationship studies revealed that adding substituents to the nitrogen atom of the urea so as to generate compds. bearing a branched linker group results in increased potency and selectivity for HDAC6.  Compd. 5g shows low nanomolar inhibitory potency against HDAC6 and a selectivity of ∼600-fold relative to the inhibition of HDAC1.  These HDACIs were evaluated for their ability to inhibit the growth of B16 melanoma cells with the most potent and selective HDAC6I being found to decrease tumor cell growth.  To the best of our knowledge, this work constitutes the first report of HDAC6-selective inhibitors that possess antiproliferative effects against melanoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTkTtPLqvwsrVg90H21EOLACvtfcHk0ljiRxTnzyyUdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsrbJ&md5=d6be4c0efb3922fc35d814ba00ae9ed1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm301098e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301098e%26sid%3Dliteratum%253Aachs%26aulast%3DBergman%26aufirst%3DJ.%2BA.%26aulast%3DWoan%26aufirst%3DK.%26aulast%3DPerez-Villarroel%26aufirst%3DP.%26aulast%3DVillagra%26aufirst%3DA.%26aulast%3DSotomayor%26aufirst%3DE.%2BM.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DSelective%2520Histone%2520Deacetylase%25206%2520Inhibitors%2520Bearing%2520Substituted%2520Urea%2520Linkers%2520Inhibit%2520Melanoma%2520Cell%2520Growth%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9891%26epage%3D9899%26doi%3D10.1021%2Fjm301098e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrientos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ordentlich, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Counter, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T.-P.</span></span> <span> </span><span class="NLM_article-title">The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic Tumorigenesis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">7561</span>– <span class="NLM_lpage">7569</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-08-0188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1158%2F0008-5472.can-08-0188" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=7561-7569&author=Y.-S.+Leeauthor=K.-H.+Limauthor=X.+Guoauthor=Y.+Kawaguchiauthor=Y.+Gaoauthor=T.+Barrientosauthor=P.+Ordentlichauthor=X.-F.+Wangauthor=C.+M.+Counterauthor=T.-P.+Yao&title=The+Cytoplasmic+Deacetylase+HDAC6+Is+Required+for+Efficient+Oncogenic+Tumorigenesis&doi=10.1158%2F0008-5472.can-08-0188"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.can-08-0188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.can-08-0188%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DY.-S.%26aulast%3DLim%26aufirst%3DK.-H.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DKawaguchi%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DBarrientos%26aufirst%3DT.%26aulast%3DOrdentlich%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DX.-F.%26aulast%3DCounter%26aufirst%3DC.%2BM.%26aulast%3DYao%26aufirst%3DT.-P.%26atitle%3DThe%2520Cytoplasmic%2520Deacetylase%2520HDAC6%2520Is%2520Required%2520for%2520Efficient%2520Oncogenic%2520Tumorigenesis%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D7561%26epage%3D7569%26doi%3D10.1158%2F0008-5472.can-08-0188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salas-Burgos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koomen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olashaw, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dent, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seto, E.</span></span> <span> </span><span class="NLM_article-title">HDAC6 Modulates Cell Motility by Altering the Acetylation Level of Cortactin</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">213</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2007.05.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1016%2Fj.molcel.2007.05.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=17643370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFamtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=197-213&author=X.+Zhangauthor=Z.+Yuanauthor=Y.+Zhangauthor=S.+Yongauthor=A.+Salas-Burgosauthor=J.+Koomenauthor=N.+Olashawauthor=J.+T.+Parsonsauthor=X.-J.+Yangauthor=S.+R.+Dentauthor=T.-P.+Yaoauthor=W.+S.+Laneauthor=E.+Seto&title=HDAC6+Modulates+Cell+Motility+by+Altering+the+Acetylation+Level+of+Cortactin&doi=10.1016%2Fj.molcel.2007.05.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 modulates cell motility by altering the acetylation level of cortactin</span></div><div class="casAuthors">Zhang, Xiaohong; Yuan, Zhigang; Zhang, Yingtao; Yong, Sarah; Salas-Burgos, Alexis; Koomen, John; Olashaw, Nancy; Parsons, J. Thomas; Yang, Xiang-Jiao; Dent, Sharon R.; Yao, Tso-Pang; Lane, William S.; Seto, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">197-213</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Histone deacetylase 6 (HDAC6) is a tubulin-specific deacetylase that regulates microtubule-dependent cell movement.  In this study, we identify the F-actin-binding protein cortactin as a HDAC6 substrate.  We demonstrate that HDAC6 binds cortactin and that overexpression of HDAC6 leads to hypoacetylation of cortactin, whereas inhibition of HDAC6 activity leads to cortactin hyperacetylation.  HDAC6 alters the ability of cortactin to bind F-actin by modulating a "charge patch" in its repeat region.  Introduction of charge-preserving or charge-neutralizing mutations in this cortactin repeat region correlates with the gain or loss of F-actin binding ability, resp.  Cells expressing a charge-neutralizing cortactin mutant were less motile than control cells or cells expressing a charge-preserving mutant.  These findings suggest that, in addn. to its role in microtubule-dependent cell motility, HDAC6 influences actin-dependent cell motility by altering the acetylation status of cortactin, which, in turn, changes the F-actin binding activity of cortactin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQSM-mAzzZOrVg90H21EOLACvtfcHk0ljF4yyqXqs5hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFamtLg%253D&md5=752a0203b7cde321c9c5de07fba79ca7</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2007.05.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2007.05.033%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYuan%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYong%26aufirst%3DS.%26aulast%3DSalas-Burgos%26aufirst%3DA.%26aulast%3DKoomen%26aufirst%3DJ.%26aulast%3DOlashaw%26aufirst%3DN.%26aulast%3DParsons%26aufirst%3DJ.%2BT.%26aulast%3DYang%26aufirst%3DX.-J.%26aulast%3DDent%26aufirst%3DS.%2BR.%26aulast%3DYao%26aufirst%3DT.-P.%26aulast%3DLane%26aufirst%3DW.%2BS.%26aulast%3DSeto%26aufirst%3DE.%26atitle%3DHDAC6%2520Modulates%2520Cell%2520Motility%2520by%2520Altering%2520the%2520Acetylation%2520Level%2520of%2520Cortactin%26jtitle%3DMol.%2520Cell%26date%3D2007%26volume%3D27%26spage%3D197%26epage%3D213%26doi%3D10.1016%2Fj.molcel.2007.05.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Namdar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, P. A.</span></span> <span> </span><span class="NLM_article-title">Selective Inhibition of Histone Deacetylase 6 (HDAC6) Induces DNA Damage and Sensitizes Transformed Cells to Anticancer Agents</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">20003</span>– <span class="NLM_lpage">20008</span>, <span class="refDoi"> DOI: 10.1073/pnas.1013754107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1073%2Fpnas.1013754107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=21037108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVyitL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=20003-20008&author=M.+Namdarauthor=G.+Perezauthor=L.+Ngoauthor=P.+A.+Marks&title=Selective+Inhibition+of+Histone+Deacetylase+6+%28HDAC6%29+Induces+DNA+Damage+and+Sensitizes+Transformed+Cells+to+Anticancer+Agents&doi=10.1073%2Fpnas.1013754107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents</span></div><div class="casAuthors">Namdar, Mandana; Perez, Gisela; Ngo, Lang; Marks, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">20003-20008, S20003/1-S20003/4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Histone deacetylase 6 (HDAC6) is structurally and functionally unique among the 11 human zinc-dependent histone deacetylases.  Here we show that chem. inhibition with the HDAC6-selective inhibitor tubacin significantly enhances cell death induced by the topoisomerase II inhibitors etoposide and doxorubicin and the pan-HDAC inhibitor SAHA (vorinostat)in transformed cells (LNCaP, MCF-7), an effect not obsd. in normal cells (human foreskin fibroblast cells).  The inactive analog of tubacin, nil-tubacin, does not sensitize transformed cells to these anticancer agents.  Further, we show that down-regulation of HDAC6 expression by shRNA in LNCaP cells enhances cell death induced by etoposide, doxorubicin, and SAHA.  Tubacin in combination with SAHA or etoposide is more potent than either drug alone in activating the intrinsic apoptotic pathway in transformed cells, as evidenced by an increase in PARP cleavage and partial inhibition of this effect by the pan-caspase inhibitor Z-VAD-fmk.  HDAC6 inhibition with tubacin induces the accumulation of γH2AX, an early marker of DNA double-strand breaks.  Tubacin enhances DNA damage induced by etoposide or SAHA as indicated by increased accumulation of γH2AX and activation of the checkpoint kinase Chk2.  Tubacin induces the expression of DDIT3 (CHOP/GADD153), a transcription factor up-regulated in response to cellular stress.  DDIT3 induction is further increased when tubacin is combined with SAHA.  These findings point to mechanisms by which HDAC6-selective inhibition can enhance the efficacy of certain anti-cancer agents in transformed cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZaEb79wuk2rVg90H21EOLACvtfcHk0ljF4yyqXqs5hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVyitL%252FP&md5=64381ac4f0421f6161c8699b30843fc1</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1013754107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1013754107%26sid%3Dliteratum%253Aachs%26aulast%3DNamdar%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DG.%26aulast%3DNgo%26aufirst%3DL.%26aulast%3DMarks%26aufirst%3DP.%2BA.%26atitle%3DSelective%2520Inhibition%2520of%2520Histone%2520Deacetylase%25206%2520%2528HDAC6%2529%2520Induces%2520DNA%2520Damage%2520and%2520Sensitizes%2520Transformed%2520Cells%2520to%2520Anticancer%2520Agents%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D20003%26epage%3D20008%26doi%3D10.1073%2Fpnas.1013754107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hideshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarpe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Duzer, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazitschek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogier, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirstea, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scullen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canavese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raje, N.</span></span> <span> </span><span class="NLM_article-title">Preclinical Activity, Pharmacodynamic, and Pharmacokinetic Properties of a Selective HDAC6 Inhibitor, ACY-1215, in Combination with Bortezomib in Multiple Myeloma</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">2579</span>– <span class="NLM_lpage">2589</span>, <span class="refDoi"> DOI: 10.1182/blood-2011-10-387365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1182%2Fblood-2011-10-387365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=22262760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVOntb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2012&pages=2579-2589&author=L.+Santoauthor=T.+Hideshimaauthor=A.+L.+Kungauthor=J.-C.+Tsengauthor=D.+Tamangauthor=M.+Yangauthor=M.+Jarpeauthor=J.+H.+van+Duzerauthor=R.+Mazitschekauthor=W.+C.+Ogierauthor=D.+Cirsteaauthor=S.+Rodigauthor=H.+Edaauthor=T.+Scullenauthor=M.+Canaveseauthor=J.+Bradnerauthor=K.+C.+Andersonauthor=S.+S.+Jonesauthor=N.+Raje&title=Preclinical+Activity%2C+Pharmacodynamic%2C+and+Pharmacokinetic+Properties+of+a+Selective+HDAC6+Inhibitor%2C+ACY-1215%2C+in+Combination+with+Bortezomib+in+Multiple+Myeloma&doi=10.1182%2Fblood-2011-10-387365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma</span></div><div class="casAuthors">Santo, Loredana; Hideshima, Teru; Kung, Andrew L.; Tseng, Jen-Chieh; Tamang, David; Yang, Min; Jarpe, Matthew; van Duzer, John H.; Mazitschek, Ralph; Ogier, Walter C.; Cirstea, Diana; Rodig, Scott; Eda, Homare; Scullen, Tyler; Canavese, Miriam; Bradner, James; Anderson, Kenneth C.; Jones, Simon S.; Raje, Noopur</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2579-2589</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Histone deacetylase (HDAC) enzymic activity has been linked to the transcription of DNA in cancers including multiple myeloma (MM).  Therefore, HDAC inhibitors used alone and in combination are being actively studied as novel therapies in MM.  In the present study, we investigated the preclin. activity of ACY-1215, an HDAC6-selective inhibitor, alone and in combination with bortezomib in MM.  Low doses of ACY-1215 combined with bortezomib triggered synergistic anti-MM activity, resulting in protracted endoplasmic reticulum stress and apoptosis via activation of caspase-3, caspase-8, and caspase-9 and poly (ADP) ribosome polymerase.  In vivo, the anti-MM activity of ACY-1215 in combination with bortezomib was confirmed using 2 different xenograft SCID mouse models: human MM injected s.c. (the plasmacytoma model) and luciferase-expressing human MM injected i.v. (the disseminated MM model).  Tumor growth was significantly delayed and overall survival was significantly prolonged in animals treated with the combination therapy.  Pharmacokinetic data showed peak plasma levels of ACY-1215 at 4 h after treatment coincident with an increase in acetylated α-tubulin, a marker of HDAC6 inhibition, by immunohistochem. and Western blot anal.  These studies provide preclin. rationale for acetylated α-tubulin use as a pharmacodynamic biomarker in future clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoelmsk1wo_LVg90H21EOLACvtfcHk0liWV9PfK38vRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVOntb4%253D&md5=094298bdd3d5b91c7060d8b294857846</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1182%2Fblood-2011-10-387365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2011-10-387365%26sid%3Dliteratum%253Aachs%26aulast%3DSanto%26aufirst%3DL.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DTseng%26aufirst%3DJ.-C.%26aulast%3DTamang%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DJarpe%26aufirst%3DM.%26aulast%3Dvan%2BDuzer%26aufirst%3DJ.%2BH.%26aulast%3DMazitschek%26aufirst%3DR.%26aulast%3DOgier%26aufirst%3DW.%2BC.%26aulast%3DCirstea%26aufirst%3DD.%26aulast%3DRodig%26aufirst%3DS.%26aulast%3DEda%26aufirst%3DH.%26aulast%3DScullen%26aufirst%3DT.%26aulast%3DCanavese%26aufirst%3DM.%26aulast%3DBradner%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DJones%26aufirst%3DS.%2BS.%26aulast%3DRaje%26aufirst%3DN.%26atitle%3DPreclinical%2520Activity%252C%2520Pharmacodynamic%252C%2520and%2520Pharmacokinetic%2520Properties%2520of%2520a%2520Selective%2520HDAC6%2520Inhibitor%252C%2520ACY-1215%252C%2520in%2520Combination%2520with%2520Bortezomib%2520in%2520Multiple%2520Myeloma%26jtitle%3DBlood%26date%3D2012%26volume%3D119%26spage%3D2579%26epage%3D2589%26doi%3D10.1182%2Fblood-2011-10-387365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, G.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, D.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, P.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, T.-L.</span></span> <span> </span><span class="NLM_article-title">The HDAC Inhibitor LBH589 Induces ERK-Dependent Prometaphase Arrest in Prostate Cancer via HDAC6 Inactivation and Down-Regulation</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e73401</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0073401</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1371%2Fjournal.pone.0073401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=24023871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVGitb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=M.-J.+Chuangauthor=S.-T.+Wuauthor=S.-H.+Tangauthor=X.-M.+Laiauthor=H.-C.+Laiauthor=K.-H.+Hsuauthor=K.-H.+Sunauthor=G.-H.+Sunauthor=S.-Y.+Changauthor=D.-S.+Yuauthor=P.-W.+Hsiaoauthor=S.-M.+Huangauthor=T.-L.+Cha&title=The+HDAC+Inhibitor+LBH589+Induces+ERK-Dependent+Prometaphase+Arrest+in+Prostate+Cancer+via+HDAC6+Inactivation+and+Down-Regulation&doi=10.1371%2Fjournal.pone.0073401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The HDAC inhibitor LBH589 induces ERK-dependent prometaphase arrest in prostate cancer via HDAC6 inactivation and down-regulation</span></div><div class="casAuthors">Chuang, Mei-Jen; Wu, Sheng-Tang; Tang, Shou-Hung; Lai, Xiang-Me; Lai, Hsiao-Chu; Hsu, Kai-Hsiang; Sun, Kuang-Hui; Sun, Guang-Huan; Chang, Sun-Yran; Yu, Dah-Shyong; Hsiao, Pei-Wen; Huang, Shih-Ming; Cha, Tai-Lung</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e73401</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Histone deacetylase inhibitors (HDACIs) have potent anti-cancer activity in a variety of cancer models.  Understanding the mol. mechanisms involved in the therapeutic responsiveness of HDACI is needed before its clin. application.  This study aimed to det. if a potent HDACI, LBH589 (Panobinostat), had differential therapeutic responsiveness towards LNCaP and PC-3 prostate cancer (PCa) cells.  The former showed prometaphase arrest with subsequent apoptosis upon LBH589 treatment, while the latter was less sensitive and had late G2 arrest.  The LBH589 treatment down-regulated HDAC6 and sustained ERK activation, and contributed to prometaphase arrest.  Mechanistically, LBH589 inhibited HDAC6 activity, caused its dissocn. from protein phosphatase PP1α, and increased 14-3-3ζ acetylation.  Acetylated 14-3-3ζ released its mask effect on serine 259 of c-Raf and serine 216 of Cdc25C subsequent to de-phosphorylation by PP1α, which contributed to ERK activation.  Enhanced ERK activity by LBH589 further down-regulated HDAC6 protein levels and sustained ERK activation by free-forward regulation.  The sustained Cdc25C and ERK activation resulted in early M-phase (prometaphase) arrest and subsequent apoptosis in the most sensitive LNCaP cells but not in PC-3 cells.  This study provides pre-clin. evidence that HDAC6 may serve as a sensitive therapeutic target in the treatment of prostate cancer with HDACI LBH589 for clin. translation.  This study also posits a novel mechanism of HDAC6 participation in regulating the c-Raf-PP1-ERK signaling pathway and contributing to M phase cell-cycle transition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHD_joXlVF8rVg90H21EOLACvtfcHk0liWV9PfK38vRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVGitb7I&md5=435d8b527734fe55327afa9473338228</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0073401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0073401%26sid%3Dliteratum%253Aachs%26aulast%3DChuang%26aufirst%3DM.-J.%26aulast%3DWu%26aufirst%3DS.-T.%26aulast%3DTang%26aufirst%3DS.-H.%26aulast%3DLai%26aufirst%3DX.-M.%26aulast%3DLai%26aufirst%3DH.-C.%26aulast%3DHsu%26aufirst%3DK.-H.%26aulast%3DSun%26aufirst%3DK.-H.%26aulast%3DSun%26aufirst%3DG.-H.%26aulast%3DChang%26aufirst%3DS.-Y.%26aulast%3DYu%26aufirst%3DD.-S.%26aulast%3DHsiao%26aufirst%3DP.-W.%26aulast%3DHuang%26aufirst%3DS.-M.%26aulast%3DCha%26aufirst%3DT.-L.%26atitle%3DThe%2520HDAC%2520Inhibitor%2520LBH589%2520Induces%2520ERK-Dependent%2520Prometaphase%2520Arrest%2520in%2520Prostate%2520Cancer%2520via%2520HDAC6%2520Inactivation%2520and%2520Down-Regulation%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0073401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.-s.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbert, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T.-P.</span></span> <span> </span><span class="NLM_article-title">The Microtubule-Associated Histone Deacetylase 6 (HDAC6) Regulates Epidermal Growth Factor Receptor (EGFR) Endocytic Trafficking and Degradation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">11219</span>– <span class="NLM_lpage">11226</span>, <span class="refDoi"> DOI: 10.1074/jbc.m109.042754</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1074%2Fjbc.m109.042754" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=11219-11226&author=Y.-s.+Gaoauthor=C.+C.+Hubbertauthor=T.-P.+Yao&title=The+Microtubule-Associated+Histone+Deacetylase+6+%28HDAC6%29+Regulates+Epidermal+Growth+Factor+Receptor+%28EGFR%29+Endocytic+Trafficking+and+Degradation&doi=10.1074%2Fjbc.m109.042754"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m109.042754&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m109.042754%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.-s.%26aulast%3DHubbert%26aufirst%3DC.%2BC.%26aulast%3DYao%26aufirst%3DT.-P.%26atitle%3DThe%2520Microtubule-Associated%2520Histone%2520Deacetylase%25206%2520%2528HDAC6%2529%2520Regulates%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520%2528EGFR%2529%2520Endocytic%2520Trafficking%2520and%2520Degradation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D11219%26epage%3D11226%26doi%3D10.1074%2Fjbc.m109.042754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, C.</span></span> <span> </span><span class="NLM_article-title">HDAC6-Mediated EGFR Stabilization and Activation Restrict Cell Response to Sorafenib in Non-Small Cell Lung Cancer Cells</span>. <i>Med. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">50</span>, <span class="refDoi"> DOI: 10.1007/s12032-016-0765-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1007%2Fs12032-016-0765-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=27090797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A280%3ADC%252BC28bhtlKktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2016&pages=50&author=Z.+Wangauthor=P.+Huauthor=F.+Tangauthor=C.+Xie&title=HDAC6-Mediated+EGFR+Stabilization+and+Activation+Restrict+Cell+Response+to+Sorafenib+in+Non-Small+Cell+Lung+Cancer+Cells&doi=10.1007%2Fs12032-016-0765-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6-mediated EGFR stabilization and activation restrict cell response to sorafenib in non-small cell lung cancer cells</span></div><div class="casAuthors">Wang Zhihao; Tang Fang; Xie Conghua; Wang Zhihao; Tang Fang; Xie Conghua; Hu Pengchao</div><div class="citationInfo"><span class="NLM_cas:title">Medical oncology (Northwood, London, England)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">50</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Sorafenib is a multi-targeted kinase inhibitor and has been the subject of extensive clinical research in advanced non-small cell lung cancer (NSCLC).  However, sorafenib fails to improve overall survival of patients with advanced NSCLC.  The molecular mechanisms that account for this phenomenon are unclear.  Here we show that sorafenib treatment stabilizes epidermal growth factor receptor (EGFR) and activates EGFR pathway.  Moreover, this is partly mediated by stabilization of histone deacetylase 6 (HDAC6), which has been shown to regulate EGFR endocytic trafficking and degradation.  Overexpression of HDAC6 confers resistance to sorafenib in NSCLC cells.  Inhibition of HDAC6 with selective inhibitors synergizes with sorafenib to kill NSCLC cells via inhibition of sorafenib-mediated EGFR pathway activation.  Taken together, our findings might partly explain the failure of Phase III trial of sorafenib in improving overall survival of advanced NSCLC patients and bear possible implications for the improvement on the efficacy of sorafenib in treatment of NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRwrkvhyIzugdLIORRPd5lbfW6udTcc2eYJFz1IsP2AHrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bhtlKktQ%253D%253D&md5=909f9461c4f4ba112123be59c6adbf91</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1007%2Fs12032-016-0765-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12032-016-0765-5%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DHu%26aufirst%3DP.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DXie%26aufirst%3DC.%26atitle%3DHDAC6-Mediated%2520EGFR%2520Stabilization%2520and%2520Activation%2520Restrict%2520Cell%2520Response%2520to%2520Sorafenib%2520in%2520Non-Small%2520Cell%2520Lung%2520Cancer%2520Cells%26jtitle%3DMed.%2520Oncol.%26date%3D2016%26volume%3D33%26spage%3D50%26doi%3D10.1007%2Fs12032-016-0765-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lienlaf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Villarroel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pabon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahakian, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woan, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smalley, K. S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montecino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinilla-Ibarz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarnaik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotomayor, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villagra, A.</span></span> <span> </span><span class="NLM_article-title">Essential Role of HDAC6 in the Regulation of PD-L1 in Melanoma</span>. <i>Med. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">750</span>, <span class="refDoi"> DOI: 10.1016/j.molonc.2015.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1016%2Fj.molonc.2015.12.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=735-750&author=M.+Lienlafauthor=P.+Perez-Villarroelauthor=T.+Knoxauthor=M.+Pabonauthor=E.+Sahakianauthor=J.+Powersauthor=K.+V.+Woanauthor=C.+Leeauthor=F.+Chengauthor=S.+Dengauthor=K.+S.+M.+Smalleyauthor=M.+Montecinoauthor=A.+Kozikowskiauthor=J.+Pinilla-Ibarzauthor=A.+Sarnaikauthor=E.+Setoauthor=J.+Weberauthor=E.+M.+Sotomayorauthor=A.+Villagra&title=Essential+Role+of+HDAC6+in+the+Regulation+of+PD-L1+in+Melanoma&doi=10.1016%2Fj.molonc.2015.12.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.molonc.2015.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molonc.2015.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DLienlaf%26aufirst%3DM.%26aulast%3DPerez-Villarroel%26aufirst%3DP.%26aulast%3DKnox%26aufirst%3DT.%26aulast%3DPabon%26aufirst%3DM.%26aulast%3DSahakian%26aufirst%3DE.%26aulast%3DPowers%26aufirst%3DJ.%26aulast%3DWoan%26aufirst%3DK.%2BV.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DF.%26aulast%3DDeng%26aufirst%3DS.%26aulast%3DSmalley%26aufirst%3DK.%2BS.%2BM.%26aulast%3DMontecino%26aufirst%3DM.%26aulast%3DKozikowski%26aufirst%3DA.%26aulast%3DPinilla-Ibarz%26aufirst%3DJ.%26aulast%3DSarnaik%26aufirst%3DA.%26aulast%3DSeto%26aufirst%3DE.%26aulast%3DWeber%26aufirst%3DJ.%26aulast%3DSotomayor%26aufirst%3DE.%2BM.%26aulast%3DVillagra%26aufirst%3DA.%26atitle%3DEssential%2520Role%2520of%2520HDAC6%2520in%2520the%2520Regulation%2520of%2520PD-L1%2520in%2520Melanoma%26jtitle%3DMed.%2520Oncol.%26date%3D2016%26volume%3D10%26spage%3D735%26epage%3D750%26doi%3D10.1016%2Fj.molonc.2015.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Houlden, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchby, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyler, S. N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagné, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd-Jones, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Booker-Milburn, K. I.</span></span> <span> </span><span class="NLM_article-title">Room-Temperature Palladium-Catalyzed C-H Activation: Ortho-Carbonylation of Aniline Derivatives</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1830</span>– <span class="NLM_lpage">1833</span>, <span class="refDoi"> DOI: 10.1002/anie.200805842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1002%2Fanie.200805842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjt1OjtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=1830-1833&author=C.+E.+Houldenauthor=M.+Hutchbyauthor=C.+D.+Baileyauthor=J.+G.+Fordauthor=S.+N.+G.+Tylerauthor=M.+R.+Gagn%C3%A9author=G.+C.+Lloyd-Jonesauthor=K.+I.+Booker-Milburn&title=Room-Temperature+Palladium-Catalyzed+C-H+Activation%3A+Ortho-Carbonylation+of+Aniline+Derivatives&doi=10.1002%2Fanie.200805842"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Room-temperature palladium-catalyzed C-H activation: Ortho-carbonylation of aniline derivatives</span></div><div class="casAuthors">Houlden, Chris E.; Hutchby, Marc; Bailey, Chris D.; Ford, J. Gair; Tyler, Simon N. G.; Gagne, Michel R.; Lloyd-Jones, Guy C.; Booker-Milburn, Kevin I.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1830-1833</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The title reaction proceeds efficiently at 18°C under CO (1 atm) with 5% [Pd(OTs)2-(MeCN)2] as precatalyst.  Depending on the solvents used, either anthranilates or cyclic imides can be obtained in high yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkntHdRJvnfrVg90H21EOLACvtfcHk0ljNBOzy20lY9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjt1OjtbY%253D&md5=8eafe11603203bc2d644abbfeea471ac</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fanie.200805842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200805842%26sid%3Dliteratum%253Aachs%26aulast%3DHoulden%26aufirst%3DC.%2BE.%26aulast%3DHutchby%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DC.%2BD.%26aulast%3DFord%26aufirst%3DJ.%2BG.%26aulast%3DTyler%26aufirst%3DS.%2BN.%2BG.%26aulast%3DGagn%25C3%25A9%26aufirst%3DM.%2BR.%26aulast%3DLloyd-Jones%26aufirst%3DG.%2BC.%26aulast%3DBooker-Milburn%26aufirst%3DK.%2BI.%26atitle%3DRoom-Temperature%2520Palladium-Catalyzed%2520C-H%2520Activation%253A%2520Ortho-Carbonylation%2520of%2520Aniline%2520Derivatives%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D1830%26epage%3D1833%26doi%3D10.1002%2Fanie.200805842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chern, J.-W.</span></span> <span> </span><span class="NLM_article-title">Efficient Microwave-Assisted Pd-Catalyzed Hydroxylation of Aryl Chlorides in the Presence of Carbonate</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">3688</span>– <span class="NLM_lpage">3691</span>, <span class="refDoi"> DOI: 10.1021/ol301523q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol301523q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BC38Xps1Giurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=3688-3691&author=C.-W.+Yuauthor=G.+S.+Chenauthor=C.-W.+Huangauthor=J.-W.+Chern&title=Efficient+Microwave-Assisted+Pd-Catalyzed+Hydroxylation+of+Aryl+Chlorides+in+the+Presence+of+Carbonate&doi=10.1021%2Fol301523q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient Microwave-Assisted Pd-Catalyzed Hydroxylation of Aryl Chlorides in the Presence of Carbonate</span></div><div class="casAuthors">Yu, Chao-Wu; Chen, Grace S.; Huang, Chen-Wei; Chern, Ji-Wang</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3688-3691</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient microwave-assisted, palladium-catalyzed hydroxylation of aryl chlorides in the presence of a weak base carbonate was developed, which rapidly converts aryl and heteroaryl chlorides to phenols, and can be used when the aryl chloride is functionalized with a ketone, aldehyde, ester, nitrile, or amide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIA1TkYC88vrVg90H21EOLACvtfcHk0ljNBOzy20lY9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xps1Giurk%253D&md5=d613d975b8ea090e95da498d0a8d638c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fol301523q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol301523q%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DC.-W.%26aulast%3DChen%26aufirst%3DG.%2BS.%26aulast%3DHuang%26aufirst%3DC.-W.%26aulast%3DChern%26aufirst%3DJ.-W.%26atitle%3DEfficient%2520Microwave-Assisted%2520Pd-Catalyzed%2520Hydroxylation%2520of%2520Aryl%2520Chlorides%2520in%2520the%2520Presence%2520of%2520Carbonate%26jtitle%3DOrg.%2520Lett.%26date%3D2012%26volume%3D14%26spage%3D3688%26epage%3D3691%26doi%3D10.1021%2Fol301523q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Molander, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gormisky, P. E.</span></span> <span> </span><span class="NLM_article-title">Cross-Coupling of Cyclopropyl- and Cyclobutyltrifluoroborates with Aryl and Heteroaryl Chlorides</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">7481</span>– <span class="NLM_lpage">7485</span>, <span class="refDoi"> DOI: 10.1021/jo801269m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo801269m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOqtLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=7481-7485&author=G.+A.+Molanderauthor=P.+E.+Gormisky&title=Cross-Coupling+of+Cyclopropyl-+and+Cyclobutyltrifluoroborates+with+Aryl+and+Heteroaryl+Chlorides&doi=10.1021%2Fjo801269m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Cross-Coupling of Cyclopropyl- and Cyclobutyltrifluoroborates with Aryl and Heteroaryl Chlorides</span></div><div class="casAuthors">Molander, Gary A.; Gormisky, Paul E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7481-7485</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Suitable conditions were found for the Suzuki-Miyaura cross-coupling reaction of potassium cyclopropyl- and cyclobutyltrifluoroborates with aryl chlorides.  Both of these secondary alkyl trifluoroborates coupled in moderate to excellent yield with electron-rich, electron-poor, and hindered aryl chlorides to give a variety of substituted aryl cyclopropanes and cyclobutanes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6VymYqSga5rVg90H21EOLACvtfcHk0liKp02mGJwxhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOqtLrF&md5=575a47623b0f8fd598563f41b81e3564</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjo801269m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo801269m%26sid%3Dliteratum%253Aachs%26aulast%3DMolander%26aufirst%3DG.%2BA.%26aulast%3DGormisky%26aufirst%3DP.%2BE.%26atitle%3DCross-Coupling%2520of%2520Cyclopropyl-%2520and%2520Cyclobutyltrifluoroborates%2520with%2520Aryl%2520and%2520Heteroaryl%2520Chlorides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D73%26spage%3D7481%26epage%3D7485%26doi%3D10.1021%2Fjo801269m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Somoza, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skene, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mol, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buggy, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, B.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynands, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leahy, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navre, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knuth, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McRee, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tari, L. W.</span></span> <span> </span><span class="NLM_article-title">Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1325</span>– <span class="NLM_lpage">1334</span>, <span class="refDoi"> DOI: 10.1016/j.str.2004.04.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1016%2Fj.str.2004.04.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=15242608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsFyrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=1325-1334&author=J.+R.+Somozaauthor=R.+J.+Skeneauthor=B.+A.+Katzauthor=C.+Molauthor=J.+D.+Hoauthor=A.+J.+Jenningsauthor=C.+Luongauthor=A.+Arvaiauthor=J.+J.+Buggyauthor=E.+Chiauthor=J.+Tangauthor=B.-C.+Sangauthor=E.+Vernerauthor=R.+Wynandsauthor=E.+M.+Leahyauthor=D.+R.+Douganauthor=G.+Snellauthor=M.+Navreauthor=M.+W.+Knuthauthor=R.+V.+Swansonauthor=D.+E.+McReeauthor=L.+W.+Tari&title=Structural+Snapshots+of+Human+HDAC8+Provide+Insights+into+the+Class+I+Histone+Deacetylases&doi=10.1016%2Fj.str.2004.04.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases</span></div><div class="casAuthors">Somoza, John R.; Skene, Robert J.; Katz, Bradley A.; Mol, Clifford; Ho, Joseph D.; Jennings, Andy J.; Luong, Christine; Arvai, Andrew; Buggy, Joseph J.; Chi, Ellen; Tang, Jie; Sang, Bi-Ching; Verner, Erik; Wynands, Robert; Leahy, Ellen M.; Dougan, Douglas R.; Snell, Gyorgy; Navre, Marc; Knuth, Mark W.; Swanson, Ronald V.; McRee, Duncan E.; Tari, Leslie W.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1325-1334</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Modulation of the acetylation state of histones plays a pivotal role in the regulation of gene expression.  Histone deacetylases (HDACs) catalyze the removal of acetyl groups from lysines near the N termini of histones.  This reaction promotes the condensation of chromatin, leading to repression of transcription.  HDAC deregulation has been linked to several types of cancer, suggesting a potential use for HDAC inhibitors in oncol.  Here we describe the first crystal structures of a human HDAC: the structures of human HDAC8 complexed with four structurally diverse hydroxamate inhibitors.  This work sheds light on the catalytic mechanism of the HDACs, and on differences in substrate specificity across the HDAC family.  The structure also suggests how phosphorylation of Ser39 affects HDAC8 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPLrZup76hGLVg90H21EOLACvtfcHk0liKp02mGJwxhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsFyrsLc%253D&md5=3f1842802bac2543509a25f5ddbea5f6</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2004.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2004.04.012%26sid%3Dliteratum%253Aachs%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DSkene%26aufirst%3DR.%2BJ.%26aulast%3DKatz%26aufirst%3DB.%2BA.%26aulast%3DMol%26aufirst%3DC.%26aulast%3DHo%26aufirst%3DJ.%2BD.%26aulast%3DJennings%26aufirst%3DA.%2BJ.%26aulast%3DLuong%26aufirst%3DC.%26aulast%3DArvai%26aufirst%3DA.%26aulast%3DBuggy%26aufirst%3DJ.%2BJ.%26aulast%3DChi%26aufirst%3DE.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DSang%26aufirst%3DB.-C.%26aulast%3DVerner%26aufirst%3DE.%26aulast%3DWynands%26aufirst%3DR.%26aulast%3DLeahy%26aufirst%3DE.%2BM.%26aulast%3DDougan%26aufirst%3DD.%2BR.%26aulast%3DSnell%26aufirst%3DG.%26aulast%3DNavre%26aufirst%3DM.%26aulast%3DKnuth%26aufirst%3DM.%2BW.%26aulast%3DSwanson%26aufirst%3DR.%2BV.%26aulast%3DMcRee%26aufirst%3DD.%2BE.%26aulast%3DTari%26aufirst%3DL.%2BW.%26atitle%3DStructural%2520Snapshots%2520of%2520Human%2520HDAC8%2520Provide%2520Insights%2520into%2520the%2520Class%2520I%2520Histone%2520Deacetylases%26jtitle%3DStructure%26date%3D2004%26volume%3D12%26spage%3D1325%26epage%3D1334%26doi%3D10.1016%2Fj.str.2004.04.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navre, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, B.-C.</span></span> <span> </span><span class="NLM_article-title">Characterization of the Two Catalytic Domains in Histone Deacetylase 6</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>341</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2005.12.144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1016%2Fj.bbrc.2005.12.144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=16412385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BD28Xoslygtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2006&pages=45-50&author=H.+Zouauthor=Y.+Wuauthor=M.+Navreauthor=B.-C.+Sang&title=Characterization+of+the+Two+Catalytic+Domains+in+Histone+Deacetylase+6&doi=10.1016%2Fj.bbrc.2005.12.144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the two catalytic domains in histone deacetylase 6</span></div><div class="casAuthors">Zou, Hua; Wu, Yiqin; Navre, Marc; Sang, Bi-Ching</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-50</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Histone deacetylase 6 (HDAC6) is the only known HDAC with two potentially functional catalytic domains, yet the role towards substrate played by these two domains remains ambiguous.  Most studies report HDAC6 activities measured using either immune complexes or in vitro translated products.  Here, we characterize the activity of highly purified recombinant HDAC6, mutants with active site histidine mutations in each domain (H216A and H611A), and individual catalytic domains.  The deacetylase activities of these proteins, as well as their kinetic parameters, were measured using histone, α-tubulin, and fluorogenic acetylated lysine as substrates.  Mutant H216A only slightly lowers the catalytic rate.  However, mutant H611A decreases the catalytic rate more than 5000-fold.  The first domain expressed alone is not catalytically active.  In contrast, the second domain shows only a modest decrease in substrate binding and product formation rate.  Our results indicate that the in vitro deacetylase activity of HDAC6 resides in the C-terminal second catalytic domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-ljQmtqSmN7Vg90H21EOLACvtfcHk0lhHxZesfDrRKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xoslygtg%253D%253D&md5=160f566a8fdd2756e398869647e54fe7</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2005.12.144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2005.12.144%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DNavre%26aufirst%3DM.%26aulast%3DSang%26aufirst%3DB.-C.%26atitle%3DCharacterization%2520of%2520the%2520Two%2520Catalytic%2520Domains%2520in%2520Histone%2520Deacetylase%25206%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2006%26volume%3D341%26spage%3D45%26epage%3D50%26doi%3D10.1016%2Fj.bbrc.2005.12.144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, S. H.</span></span> <span> </span><span class="NLM_article-title">Histone Deacetylase 6 Plays a Role as a Distinct Regulator of Diverse Cellular Processes</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">775</span>– <span class="NLM_lpage">793</span>, <span class="refDoi"> DOI: 10.1111/febs.12079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1111%2Ffebs.12079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=23181831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVKrs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2013&pages=775-793&author=Y.+Liauthor=D.+Shinauthor=S.+H.+Kwon&title=Histone+Deacetylase+6+Plays+a+Role+as+a+Distinct+Regulator+of+Diverse+Cellular+Processes&doi=10.1111%2Ffebs.12079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase 6 plays a role as a distinct regulator of diverse cellular processes</span></div><div class="casAuthors">Li, Yingxiu; Shin, Donghee; Kwon, So Hee</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">775-793</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase (HDAC) 6 is the best-characterized class IIb deacetylase that regulates many important biol. processes via the formation of complexes with its partner proteins.  HDAC6 is important both for cytoplasmic and nuclear functions.  Unlike other deacetylases, HDAC6 has unique substrate specificity for nonhistone proteins.  Such diverse functions of HDAC6 suggest that it serves a potential therapeutic target for the treatment of a wide range of diseases.  This therapeutic interest in HDAC6 stems from the observation that HDAC6 may be overexpressed or deregulated in various cancers, neurodegenerative diseases and inflammatory disorders.  Despite extensive efforts, however, very few HDAC6-selective inhibitors have been identified and the precise structural determinants remain undefined.  Future efforts aiming to better define the structure and function of HDAC6 should provide the basis for the discovery of novel effective inhibitors.  In this review, we focus on recent studies that highlight the importance of HDAC6-mediated biol. processes, disease mechanisms and HDAC6-selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrphsn42_IKCLVg90H21EOLACvtfcHk0lhHxZesfDrRKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVKrs78%253D&md5=1343243c2d7ba72ef6b67104ad3749b8</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12079%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DShin%26aufirst%3DD.%26aulast%3DKwon%26aufirst%3DS.%2BH.%26atitle%3DHistone%2520Deacetylase%25206%2520Plays%2520a%2520Role%2520as%2520a%2520Distinct%2520Regulator%2520of%2520Diverse%2520Cellular%2520Processes%26jtitle%3DFEBS%2520J.%26date%3D2013%26volume%3D280%26spage%3D775%26epage%3D793%26doi%3D10.1111%2Ffebs.12079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brent Derry, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copp, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, L.</span></span> <span> </span><span class="NLM_article-title">Mitotic Block Induced in HeLa Cells by Low Concentrations of Paclitaxel (Taxol) Results in Abnormal Mitotic Exit and Apoptotic Cell Death</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">816</span>– <span class="NLM_lpage">825</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=8631019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADyaK28XhtVClsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1996&pages=816-825&author=M.+A.+Jordanauthor=K.+Wendellauthor=S.+Gardinerauthor=W.+Brent+Derryauthor=H.+Coppauthor=L.+Wilson&title=Mitotic+Block+Induced+in+HeLa+Cells+by+Low+Concentrations+of+Paclitaxel+%28Taxol%29+Results+in+Abnormal+Mitotic+Exit+and+Apoptotic+Cell+Death"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exist and apoptotic cell death</span></div><div class="casAuthors">Jordan, Mary Ann; Wendell, Kim; Gardiner, Sara; Derry, W. Brent; Copp, Hillary; Wilson, Leslie</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">816-25</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Paclitaxel at low concns. (10 nm for 20 h) induces ∼90% mitotic block at the metaphase/anaphase transition in HeLa cells, apparently by suppressing dynamics of spindle microtubules.  It is not known, however, whether inhibition of mitosis by such low paclitaxel concns. results in cell death.  In the present work, we found that after removal of paclitaxel (10 nm-1 μm), blocked cells did not resume proliferation.  Instead, cells exited mitosis abnormally within 24 h.  They did not progress through anaphase or cytokinesis but entered an interphase-like state (chromatin decondensed, and an interphase-like microtubule array and nuclear membranes reformed).  Many cells (≥55%) contained multiple nuclei.  Addnl. DNA synthesis and polyploidy did not occur.  DNA degrdn. into nucleosome-sized fragments characteristic of apoptosis began during drug incubation and increased after drug removal.  Cells died within 48-72 h.  Incubation with paclitaxel (10 nm for 20 h) resulted in high intracellular drug accumulation (8.3 μm) and little efflux after paclitaxel removal; intracellular retention of paclitaxel may contribute to its efficacy.  The results support the hypothesis that the most potent chemotherapeutic mechanism of paclitaxel is kinetic stabilization of spindle microtubule dynamics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdfuHo0TTnJrVg90H21EOLACvtfcHk0lhHxZesfDrRKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhtVClsbo%253D&md5=5114e564fbf8b8ed0b45df06dbfd5286</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DM.%2BA.%26aulast%3DWendell%26aufirst%3DK.%26aulast%3DGardiner%26aufirst%3DS.%26aulast%3DBrent%2BDerry%26aufirst%3DW.%26aulast%3DCopp%26aufirst%3DH.%26aulast%3DWilson%26aufirst%3DL.%26atitle%3DMitotic%2520Block%2520Induced%2520in%2520HeLa%2520Cells%2520by%2520Low%2520Concentrations%2520of%2520Paclitaxel%2520%2528Taxol%2529%2520Results%2520in%2520Abnormal%2520Mitotic%2520Exit%2520and%2520Apoptotic%2520Cell%2520Death%26jtitle%3DCancer%2520Res.%26date%3D1996%26volume%3D56%26spage%3D816%26epage%3D825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamanishi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abiko, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murat, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horikawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konishi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandai, M.</span></span> <span> </span><span class="NLM_article-title">Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-ΚB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">5034</span>– <span class="NLM_lpage">5045</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-14-3098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1158%2F0008-5472.can-14-3098" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=5034-5045&author=J.+Pengauthor=J.+Hamanishiauthor=N.+Matsumuraauthor=K.+Abikoauthor=K.+Muratauthor=T.+Babaauthor=K.+Yamaguchiauthor=N.+Horikawaauthor=Y.+Hosoeauthor=S.+K.+Murphyauthor=I.+Konishiauthor=M.+Mandai&title=Chemotherapy+Induces+Programmed+Cell+Death-Ligand+1+Overexpression+via+the+Nuclear+Factor-%CE%9AB+to+Foster+an+Immunosuppressive+Tumor+Microenvironment+in+Ovarian+Cancer&doi=10.1158%2F0008-5472.can-14-3098"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.can-14-3098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.can-14-3098%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DHamanishi%26aufirst%3DJ.%26aulast%3DMatsumura%26aufirst%3DN.%26aulast%3DAbiko%26aufirst%3DK.%26aulast%3DMurat%26aufirst%3DK.%26aulast%3DBaba%26aufirst%3DT.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DHorikawa%26aufirst%3DN.%26aulast%3DHosoe%26aufirst%3DY.%26aulast%3DMurphy%26aufirst%3DS.%2BK.%26aulast%3DKonishi%26aufirst%3DI.%26aulast%3DMandai%26aufirst%3DM.%26atitle%3DChemotherapy%2520Induces%2520Programmed%2520Cell%2520Death-Ligand%25201%2520Overexpression%2520via%2520the%2520Nuclear%2520Factor-%25CE%259AB%2520to%2520Foster%2520an%2520Immunosuppressive%2520Tumor%2520Microenvironment%2520in%2520Ovarian%2520Cancer%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D5034%26epage%3D5045%26doi%3D10.1158%2F0008-5472.can-14-3098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramalingam, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parise, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramananthan, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagattuta, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musguire, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoller, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argiris, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwiebel, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egorin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belani, C. P.</span></span> <span> </span><span class="NLM_article-title">Phae I and Pharmacokinetic Study of Vorinostat, A Histone Deacetylase Inhibitor, in Combination with Carboplatin and Paclitaxel for Advanced Solid Malignancies</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">3605</span>– <span class="NLM_lpage">3610</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.ccr-07-0162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1158%2F1078-0432.ccr-07-0162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=17510206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFCqur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=3605-3610&author=S.+S.+Ramalingamauthor=R.+A.+Pariseauthor=R.+K.+Ramananthanauthor=T.+F.+Lagattutaauthor=L.+A.+Musguireauthor=R.+G.+Stollerauthor=D.+M.+Potterauthor=A.+E.+Argirisauthor=J.+A.+Zwiebelauthor=M.+J.+Egorinauthor=C.+P.+Belani&title=Phae+I+and+Pharmacokinetic+Study+of+Vorinostat%2C+A+Histone+Deacetylase+Inhibitor%2C+in+Combination+with+Carboplatin+and+Paclitaxel+for+Advanced+Solid+Malignancies&doi=10.1158%2F1078-0432.ccr-07-0162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I and Pharmacokinetic Study of Vorinostat, A Histone Deacetylase Inhibitor, in Combination with Carboplatin and Paclitaxel for Advanced Solid Malignancies</span></div><div class="casAuthors">Ramalingam, Suresh S.; Parise, Robert A.; Ramananthan, Ramesh K.; Lagattuta, Theodore F.; Musguire, Lori A.; Stoller, Ronald G.; Potter, Douglas M.; Argiris, Athanassios E.; Zwiebel, James A.; Egorin, Merrill J.; Belani, Chandra P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3605-3610</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The primary objective of this study was to det. the recommended phase II doses of the novel histone deacetylase inhibitor vorinostat when administered in combination with carboplatin and paclitaxel.  Exptl. DESIGN: Patients (N = 28) with advanced solid malignancies were treated with vorinostat, administered orally once daily for 2 wk or twice daily for 1 wk, every 3 wk.  Carboplatin and paclitaxel were administered i.v. once every 3 wk.  Doses of vorinostat and paclitaxel were escalated in sequential cohorts of three patients.  The pharmacokinetics of vorinostat, its metabolites, and paclitaxel were characterized.  RESULTS: Vorinostat was administered safely up to 400 mg qd or 300 mg bd with carboplatin and paclitaxel.  Two of 12 patients at the 400 mg qd schedule experienced dose-limiting toxicities of grade 3 emesis and grade 4 neutropenia with fever.  Non-dose-limiting toxicity included nausea, diarrhea, fatigue, neuropathy, thrombocytopenia, and anemia.  Of 25 patients evaluable for response, partial responses occurred in 11 (10 non-small cell lung cancer and 1 head and neck cancer) and stable disease occurred in 7.  Vorinostat pharmacokinetics were linear over the dose range studied.  Vorinostat area under the concn. vs. time curve and half-life increased when vorinostat was coadministered with carboplatin and paclitaxel, but vorinostat did not alter paclitaxel pharmacokinetics.  CONCLUSIONS: Both schedules of vorinostat (400 mg oral qd x 14 days or 300 mg bd x 7 days) were tolerated well in combination with carboplatin (area under the concn. vs. time curve = 6 mg/mL x min) and paclitaxel (200 mg/m2).  Encouraging anticancer activity was noted in patients with previously untreated non-small cell lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE_xqO3LrE6LVg90H21EOLACvtfcHk0ljXDbfzYNrIJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFCqur8%253D&md5=393c48c8bd6bc8e809f5eff929884cd2</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.ccr-07-0162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.ccr-07-0162%26sid%3Dliteratum%253Aachs%26aulast%3DRamalingam%26aufirst%3DS.%2BS.%26aulast%3DParise%26aufirst%3DR.%2BA.%26aulast%3DRamananthan%26aufirst%3DR.%2BK.%26aulast%3DLagattuta%26aufirst%3DT.%2BF.%26aulast%3DMusguire%26aufirst%3DL.%2BA.%26aulast%3DStoller%26aufirst%3DR.%2BG.%26aulast%3DPotter%26aufirst%3DD.%2BM.%26aulast%3DArgiris%26aufirst%3DA.%2BE.%26aulast%3DZwiebel%26aufirst%3DJ.%2BA.%26aulast%3DEgorin%26aufirst%3DM.%2BJ.%26aulast%3DBelani%26aufirst%3DC.%2BP.%26atitle%3DPhae%2520I%2520and%2520Pharmacokinetic%2520Study%2520of%2520Vorinostat%252C%2520A%2520Histone%2520Deacetylase%2520Inhibitor%252C%2520in%2520Combination%2520with%2520Carboplatin%2520and%2520Paclitaxel%2520for%2520Advanced%2520Solid%2520Malignancies%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D3605%26epage%3D3610%26doi%3D10.1158%2F1078-0432.ccr-07-0162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 12 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Xin-Hui Zhang, Qin-Ma, Hui-Pan Wu, Mussa Yussuf Khamis, Yi-Han Li, Li-Ying Ma, <span class="NLM_string-name hlFld-ContribAuthor">Hong-Min Liu</span>. </span><span class="cited-content_cbyCitation_article-title">A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1362-1391. <a href="https://doi.org/10.1021/acs.jmedchem.0c01782" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01782</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01782%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BReview%252Bof%252BProgress%252Bin%252BHistone%252BDeacetylase%252B6%252BInhibitors%252BResearch%25253A%252BStructural%252BSpecificity%252Band%252BFunctional%252BDiversity%26aulast%3DZhang%26aufirst%3DXin-Hui%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D12102020%26date%3D01022021%26volume%3D64%26issue%3D3%26spage%3D1362%26epage%3D1391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hao Wu, Ka Yang, Zhongrui Zhang, Eric D. Leisten, Ziyuan Li, Haibo Xie, Jin Liu, Kerry A. Smith, Zora Novakova, Cyril Barinka, <span class="NLM_string-name hlFld-ContribAuthor">Weiping Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Multifunctional Histone Deacetylase 6 Degraders with Potent Antimyeloma Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (15)
                                     , 7042-7057. <a href="https://doi.org/10.1021/acs.jmedchem.9b00516" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00516</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00516%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BMultifunctional%252BHistone%252BDeacetylase%252B6%252BDegraders%252Bwith%252BPotent%252BAntimyeloma%252BActivity%26aulast%3DWu%26aufirst%3DHao%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D24032019%26date%3D17072019%26date%3D04072019%26volume%3D62%26issue%3D15%26spage%3D7042%26epage%3D7057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yang Zhang, Jun Biao Ying, Jia Jun Hong, Feng Cheng Li, Ting Ting Fu, Feng Yuan Yang, Guo Xun Zheng, Xiao Jun Yao, Yan Lou, Yunqing Qiu, Wei Wei Xue, <span class="NLM_string-name hlFld-ContribAuthor">Feng Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">How Does Chirality Determine the Selective Inhibition of Histone Deacetylase 6? A Lesson from Trichostatin A Enantiomers Based on Molecular Dynamics. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (5)
                                     , 2467-2480. <a href="https://doi.org/10.1021/acschemneuro.8b00729" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00729</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00729%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DHow%252BDoes%252BChirality%252BDetermine%252Bthe%252BSelective%252BInhibition%252Bof%252BHistone%252BDeacetylase%252B6%25253F%252BA%252BLesson%252Bfrom%252BTrichostatin%252BA%252BEnantiomers%252BBased%252Bon%252BMolecular%252BDynamics%26aulast%3DZhang%26aufirst%3DYang%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D24122018%26date%3D20022019%26date%3D26022019%26date%3D20022019%26volume%3D10%26issue%3D5%26spage%3D2467%26epage%3D2480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heba S.A.  ElZahabi</span>, <span class="hlFld-ContribAuthor ">Mohamed S.  Nafie</span>, <span class="hlFld-ContribAuthor ">Dina  Osman</span>, <span class="hlFld-ContribAuthor ">Nehal H.  Elghazawy</span>, <span class="hlFld-ContribAuthor ">Dalia H.  Soliman</span>, <span class="hlFld-ContribAuthor ">Abdelghany Ali H.  EL-Helby</span>, <span class="hlFld-ContribAuthor ">Reem K.  Arafa</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of new quinazolin-4-one derivatives as apoptotic enhancers and autophagy inhibitors with potent antitumor activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>222 </em>, 113609. <a href="https://doi.org/10.1016/j.ejmech.2021.113609" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113609</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113609%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bnew%252Bquinazolin-4-one%252Bderivatives%252Bas%252Bapoptotic%252Benhancers%252Band%252Bautophagy%252Binhibitors%252Bwith%252Bpotent%252Bantitumor%252Bactivity%26aulast%3DElZahabi%26aufirst%3DHeba%2BS.A.%26date%3D2021%26volume%3D222%26spage%3D113609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaopeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Qianqian  Ding</span>, <span class="hlFld-ContribAuthor ">Jinjun  Wang</span>, <span class="hlFld-ContribAuthor ">Jingyi  Yang</span>, <span class="hlFld-ContribAuthor ">Xuesen  Fan</span>, <span class="hlFld-ContribAuthor ">Guisheng  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Pd(
              ii
              )-Catalyzed [4 + 1 + 1] cycloaddition of simple
              o
              -aminobenzoic acids, CO and amines: direct and versatile synthesis of diverse
              N
              -substituted quinazoline-2,4(1
              H
              ,3
              H
              )-diones. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2021,</strong> <em>23 </em>
                                    (1)
                                     , 526-535. <a href="https://doi.org/10.1039/D0GC03254A" title="DOI URL">https://doi.org/10.1039/D0GC03254A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0GC03254A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0GC03254A%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DPd%252528%252Bii%252B%252529-Catalyzed%252B%25255B4%252B%25252B%252B1%252B%25252B%252B1%25255D%252Bcycloaddition%252Bof%252Bsimple%252Bo%252B-aminobenzoic%252Bacids%25252C%252BCO%252Band%252Bamines%25253A%252Bdirect%252Band%252Bversatile%252Bsynthesis%252Bof%252Bdiverse%252BN%252B-substituted%252Bquinazoline-2%25252C4%2525281%252BH%252B%25252C3%252BH%252B%252529-diones%26aulast%3DZhang%26aufirst%3DXiaopeng%26date%3D2021%26date%3D2021%26volume%3D23%26issue%3D1%26spage%3D526%26epage%3D535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sravani  Pulya</span>, <span class="hlFld-ContribAuthor ">Sk. Abdul  Amin</span>, <span class="hlFld-ContribAuthor ">Nilanjan  Adhikari</span>, <span class="hlFld-ContribAuthor ">Swati  Biswas</span>, <span class="hlFld-ContribAuthor ">Tarun  Jha</span>, <span class="hlFld-ContribAuthor ">Balaram  Ghosh</span>. </span><span class="cited-content_cbyCitation_article-title">HDAC6 as privileged target in drug discovery: A perspective. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2021,</strong> <em>163 </em>, 105274. <a href="https://doi.org/10.1016/j.phrs.2020.105274" title="DOI URL">https://doi.org/10.1016/j.phrs.2020.105274</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2020.105274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2020.105274%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DHDAC6%252Bas%252Bprivileged%252Btarget%252Bin%252Bdrug%252Bdiscovery%25253A%252BA%252Bperspective%26aulast%3DPulya%26aufirst%3DSravani%26date%3D2021%26volume%3D163%26spage%3D105274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dahong  Yao</span>, <span class="hlFld-ContribAuthor ">Chenyang  Li</span>, <span class="hlFld-ContribAuthor ">Jin  Jiang</span>, <span class="hlFld-ContribAuthor ">Jian  Huang</span>, <span class="hlFld-ContribAuthor ">Jinhui  Wang</span>, <span class="hlFld-ContribAuthor ">Zhendan  He</span>, <span class="hlFld-ContribAuthor ">Jin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel HDAC inhibitors with improved pharmacokinetic profile in breast cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>205 </em>, 112648. <a href="https://doi.org/10.1016/j.ejmech.2020.112648" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112648</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112648%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252BHDAC%252Binhibitors%252Bwith%252Bimproved%252Bpharmacokinetic%252Bprofile%252Bin%252Bbreast%252Bcancer%26aulast%3DYao%26aufirst%3DDahong%26date%3D2020%26volume%3D205%26spage%3D112648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenhua  Liu</span>, <span class="hlFld-ContribAuthor ">Yuchen  Liang</span>, <span class="hlFld-ContribAuthor ">Xiaoyong  Si</span>. </span><span class="cited-content_cbyCitation_article-title">Hydroxamic acid hybrids as the potential anticancer agents: An Overview. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>205 </em>, 112679. <a href="https://doi.org/10.1016/j.ejmech.2020.112679" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112679</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112679%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHydroxamic%252Bacid%252Bhybrids%252Bas%252Bthe%252Bpotential%252Banticancer%252Bagents%25253A%252BAn%252BOverview%26aulast%3DLiu%26aufirst%3DWenhua%26date%3D2020%26volume%3D205%26spage%3D112679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaopeng  Peng</span>, <span class="hlFld-ContribAuthor ">Ling  Li</span>, <span class="hlFld-ContribAuthor ">Yichang  Ren</span>, <span class="hlFld-ContribAuthor ">Huanxin  Xue</span>, <span class="hlFld-ContribAuthor ">Jin  Liu</span>, <span class="hlFld-ContribAuthor ">Shijun  Wen</span>, <span class="hlFld-ContribAuthor ">Jianjun  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of
              N
              ‐Carbonyl Acridanes as Highly Potent Inhibitors of Tubulin Polymerization
              via
              One‐Pot Copper‐Catalyzed Dual Arylation of Nitriles with Cyclic Diphenyl Iodoniums. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (10)
                                     , 2030-2038. <a href="https://doi.org/10.1002/adsc.201901460" title="DOI URL">https://doi.org/10.1002/adsc.201901460</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201901460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201901460%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DSynthesis%252Bof%252BN%252B%2525E2%252580%252590Carbonyl%252BAcridanes%252Bas%252BHighly%252BPotent%252BInhibitors%252Bof%252BTubulin%252BPolymerization%252Bvia%252BOne%2525E2%252580%252590Pot%252BCopper%2525E2%252580%252590Catalyzed%252BDual%252BArylation%252Bof%252BNitriles%252Bwith%252BCyclic%252BDiphenyl%252BIodoniums%26aulast%3DPeng%26aufirst%3DXiaopeng%26date%3D2020%26date%3D2020%26volume%3D362%26issue%3D10%26spage%3D2030%26epage%3D2038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel A.  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Fabiana S.  Guerra</span>, <span class="hlFld-ContribAuthor ">Fernanda S.  Sagrillo</span>, <span class="hlFld-ContribAuthor ">Pedro  Sena M. Pinheiro</span>, <span class="hlFld-ContribAuthor ">Marina A.  Alves</span>, <span class="hlFld-ContribAuthor ">Sreekanth  Thota</span>, <span class="hlFld-ContribAuthor ">Lorrane S.  Chaves</span>, <span class="hlFld-ContribAuthor ">Carlos M. R.  Sant'Anna</span>, <span class="hlFld-ContribAuthor ">Patrícia D.  Fernandes</span>, <span class="hlFld-ContribAuthor ">Carlos A. M.  Fraga</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Pharmacological Evaluation of First‐in‐Class Multitarget
              N
              ‐Acylhydrazone Derivatives as Selective HDAC6/8 and PI3Kα Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (6)
                                     , 539-551. <a href="https://doi.org/10.1002/cmdc.201900716" title="DOI URL">https://doi.org/10.1002/cmdc.201900716</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900716%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BPharmacological%252BEvaluation%252Bof%252BFirst%2525E2%252580%252590in%2525E2%252580%252590Class%252BMultitarget%252BN%252B%2525E2%252580%252590Acylhydrazone%252BDerivatives%252Bas%252BSelective%252BHDAC6%25252F8%252Band%252BPI3K%2525CE%2525B1%252BInhibitors%26aulast%3DRodrigues%26aufirst%3DDaniel%2BA.%26date%3D2020%26volume%3D15%26issue%3D6%26spage%3D539%26epage%3D551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhuang  Yang</span>, <span class="hlFld-ContribAuthor ">Mingsheng  Shen</span>, <span class="hlFld-ContribAuthor ">Minghai  Tang</span>, <span class="hlFld-ContribAuthor ">Wanhua  Zhang</span>, <span class="hlFld-ContribAuthor ">Xue  Cui</span>, <span class="hlFld-ContribAuthor ">Zihao  Zhang</span>, <span class="hlFld-ContribAuthor ">Heying  Pei</span>, <span class="hlFld-ContribAuthor ">Yong  Li</span>, <span class="hlFld-ContribAuthor ">Mengshi  Hu</span>, <span class="hlFld-ContribAuthor ">Peng  Bai</span>, <span class="hlFld-ContribAuthor ">Lijuan  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 1,2,4-oxadiazole-Containing hydroxamic acid derivatives as histone deacetylase inhibitors potential application in cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>178 </em>, 116-130. <a href="https://doi.org/10.1016/j.ejmech.2019.05.089" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.05.089</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.05.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.05.089%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B1%25252C2%25252C4-oxadiazole-Containing%252Bhydroxamic%252Bacid%252Bderivatives%252Bas%252Bhistone%252Bdeacetylase%252Binhibitors%252Bpotential%252Bapplication%252Bin%252Bcancer%252Btherapy%26aulast%3DYang%26aufirst%3DZhuang%26date%3D2019%26volume%3D178%26spage%3D116%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia-Rong  Liu</span>, <span class="hlFld-ContribAuthor ">Chao-Wu  Yu</span>, <span class="hlFld-ContribAuthor ">Pei-Yun  Hung</span>, <span class="hlFld-ContribAuthor ">Ling-Wei  Hsin</span>, <span class="hlFld-ContribAuthor ">Ji-Wang  Chern</span>. </span><span class="cited-content_cbyCitation_article-title">High-selective HDAC6 inhibitor promotes HDAC6 degradation following autophagy modulation and enhanced antitumor immunity in glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2019,</strong> <em>163 </em>, 458-471. <a href="https://doi.org/10.1016/j.bcp.2019.03.023" title="DOI URL">https://doi.org/10.1016/j.bcp.2019.03.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2019.03.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2019.03.023%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DHigh-selective%252BHDAC6%252Binhibitor%252Bpromotes%252BHDAC6%252Bdegradation%252Bfollowing%252Bautophagy%252Bmodulation%252Band%252Benhanced%252Bantitumor%252Bimmunity%252Bin%252Bglioblastoma%26aulast%3DLiu%26aufirst%3DJia-Rong%26date%3D2019%26volume%3D163%26spage%3D458%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of HDAC6-selective inhibitors by scaffold hopping.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Syntheses of Compounds <b>3a</b>–<b>3h</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) PhOCOCl, 1 N NaOH, dioxane, ice bath, 1 h; (b) EDCI, HOBt, PhCH<sub>2</sub>CH<sub>2</sub>NH<sub>2</sub>, DMF, rt, 4.5 h; (c) TEA, DMF, μW 150 W, 20 min; (d) PhCH<sub>2</sub>CH<sub>2</sub>NH<sub>2</sub>, TEA, DMF/MeOH (1:1), μW 100 W, 20 min; (e) Pd(MeCN)<sub>2</sub>(OTf)<sub>2</sub>, BQ, <i>p</i>-TSA·H<sub>2</sub>O, CO (1 atm), THF/MeOH (1:1), rt, 5 h; (f) NaOH (2 N), THF, 80 °C, 2 h; (g) PhCH<sub>2</sub>CH<sub>2</sub>NH<sub>2</sub>, DMAC, μW 250 W, reflux, 6 min; (h) EtOCOCl, THF, reflux, 3.5 h; (i) NaOH (2 N), EtOH, 100 °C, 1 h; (j) (i) NaH, DMF, ice bath, 1.5 h and (ii) 4-COOEtC<sub>6</sub>H<sub>4</sub>CH<sub>2</sub>Br or 3-COOEtC<sub>6</sub>H<sub>4</sub>CH<sub>2</sub>Br, 15 h; (k) LiOH (2.5 N), THF/MeOH (5:1), rt, 4 h; (l) NH<sub>2</sub>OBn·HCl, EDCI, HOBt, TEA, DMF, 4 h; (m) Pd/C, (10% w/w), H<sub>2</sub> (1 atm), MeOH/THF (3:1), rt, 5 h; and (n) BBr<sub>3</sub> (1 M in DCM), DCM, ice bath 1 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>3i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) PhCH<sub>2</sub>CH<sub>2</sub>NH<sub>2</sub>, EDCI, HOBt, DMF, rt, 4.5 h; (b) EtOCOCl, THF, reflux 3.5 h; (c) NaOH (2 N), EtOH, 100 °C, 1 h; (d) (i) NaH, DMF, ice bath, 1.5 h; (ii) 4-COOEtC<sub>6</sub>H<sub>4</sub>CH<sub>2</sub>Br, 15 h; (e) LiOH (2.5 N), THF/MeOH (5:1), rt, 4 h; (f) NH<sub>2</sub>OBn·HCl, EDCI, HOBt, TEA, DMF, 4 h; and (g) Pd/C, (10% w/w), H<sub>2</sub> (1 atm), MeOH/THF (3:1), rt, 5 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Syntheses of Compounds <b>3j</b>–<b>3l</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) NaH, DMF, ice bath, 1.5 h and (ii) 4-COOEtC<sub>6</sub>H<sub>4</sub>CH<sub>2</sub>Br, 15 h; (b) Pd(OAc)<sub>2</sub>, XPhos, Cs<sub>2</sub>CO<sub>3</sub>, DMF/H<sub>2</sub>O (10:1), μW, reflux, 30 min; (c) (CH<sub>3</sub>)<sub>2</sub>Zn, Pd<sub>2</sub>(dba)<sub>3</sub>, [(<i>t</i>-Bu)<sub>3</sub>PH]BF<sub>4</sub>, THF, μW, 120 °C, 30 min; (d) (CH<sub>2</sub>)<sub>2</sub>CHBF<sub>3</sub>K, Pd(OAc)<sub>2</sub>, XPhos, Cs<sub>2</sub>CO<sub>3</sub>, THF/H<sub>2</sub>O (10:1), 80 °C, 24 h; (e) LiOH (2.5 N), THF/MeOH (5:1), rt, 4 h; (f) NH<sub>2</sub>OBn·HCl, EDCI, HOBt, TEA, DMF, 4 h; and (g) Pd/C, (10% w/w), H<sub>2</sub> (1 atm), MeOH/THF (3:1), rt, 5–8 h.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Syntheses of Compounds <b>3m</b>–<b>3r</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) PhCH<sub>2</sub>CH<sub>2</sub>NH<sub>2</sub>, DMAC, μW 250 W, reflux, 6 min; (b) EtOCOCl, THF, reflux 3.5 h; (c) NaOH (2 N), EtOH, 100 °C, 1 h; (d) (i) NaH, DMF, ice bath, 1.5 h and (ii) 4-COOEtC<sub>6</sub>H<sub>4</sub>CH<sub>2</sub>Br, 15 h; (e) LiOH (2.5 N), THF/MeOH (5:1), rt, 4 h; (f) NH<sub>2</sub>OBn·HCl, EDCI, HOBt, TEA, DMF, 4 h; (g) Pd/C, (10% w/w), H<sub>2</sub> (1 atm), MeOH/THF (3:1), rt, 5 h; and (h) BBr<sub>3</sub> (1 M in DCM), DCM, ice bath 1 h.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Syntheses of Compounds <b>3s</b>–<b>3u</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) NaH, DMF, ice bath, 0.5 h and (ii) methyl 5-(bromomethyl)thiophene-2-carboxylate or methyl 4-(bromomethyl)thiophene-2-carboxylate or 4-COOEtCH<sub>6</sub>H<sub>4</sub>CH<sub>2</sub>Br, 5 h; (b) LiOH (2.5 N), THF/MeOH (5:1), rt, 4 h; (c) NH<sub>2</sub>OBn·HCl, EDCI, HOBt, TEA, DMF, 4 h; (d) BBr<sub>3</sub> (1 M in DCM), DCM, ice bath 1 h; (e) PhOCOCl, THF, μW, 200 W, reflux, 10 min; (f) PhCH<sub>2</sub>CH<sub>2</sub>NH<sub>2</sub>, TEA, MeOH, μW 100 W, 10 min; and (g) NaOH (2 N), EtOH, 100 °C, 8 h.</p></p></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Combined treatment of <b>3d</b> or <b>3r</b> and PAX reduced LL/2 cell viability. (A) LL/2 cells were incubated with <b>3d</b> (4 μM) and/or PAX (10 nM) for 3 days after which the relative number of viable cells were determined by the MTT assay. (B) LL/2 cells were exposed to <b>3d</b> or PAX for up to 3 days, and the relative number of viable cells were determined by the MTT assay. (C) At the end of the 3 day period, the cells were fixed with formaldehyde and then stained with 0.02% (w/v) crystal violet. (D) LL/2 cells were treated with PAX in the presence or absence of <b>3d</b> at different concentrations (0–10 μM) for 72 h, and the cytotoxicity was assayed by MTT. The isobologram analysis confirms the synergistic effect.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>3d</b> increased α-tubulin acetylation in the human lung cancer cell line, A549. (A) Cells were treated with the indicated concentrations of <b>3d</b> or ACY-1215 for 24 h, and the expression of acetylated α-tubulin (Ac-tubulin) was assessed by Western blotting. (B) Cells were treated with 1 μM of <b>3d</b> for different periods of time, and the expression of Ac-tubulin was assessed by Western blotting. Ctrl, control. The intensities of each bands were calculated with Image J.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Combined treatment with <b>3d</b> and PAX enhanced acetylation of α-tubulin in LL/2 cells. The cells were treated with <b>3d</b> and/or PAX for 24 h, and the expression of acetylated-α-tubulin and actin was assessed by Western blotting. The intensities of each bands were calculated with Image J.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Combination of <b>3d</b> and PAX induced development of abnormal nuclei in LL/2 cells. LL/2 cells were treated with <b>3d</b> and/or PAX for 24 h prior to fixation. Nuclei were visualized by staining with 4′,6-diamidino-2-phenylindole (blue).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Combined treatment of <b>3d</b> and PAX synergistically induced apoptosis in A549 and LL/2 cells. The cells were treated for 24 h. The extent of apoptosis in each group of cells was detected using flow cytometry.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0010.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>3d</b> decreased PD-L1 expression in LL/2 cells. The cells were treated with <b>3d</b> and/or PAX for 24 h, and then expression of PD-L1 was assessed by Western blotting. Tub A, tubastatin A.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0011.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Antitumor activity of <b>3d</b> alone or in combination with PAX on LL/2 tumors in [B6 OR C57BL/6] mice. Tumor growth was defined as an increase in tumor volume (TV) (mm<sup>3</sup> = 1/2 × length × width) and measured using a caliper. Percentage TGI was defined as the relationship between the TV of a test group and the control group, using the formula: % TGI = [(TV<sub>control</sub> – TV<sub>treated</sub>)/TV<sub>control</sub>] × 100.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0012.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Tissue distribution of ACY-1215 in mice after applying a 40 mg/kg oral gavage (data are the mean ± SE).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0002.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Tissue distribution of <b>3d</b> in mice after applying a 40 mg/kg oral gavage (data are the mean ± SE).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0003.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Tissue distribution of <b>3d</b> metabolite in mice after applying a 40 mg/kg oral gavage of <b>3d</b> (data are the mean ± SE).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/medium/jm-2018-015902_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0004.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Tissue distribution of <b>3d</b> in mice after applying a 40 mg/kg oral gavage combined with or without 10 mg/kg intraperitoneal injection of PAX (data are the mean ± SE).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01590/20190116/images/large/jm-2018-015902_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01590&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i94">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46412" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46412" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 25 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parmigiani, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venta-Perez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdjument-Bromage, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaneva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tempst, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, P. A.</span></span> <span> </span><span class="NLM_article-title">HDAC6 Is a Specific Deacetylase of Peroxiredoxins and Is Involved in Redox Regulation</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">9633</span>– <span class="NLM_lpage">9638</span>, <span class="refDoi"> DOI: 10.1073/pnas.0803749105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1073%2Fpnas.0803749105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=18606987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovVOjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=9633-9638&author=R.+B.+Parmigianiauthor=W.+S.+Xuauthor=G.+Venta-Perezauthor=H.+Erdjument-Bromageauthor=M.+Yanevaauthor=P.+Tempstauthor=P.+A.+Marks&title=HDAC6+Is+a+Specific+Deacetylase+of+Peroxiredoxins+and+Is+Involved+in+Redox+Regulation&doi=10.1073%2Fpnas.0803749105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation</span></div><div class="casAuthors">Parmigiani, R. B.; Xu, W. S.; Venta-Perez, G.; Erdjumen-Bromage, H.; Yaneva, M.; Tempst, P.; Marks, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">9633-9638</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Eighteen histone deacetylases (HDACs) are present in humans, categorized into 2 groups: (1) Zn-dependent enzymes (HDAC1-11) and (2) NAD-dependent enzymes (sirtuins 1-7).  Among Zn-dependent HDACs, HDAC6 is unique.  It has a cytoplasmic localization, 2 catalytic sites, a ubiquitin-binding site, and it selectively deacetylates α-tubulin and Hsp90.  Here, the authors report the discovery that the redox regulatory proteins, peroxiredoxins (Prxs) I and II are specific targets of HDAC6 in human prostate cancer cells.  Prxs are antioxidant enzymes whose main function is H2O2 redn.  Prxs are elevated in many cancers and neurodegenerative diseases.  The acetylated form of Prx accumulates in the absence of an active HDAC6.  Acetylation of Prx increases its reducing activity, its resistance to superoxidn., and its resistance to transition to high-mol.-wt. complexes.  Thus, HDAC6 and Prxs are targets for modulating intracellular redox status in therapeutic strategies for disorders as disparate as cancers and neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPhHinn-zsRbVg90H21EOLACvtfcHk0lj0qZRY9FzXIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovVOjt7g%253D&md5=205d33a2f6c154d83b1d1cee59d29108</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0803749105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0803749105%26sid%3Dliteratum%253Aachs%26aulast%3DParmigiani%26aufirst%3DR.%2BB.%26aulast%3DXu%26aufirst%3DW.%2BS.%26aulast%3DVenta-Perez%26aufirst%3DG.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DYaneva%26aufirst%3DM.%26aulast%3DTempst%26aufirst%3DP.%26aulast%3DMarks%26aufirst%3DP.%2BA.%26atitle%3DHDAC6%2520Is%2520a%2520Specific%2520Deacetylase%2520of%2520Peroxiredoxins%2520and%2520Is%2520Involved%2520in%2520Redox%2520Regulation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D9633%26epage%3D9638%26doi%3D10.1073%2Fpnas.0803749105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valenzuela-Fernández, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrero, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrador, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Madrid, F.</span></span> <span> </span><span class="NLM_article-title">HDAC6: A Key Regulator of Cytoskeleton, Cell Migration and Cell-Cell Interactions</span>. <i>Trends Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">291</span>– <span class="NLM_lpage">297</span>, <span class="refDoi"> DOI: 10.1016/j.tcb.2008.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1016%2Fj.tcb.2008.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=18472263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvVymu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=291-297&author=A.+Valenzuela-Fern%C3%A1ndezauthor=J.+R.+Cabreroauthor=J.+M.+Serradorauthor=F.+S%C3%A1nchez-Madrid&title=HDAC6%3A+A+Key+Regulator+of+Cytoskeleton%2C+Cell+Migration+and+Cell-Cell+Interactions&doi=10.1016%2Fj.tcb.2008.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions</span></div><div class="casAuthors">Valenzuela-Fernandez, Agustin; Cabrero, J. Roman; Serrador, Juan M.; Sanchez-Madrid, Francisco</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">291-297</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase 6 (HDAC6) is a cytoplasmic enzyme that regulates many important biol. processes, including cell migration, immune synapse formation, viral infection, and the degrdn. of misfolded proteins.  HDAC6 deacetylates tubulin, Hsp90 and cortactin, and forms complexes with other partner proteins.  Although HDAC6 enzymic activity seems to be required for the regulation of cell morphol., the role of HDAC6 in lymphocyte chemotaxis is independent of its tubulin deacetylase activity.  The diverse functions of HDAC6 suggest that it is a potential therapeutic target for the treatment of a range of diseases.  This review examines the biol. actions of HDAC6, focusing on its deacetylase activity and its potential scaffold functions in the regulation of cell migration and other key biol. processes in which the cytoskeleton plays an important role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqds4gVWXQSw7Vg90H21EOLACvtfcHk0li3JEmnBtbxJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvVymu7g%253D&md5=146b21482aa0828a1e7c1c9c24339199</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2008.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2008.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DValenzuela-Fern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DCabrero%26aufirst%3DJ.%2BR.%26aulast%3DSerrador%26aufirst%3DJ.%2BM.%26aulast%3DS%25C3%25A1nchez-Madrid%26aufirst%3DF.%26atitle%3DHDAC6%253A%2520A%2520Key%2520Regulator%2520of%2520Cytoskeleton%252C%2520Cell%2520Migration%2520and%2520Cell-Cell%2520Interactions%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2008%26volume%3D18%26spage%3D291%26epage%3D297%26doi%3D10.1016%2Fj.tcb.2008.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, S. C.</span></span> <span> </span><span class="NLM_article-title">Histone Deacetylase Inhibitors: Molecular Mechanisms of Action and Clinical Trials as Anti-Cancer Drugs</span>. <i>Am. J. Transl. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">166</span>– <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=21416059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtVSqur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=166-79&author=H.+J.+Kimauthor=S.+C.+Bae&title=Histone+Deacetylase+Inhibitors%3A+Molecular+Mechanisms+of+Action+and+Clinical+Trials+as+Anti-Cancer+Drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs</span></div><div class="casAuthors">Kim, Hyun-Jung; Bae, Suk-Chul</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Translational Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">166-179</span>CODEN:
                <span class="NLM_cas:coden">AJTRA7</span>;
        ISSN:<span class="NLM_cas:issn">1943-8141</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase (HDAC) inhibitors are a relatively new class of anti-cancer agents that play important roles in epigenetic or non-epigenetic regulation, inducing death, apoptosis, and cell cycle arrest in cancer cells.  Recently, their use has been clin. validated in cancer patients resulting in the approval of two HDAC inhibitors, vorinostat and depsipetide, by the FDA.  Also, clin. trials of several HDAC inhibitors for use as anti-cancer drugs (alone or in combination with other anti-cancer therapeutics) are ongoing.  However, the mol. mechanisms underlying the response to HDAC inhibitors in cancer patients are not fully understood.  In this review, we summarize our understanding of the mol. and biol. events that underpin the anti-cancer effects of HDAC inhibitors and the outcomes of recent clin. trials involving these drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6o4vH0OXL7bVg90H21EOLACvtfcHk0liahuWWiO3BTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtVSqur0%253D&md5=2f4388dec15ec9b517836f4f3b225641</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DBae%26aufirst%3DS.%2BC.%26atitle%3DHistone%2520Deacetylase%2520Inhibitors%253A%2520Molecular%2520Mechanisms%2520of%2520Action%2520and%2520Clinical%2520Trials%2520as%2520Anti-Cancer%2520Drugs%26jtitle%3DAm.%2520J.%2520Transl.%2520Res.%26date%3D2011%26volume%3D3%26spage%3D166%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">West, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, R. W.</span></span> <span> </span><span class="NLM_article-title">New and Emerging HDAC Inhibitors for Cancer Treatment</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1172/jci69738</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1172%2Fjci69738" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=24382387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntFejtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=30-39&author=A.+C.+Westauthor=R.+W.+Johnstone&title=New+and+Emerging+HDAC+Inhibitors+for+Cancer+Treatment&doi=10.1172%2Fjci69738"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">New and emerging HDAC inhibitors for cancer treatment</span></div><div class="casAuthors">West, Alison C.; Johnstone, Ricky W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">30-39</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review.  Epigenetic enzymes are often dysregulated in human tumors through mutation, altered expression, or inappropriate recruitment to certain loci.  The identification of these enzymes and their partner proteins has driven the rapid development of small-mol. inhibitors that target the cancer epigenome.  Herein, the authors discuss the influence of aberrantly regulated histone deacetylases (HDACs) in tumorigenesis.  The authors examine HDAC inhibitors (HDACis) targeting class I, II, and IV HDACs that are currently under development for use as anticancer agents following the FDA approval of two HDACis, vorinostat and romidepsin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpELUU7P0B_grVg90H21EOLACvtfcHk0liahuWWiO3BTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntFejtg%253D%253D&md5=ab59960223b33e89725f6539b031f531</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1172%2Fjci69738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252Fjci69738%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DA.%2BC.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26atitle%3DNew%2520and%2520Emerging%2520HDAC%2520Inhibitors%2520for%2520Cancer%2520Treatment%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2014%26volume%3D124%26spage%3D30%26epage%3D39%26doi%3D10.1172%2Fjci69738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raedler, L. A.</span></span> <span> </span><span class="NLM_article-title">Farydak (Panobinostat): First HDAC Inhibitor Approved for Patients with Relapsed Multiple Myeloma</span>. <i>Am. Heal. Drug Benefits</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">87</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=27668050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A280%3ADC%252BC2svjvFWrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=84-87&author=L.+A.+Raedler&title=Farydak+%28Panobinostat%29%3A+First+HDAC+Inhibitor+Approved+for+Patients+with+Relapsed+Multiple+Myeloma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Farydak (Panobinostat): First HDAC Inhibitor Approved for Patients with Relapsed Multiple Myeloma</span></div><div class="casAuthors">Raedler Lisa A</div><div class="citationInfo"><span class="NLM_cas:title">American health & drug benefits</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">Spec Feature</span>),
    <span class="NLM_cas:pages">84-7</span>
        ISSN:<span class="NLM_cas:issn">1942-2962</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAmJOZnkDiwS86Js-BCLiifW6udTcc2eYLLu6YCOz1pbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2svjvFWrtg%253D%253D&md5=683cd02a397160b722022cf3ac3fdfa9</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaedler%26aufirst%3DL.%2BA.%26atitle%3DFarydak%2520%2528Panobinostat%2529%253A%2520First%2520HDAC%2520Inhibitor%2520Approved%2520for%2520Patients%2520with%2520Relapsed%2520Multiple%2520Myeloma%26jtitle%3DAm.%2520Heal.%2520Drug%2520Benefits%26date%3D2016%26volume%3D9%26spage%3D84%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalin, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akimova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">Second-Generation Histone Deacetylase 6 Inhibitors Enhance the Immunosuppressive Effects of Foxp3+ T-Regulatory Cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">639</span>– <span class="NLM_lpage">651</span>, <span class="refDoi"> DOI: 10.1021/jm200773h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200773h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1SrtbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=639-651&author=J.+H.+Kalinauthor=K.+V.+Butlerauthor=T.+Akimovaauthor=W.+W.+Hancockauthor=A.+P.+Kozikowski&title=Second-Generation+Histone+Deacetylase+6+Inhibitors+Enhance+the+Immunosuppressive+Effects+of+Foxp3%2B+T-Regulatory+Cells&doi=10.1021%2Fjm200773h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Second-Generation Histone Deacetylase 6 Inhibitors Enhance the Immunosuppressive Effects of Foxp3+ T-Regulatory Cells</span></div><div class="casAuthors">Kalin, Jay H.; Butler, Kyle V.; Akimova, Tatiana; Hancock, Wayne W.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">639-651</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Second-generation Tubastatin A analogs were synthesized and evaluated for their ability to inhibit selectively histone deacetylase 6 (HDAC6).  Substitutions to the carboline cap group were well-tolerated with substitution at the 2-position of both β- and γ-carbolines being optimal for HDAC6 activity and selectivity.  Some compds. in this series were detd. to have subnanomolar activity at HDAC6 with more than 7000 fold selectivity for HDAC6 vs. HDAC1.  Selected compds. were then evaluated for their ability to augment the immunosuppressive effect of Foxp3+ regulatory T cells.  All compds. tested were found to enhance the ability of regulatory T cells to inhibit the mitotic division of effector T cells both in vitro and in vivo, suggesting that further investigation into the use of these compds. for the treatment of autoimmune disorders is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzt2Rz2tD6ibVg90H21EOLACvtfcHk0lhgqChWBM41Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1SrtbzM&md5=88a4f02045fdc5387970abe53ec00c7a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm200773h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200773h%26sid%3Dliteratum%253Aachs%26aulast%3DKalin%26aufirst%3DJ.%2BH.%26aulast%3DButler%26aufirst%3DK.%2BV.%26aulast%3DAkimova%26aufirst%3DT.%26aulast%3DHancock%26aufirst%3DW.%2BW.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DSecond-Generation%2520Histone%2520Deacetylase%25206%2520Inhibitors%2520Enhance%2520the%2520Immunosuppressive%2520Effects%2520of%2520Foxp3%252B%2520T-Regulatory%2520Cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D639%26epage%3D651%26doi%3D10.1021%2Fjm200773h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, P.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsin, L.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chern, J.-W.</span></span> <span> </span><span class="NLM_article-title">Quinazolin-4-One Derivatives as Selective Histone Deacetylase-6 Inhibitors for the Treatment of Alzheimer’s Disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">6775</span>– <span class="NLM_lpage">6791</span>, <span class="refDoi"> DOI: 10.1021/jm400564j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400564j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Slsb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6775-6791&author=C.-W.+Yuauthor=P.-T.+Changauthor=L.-W.+Hsinauthor=J.-W.+Chern&title=Quinazolin-4-One+Derivatives+as+Selective+Histone+Deacetylase-6+Inhibitors+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1021%2Fjm400564j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Quinazolin-4-one Derivatives as Selective Histone Deacetylase-6 Inhibitors for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Yu, Chao-Wu; Chang, Pei-Teh; Hsin, Ling-Wei; Chern, Ji-Wang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6775-6791</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel quinazolin-4-one derivs. contg. a hydroxamic acid moiety were designed and synthesized.  All compds. were subjected to histone deacetylase (HDAC) enzymic assays to identify selective HDAC6 inhibitors with nanomolar IC50 values.  (E)-3-(2-Ethyl-7-fluoro-4-oxo-3-phenethyl-3,4-dihydroquinazolin-6-yl)-N-hydroxyacrylamide (I) is the most potent HDAC6 inhibitor (IC50, 8 nM).  In vitro, these compds. induced neurite outgrowth accompanied by growth-assocd. protein 43 expression, and they enhanced the synaptic activities of PC12 and SH-SY5Y neuronal cells without producing toxic or mitogenic effects.  Several of the compds. dramatically increased nonhistone protein acetylation, specifically of α-tubulin.  Some of the more potent HDAC6 inhibitors decreased zinc-mediated β-amyloid aggregation in vitro.  N-Hydroxy-3-(2-methyl-4-oxo-3-phenethyl-3,4-dihydro-quinazolin-7-yl)-acrylamide (II) the most promising drug candidate, selectively inhibits HDAC6 (IC50, 29 nM), practically does not affect human ether-a-go-go-related membrane channel activity (IC50 >10 μM) or cytochrome P 450 activity (IC50 >6.5 μM) in vitro, and significantly improves learning-based performances of mice with β-amyloid-induced hippocampal lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9ZyFO0SBaDLVg90H21EOLACvtfcHk0lhgqChWBM41Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Slsb7J&md5=bcc20d956982b1e4e9a706327087f233</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm400564j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400564j%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DC.-W.%26aulast%3DChang%26aufirst%3DP.-T.%26aulast%3DHsin%26aufirst%3DL.-W.%26aulast%3DChern%26aufirst%3DJ.-W.%26atitle%3DQuinazolin-4-One%2520Derivatives%2520as%2520Selective%2520Histone%2520Deacetylase-6%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6775%26epage%3D6791%26doi%3D10.1021%2Fjm400564j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Villarroel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villagra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotomayor, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">Selective Histone Deacetylase 6 Inhibitors Bearing Substituted Urea Linkers Inhibit Melanoma Cell Growth</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9891</span>– <span class="NLM_lpage">9899</span>, <span class="refDoi"> DOI: 10.1021/jm301098e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301098e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9891-9899&author=J.+A.+Bergmanauthor=K.+Woanauthor=P.+Perez-Villarroelauthor=A.+Villagraauthor=E.+M.+Sotomayorauthor=A.+P.+Kozikowski&title=Selective+Histone+Deacetylase+6+Inhibitors+Bearing+Substituted+Urea+Linkers+Inhibit+Melanoma+Cell+Growth&doi=10.1021%2Fjm301098e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Histone Deacetylase 6 Inhibitors Bearing Substituted Urea Linkers Inhibit Melanoma Cell Growth</span></div><div class="casAuthors">Bergman, Joel A.; Woan, Karrune; Perez-Villarroel, Patricio; Villagra, Alejandro; Sotomayor, Eduardo M.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9891-9899</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The incidence of malignant melanoma has dramatically increased in recent years thus requiring the need for improved therapeutic strategies.  In our efforts to design selective histone deactylase inhibitors (HDACI), we discovered that the aryl urea 1 is a modestly potent yet nonselective inhibitor.  Structure-activity relationship studies revealed that adding substituents to the nitrogen atom of the urea so as to generate compds. bearing a branched linker group results in increased potency and selectivity for HDAC6.  Compd. 5g shows low nanomolar inhibitory potency against HDAC6 and a selectivity of ∼600-fold relative to the inhibition of HDAC1.  These HDACIs were evaluated for their ability to inhibit the growth of B16 melanoma cells with the most potent and selective HDAC6I being found to decrease tumor cell growth.  To the best of our knowledge, this work constitutes the first report of HDAC6-selective inhibitors that possess antiproliferative effects against melanoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTkTtPLqvwsrVg90H21EOLACvtfcHk0lhgqChWBM41Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsrbJ&md5=d6be4c0efb3922fc35d814ba00ae9ed1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm301098e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301098e%26sid%3Dliteratum%253Aachs%26aulast%3DBergman%26aufirst%3DJ.%2BA.%26aulast%3DWoan%26aufirst%3DK.%26aulast%3DPerez-Villarroel%26aufirst%3DP.%26aulast%3DVillagra%26aufirst%3DA.%26aulast%3DSotomayor%26aufirst%3DE.%2BM.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DSelective%2520Histone%2520Deacetylase%25206%2520Inhibitors%2520Bearing%2520Substituted%2520Urea%2520Linkers%2520Inhibit%2520Melanoma%2520Cell%2520Growth%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9891%26epage%3D9899%26doi%3D10.1021%2Fjm301098e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrientos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ordentlich, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Counter, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T.-P.</span></span> <span> </span><span class="NLM_article-title">The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic Tumorigenesis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">7561</span>– <span class="NLM_lpage">7569</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-08-0188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1158%2F0008-5472.can-08-0188" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=7561-7569&author=Y.-S.+Leeauthor=K.-H.+Limauthor=X.+Guoauthor=Y.+Kawaguchiauthor=Y.+Gaoauthor=T.+Barrientosauthor=P.+Ordentlichauthor=X.-F.+Wangauthor=C.+M.+Counterauthor=T.-P.+Yao&title=The+Cytoplasmic+Deacetylase+HDAC6+Is+Required+for+Efficient+Oncogenic+Tumorigenesis&doi=10.1158%2F0008-5472.can-08-0188"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.can-08-0188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.can-08-0188%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DY.-S.%26aulast%3DLim%26aufirst%3DK.-H.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DKawaguchi%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DBarrientos%26aufirst%3DT.%26aulast%3DOrdentlich%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DX.-F.%26aulast%3DCounter%26aufirst%3DC.%2BM.%26aulast%3DYao%26aufirst%3DT.-P.%26atitle%3DThe%2520Cytoplasmic%2520Deacetylase%2520HDAC6%2520Is%2520Required%2520for%2520Efficient%2520Oncogenic%2520Tumorigenesis%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D7561%26epage%3D7569%26doi%3D10.1158%2F0008-5472.can-08-0188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salas-Burgos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koomen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olashaw, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dent, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seto, E.</span></span> <span> </span><span class="NLM_article-title">HDAC6 Modulates Cell Motility by Altering the Acetylation Level of Cortactin</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">213</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2007.05.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1016%2Fj.molcel.2007.05.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=17643370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFamtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=197-213&author=X.+Zhangauthor=Z.+Yuanauthor=Y.+Zhangauthor=S.+Yongauthor=A.+Salas-Burgosauthor=J.+Koomenauthor=N.+Olashawauthor=J.+T.+Parsonsauthor=X.-J.+Yangauthor=S.+R.+Dentauthor=T.-P.+Yaoauthor=W.+S.+Laneauthor=E.+Seto&title=HDAC6+Modulates+Cell+Motility+by+Altering+the+Acetylation+Level+of+Cortactin&doi=10.1016%2Fj.molcel.2007.05.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 modulates cell motility by altering the acetylation level of cortactin</span></div><div class="casAuthors">Zhang, Xiaohong; Yuan, Zhigang; Zhang, Yingtao; Yong, Sarah; Salas-Burgos, Alexis; Koomen, John; Olashaw, Nancy; Parsons, J. Thomas; Yang, Xiang-Jiao; Dent, Sharon R.; Yao, Tso-Pang; Lane, William S.; Seto, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">197-213</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Histone deacetylase 6 (HDAC6) is a tubulin-specific deacetylase that regulates microtubule-dependent cell movement.  In this study, we identify the F-actin-binding protein cortactin as a HDAC6 substrate.  We demonstrate that HDAC6 binds cortactin and that overexpression of HDAC6 leads to hypoacetylation of cortactin, whereas inhibition of HDAC6 activity leads to cortactin hyperacetylation.  HDAC6 alters the ability of cortactin to bind F-actin by modulating a "charge patch" in its repeat region.  Introduction of charge-preserving or charge-neutralizing mutations in this cortactin repeat region correlates with the gain or loss of F-actin binding ability, resp.  Cells expressing a charge-neutralizing cortactin mutant were less motile than control cells or cells expressing a charge-preserving mutant.  These findings suggest that, in addn. to its role in microtubule-dependent cell motility, HDAC6 influences actin-dependent cell motility by altering the acetylation status of cortactin, which, in turn, changes the F-actin binding activity of cortactin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQSM-mAzzZOrVg90H21EOLACvtfcHk0lhx1xdWGYSGCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFamtLg%253D&md5=752a0203b7cde321c9c5de07fba79ca7</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2007.05.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2007.05.033%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYuan%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYong%26aufirst%3DS.%26aulast%3DSalas-Burgos%26aufirst%3DA.%26aulast%3DKoomen%26aufirst%3DJ.%26aulast%3DOlashaw%26aufirst%3DN.%26aulast%3DParsons%26aufirst%3DJ.%2BT.%26aulast%3DYang%26aufirst%3DX.-J.%26aulast%3DDent%26aufirst%3DS.%2BR.%26aulast%3DYao%26aufirst%3DT.-P.%26aulast%3DLane%26aufirst%3DW.%2BS.%26aulast%3DSeto%26aufirst%3DE.%26atitle%3DHDAC6%2520Modulates%2520Cell%2520Motility%2520by%2520Altering%2520the%2520Acetylation%2520Level%2520of%2520Cortactin%26jtitle%3DMol.%2520Cell%26date%3D2007%26volume%3D27%26spage%3D197%26epage%3D213%26doi%3D10.1016%2Fj.molcel.2007.05.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Namdar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, P. A.</span></span> <span> </span><span class="NLM_article-title">Selective Inhibition of Histone Deacetylase 6 (HDAC6) Induces DNA Damage and Sensitizes Transformed Cells to Anticancer Agents</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">20003</span>– <span class="NLM_lpage">20008</span>, <span class="refDoi"> DOI: 10.1073/pnas.1013754107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1073%2Fpnas.1013754107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=21037108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVyitL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=20003-20008&author=M.+Namdarauthor=G.+Perezauthor=L.+Ngoauthor=P.+A.+Marks&title=Selective+Inhibition+of+Histone+Deacetylase+6+%28HDAC6%29+Induces+DNA+Damage+and+Sensitizes+Transformed+Cells+to+Anticancer+Agents&doi=10.1073%2Fpnas.1013754107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents</span></div><div class="casAuthors">Namdar, Mandana; Perez, Gisela; Ngo, Lang; Marks, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">20003-20008, S20003/1-S20003/4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Histone deacetylase 6 (HDAC6) is structurally and functionally unique among the 11 human zinc-dependent histone deacetylases.  Here we show that chem. inhibition with the HDAC6-selective inhibitor tubacin significantly enhances cell death induced by the topoisomerase II inhibitors etoposide and doxorubicin and the pan-HDAC inhibitor SAHA (vorinostat)in transformed cells (LNCaP, MCF-7), an effect not obsd. in normal cells (human foreskin fibroblast cells).  The inactive analog of tubacin, nil-tubacin, does not sensitize transformed cells to these anticancer agents.  Further, we show that down-regulation of HDAC6 expression by shRNA in LNCaP cells enhances cell death induced by etoposide, doxorubicin, and SAHA.  Tubacin in combination with SAHA or etoposide is more potent than either drug alone in activating the intrinsic apoptotic pathway in transformed cells, as evidenced by an increase in PARP cleavage and partial inhibition of this effect by the pan-caspase inhibitor Z-VAD-fmk.  HDAC6 inhibition with tubacin induces the accumulation of γH2AX, an early marker of DNA double-strand breaks.  Tubacin enhances DNA damage induced by etoposide or SAHA as indicated by increased accumulation of γH2AX and activation of the checkpoint kinase Chk2.  Tubacin induces the expression of DDIT3 (CHOP/GADD153), a transcription factor up-regulated in response to cellular stress.  DDIT3 induction is further increased when tubacin is combined with SAHA.  These findings point to mechanisms by which HDAC6-selective inhibition can enhance the efficacy of certain anti-cancer agents in transformed cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZaEb79wuk2rVg90H21EOLACvtfcHk0lhx1xdWGYSGCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVyitL%252FP&md5=64381ac4f0421f6161c8699b30843fc1</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1013754107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1013754107%26sid%3Dliteratum%253Aachs%26aulast%3DNamdar%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DG.%26aulast%3DNgo%26aufirst%3DL.%26aulast%3DMarks%26aufirst%3DP.%2BA.%26atitle%3DSelective%2520Inhibition%2520of%2520Histone%2520Deacetylase%25206%2520%2528HDAC6%2529%2520Induces%2520DNA%2520Damage%2520and%2520Sensitizes%2520Transformed%2520Cells%2520to%2520Anticancer%2520Agents%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D20003%26epage%3D20008%26doi%3D10.1073%2Fpnas.1013754107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hideshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarpe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Duzer, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazitschek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogier, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirstea, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scullen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canavese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raje, N.</span></span> <span> </span><span class="NLM_article-title">Preclinical Activity, Pharmacodynamic, and Pharmacokinetic Properties of a Selective HDAC6 Inhibitor, ACY-1215, in Combination with Bortezomib in Multiple Myeloma</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">2579</span>– <span class="NLM_lpage">2589</span>, <span class="refDoi"> DOI: 10.1182/blood-2011-10-387365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1182%2Fblood-2011-10-387365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=22262760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVOntb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2012&pages=2579-2589&author=L.+Santoauthor=T.+Hideshimaauthor=A.+L.+Kungauthor=J.-C.+Tsengauthor=D.+Tamangauthor=M.+Yangauthor=M.+Jarpeauthor=J.+H.+van+Duzerauthor=R.+Mazitschekauthor=W.+C.+Ogierauthor=D.+Cirsteaauthor=S.+Rodigauthor=H.+Edaauthor=T.+Scullenauthor=M.+Canaveseauthor=J.+Bradnerauthor=K.+C.+Andersonauthor=S.+S.+Jonesauthor=N.+Raje&title=Preclinical+Activity%2C+Pharmacodynamic%2C+and+Pharmacokinetic+Properties+of+a+Selective+HDAC6+Inhibitor%2C+ACY-1215%2C+in+Combination+with+Bortezomib+in+Multiple+Myeloma&doi=10.1182%2Fblood-2011-10-387365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma</span></div><div class="casAuthors">Santo, Loredana; Hideshima, Teru; Kung, Andrew L.; Tseng, Jen-Chieh; Tamang, David; Yang, Min; Jarpe, Matthew; van Duzer, John H.; Mazitschek, Ralph; Ogier, Walter C.; Cirstea, Diana; Rodig, Scott; Eda, Homare; Scullen, Tyler; Canavese, Miriam; Bradner, James; Anderson, Kenneth C.; Jones, Simon S.; Raje, Noopur</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2579-2589</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Histone deacetylase (HDAC) enzymic activity has been linked to the transcription of DNA in cancers including multiple myeloma (MM).  Therefore, HDAC inhibitors used alone and in combination are being actively studied as novel therapies in MM.  In the present study, we investigated the preclin. activity of ACY-1215, an HDAC6-selective inhibitor, alone and in combination with bortezomib in MM.  Low doses of ACY-1215 combined with bortezomib triggered synergistic anti-MM activity, resulting in protracted endoplasmic reticulum stress and apoptosis via activation of caspase-3, caspase-8, and caspase-9 and poly (ADP) ribosome polymerase.  In vivo, the anti-MM activity of ACY-1215 in combination with bortezomib was confirmed using 2 different xenograft SCID mouse models: human MM injected s.c. (the plasmacytoma model) and luciferase-expressing human MM injected i.v. (the disseminated MM model).  Tumor growth was significantly delayed and overall survival was significantly prolonged in animals treated with the combination therapy.  Pharmacokinetic data showed peak plasma levels of ACY-1215 at 4 h after treatment coincident with an increase in acetylated α-tubulin, a marker of HDAC6 inhibition, by immunohistochem. and Western blot anal.  These studies provide preclin. rationale for acetylated α-tubulin use as a pharmacodynamic biomarker in future clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoelmsk1wo_LVg90H21EOLACvtfcHk0lhRyv6O_ed3BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVOntb4%253D&md5=094298bdd3d5b91c7060d8b294857846</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1182%2Fblood-2011-10-387365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2011-10-387365%26sid%3Dliteratum%253Aachs%26aulast%3DSanto%26aufirst%3DL.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DTseng%26aufirst%3DJ.-C.%26aulast%3DTamang%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DJarpe%26aufirst%3DM.%26aulast%3Dvan%2BDuzer%26aufirst%3DJ.%2BH.%26aulast%3DMazitschek%26aufirst%3DR.%26aulast%3DOgier%26aufirst%3DW.%2BC.%26aulast%3DCirstea%26aufirst%3DD.%26aulast%3DRodig%26aufirst%3DS.%26aulast%3DEda%26aufirst%3DH.%26aulast%3DScullen%26aufirst%3DT.%26aulast%3DCanavese%26aufirst%3DM.%26aulast%3DBradner%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DJones%26aufirst%3DS.%2BS.%26aulast%3DRaje%26aufirst%3DN.%26atitle%3DPreclinical%2520Activity%252C%2520Pharmacodynamic%252C%2520and%2520Pharmacokinetic%2520Properties%2520of%2520a%2520Selective%2520HDAC6%2520Inhibitor%252C%2520ACY-1215%252C%2520in%2520Combination%2520with%2520Bortezomib%2520in%2520Multiple%2520Myeloma%26jtitle%3DBlood%26date%3D2012%26volume%3D119%26spage%3D2579%26epage%3D2589%26doi%3D10.1182%2Fblood-2011-10-387365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, G.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, D.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, P.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, T.-L.</span></span> <span> </span><span class="NLM_article-title">The HDAC Inhibitor LBH589 Induces ERK-Dependent Prometaphase Arrest in Prostate Cancer via HDAC6 Inactivation and Down-Regulation</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e73401</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0073401</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1371%2Fjournal.pone.0073401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=24023871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVGitb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=M.-J.+Chuangauthor=S.-T.+Wuauthor=S.-H.+Tangauthor=X.-M.+Laiauthor=H.-C.+Laiauthor=K.-H.+Hsuauthor=K.-H.+Sunauthor=G.-H.+Sunauthor=S.-Y.+Changauthor=D.-S.+Yuauthor=P.-W.+Hsiaoauthor=S.-M.+Huangauthor=T.-L.+Cha&title=The+HDAC+Inhibitor+LBH589+Induces+ERK-Dependent+Prometaphase+Arrest+in+Prostate+Cancer+via+HDAC6+Inactivation+and+Down-Regulation&doi=10.1371%2Fjournal.pone.0073401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The HDAC inhibitor LBH589 induces ERK-dependent prometaphase arrest in prostate cancer via HDAC6 inactivation and down-regulation</span></div><div class="casAuthors">Chuang, Mei-Jen; Wu, Sheng-Tang; Tang, Shou-Hung; Lai, Xiang-Me; Lai, Hsiao-Chu; Hsu, Kai-Hsiang; Sun, Kuang-Hui; Sun, Guang-Huan; Chang, Sun-Yran; Yu, Dah-Shyong; Hsiao, Pei-Wen; Huang, Shih-Ming; Cha, Tai-Lung</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e73401</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Histone deacetylase inhibitors (HDACIs) have potent anti-cancer activity in a variety of cancer models.  Understanding the mol. mechanisms involved in the therapeutic responsiveness of HDACI is needed before its clin. application.  This study aimed to det. if a potent HDACI, LBH589 (Panobinostat), had differential therapeutic responsiveness towards LNCaP and PC-3 prostate cancer (PCa) cells.  The former showed prometaphase arrest with subsequent apoptosis upon LBH589 treatment, while the latter was less sensitive and had late G2 arrest.  The LBH589 treatment down-regulated HDAC6 and sustained ERK activation, and contributed to prometaphase arrest.  Mechanistically, LBH589 inhibited HDAC6 activity, caused its dissocn. from protein phosphatase PP1α, and increased 14-3-3ζ acetylation.  Acetylated 14-3-3ζ released its mask effect on serine 259 of c-Raf and serine 216 of Cdc25C subsequent to de-phosphorylation by PP1α, which contributed to ERK activation.  Enhanced ERK activity by LBH589 further down-regulated HDAC6 protein levels and sustained ERK activation by free-forward regulation.  The sustained Cdc25C and ERK activation resulted in early M-phase (prometaphase) arrest and subsequent apoptosis in the most sensitive LNCaP cells but not in PC-3 cells.  This study provides pre-clin. evidence that HDAC6 may serve as a sensitive therapeutic target in the treatment of prostate cancer with HDACI LBH589 for clin. translation.  This study also posits a novel mechanism of HDAC6 participation in regulating the c-Raf-PP1-ERK signaling pathway and contributing to M phase cell-cycle transition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHD_joXlVF8rVg90H21EOLACvtfcHk0lhRyv6O_ed3BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVGitb7I&md5=435d8b527734fe55327afa9473338228</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0073401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0073401%26sid%3Dliteratum%253Aachs%26aulast%3DChuang%26aufirst%3DM.-J.%26aulast%3DWu%26aufirst%3DS.-T.%26aulast%3DTang%26aufirst%3DS.-H.%26aulast%3DLai%26aufirst%3DX.-M.%26aulast%3DLai%26aufirst%3DH.-C.%26aulast%3DHsu%26aufirst%3DK.-H.%26aulast%3DSun%26aufirst%3DK.-H.%26aulast%3DSun%26aufirst%3DG.-H.%26aulast%3DChang%26aufirst%3DS.-Y.%26aulast%3DYu%26aufirst%3DD.-S.%26aulast%3DHsiao%26aufirst%3DP.-W.%26aulast%3DHuang%26aufirst%3DS.-M.%26aulast%3DCha%26aufirst%3DT.-L.%26atitle%3DThe%2520HDAC%2520Inhibitor%2520LBH589%2520Induces%2520ERK-Dependent%2520Prometaphase%2520Arrest%2520in%2520Prostate%2520Cancer%2520via%2520HDAC6%2520Inactivation%2520and%2520Down-Regulation%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0073401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.-s.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbert, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T.-P.</span></span> <span> </span><span class="NLM_article-title">The Microtubule-Associated Histone Deacetylase 6 (HDAC6) Regulates Epidermal Growth Factor Receptor (EGFR) Endocytic Trafficking and Degradation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">11219</span>– <span class="NLM_lpage">11226</span>, <span class="refDoi"> DOI: 10.1074/jbc.m109.042754</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1074%2Fjbc.m109.042754" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=11219-11226&author=Y.-s.+Gaoauthor=C.+C.+Hubbertauthor=T.-P.+Yao&title=The+Microtubule-Associated+Histone+Deacetylase+6+%28HDAC6%29+Regulates+Epidermal+Growth+Factor+Receptor+%28EGFR%29+Endocytic+Trafficking+and+Degradation&doi=10.1074%2Fjbc.m109.042754"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m109.042754&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m109.042754%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.-s.%26aulast%3DHubbert%26aufirst%3DC.%2BC.%26aulast%3DYao%26aufirst%3DT.-P.%26atitle%3DThe%2520Microtubule-Associated%2520Histone%2520Deacetylase%25206%2520%2528HDAC6%2529%2520Regulates%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520%2528EGFR%2529%2520Endocytic%2520Trafficking%2520and%2520Degradation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D11219%26epage%3D11226%26doi%3D10.1074%2Fjbc.m109.042754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, C.</span></span> <span> </span><span class="NLM_article-title">HDAC6-Mediated EGFR Stabilization and Activation Restrict Cell Response to Sorafenib in Non-Small Cell Lung Cancer Cells</span>. <i>Med. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">50</span>, <span class="refDoi"> DOI: 10.1007/s12032-016-0765-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1007%2Fs12032-016-0765-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=27090797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A280%3ADC%252BC28bhtlKktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2016&pages=50&author=Z.+Wangauthor=P.+Huauthor=F.+Tangauthor=C.+Xie&title=HDAC6-Mediated+EGFR+Stabilization+and+Activation+Restrict+Cell+Response+to+Sorafenib+in+Non-Small+Cell+Lung+Cancer+Cells&doi=10.1007%2Fs12032-016-0765-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6-mediated EGFR stabilization and activation restrict cell response to sorafenib in non-small cell lung cancer cells</span></div><div class="casAuthors">Wang Zhihao; Tang Fang; Xie Conghua; Wang Zhihao; Tang Fang; Xie Conghua; Hu Pengchao</div><div class="citationInfo"><span class="NLM_cas:title">Medical oncology (Northwood, London, England)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">50</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Sorafenib is a multi-targeted kinase inhibitor and has been the subject of extensive clinical research in advanced non-small cell lung cancer (NSCLC).  However, sorafenib fails to improve overall survival of patients with advanced NSCLC.  The molecular mechanisms that account for this phenomenon are unclear.  Here we show that sorafenib treatment stabilizes epidermal growth factor receptor (EGFR) and activates EGFR pathway.  Moreover, this is partly mediated by stabilization of histone deacetylase 6 (HDAC6), which has been shown to regulate EGFR endocytic trafficking and degradation.  Overexpression of HDAC6 confers resistance to sorafenib in NSCLC cells.  Inhibition of HDAC6 with selective inhibitors synergizes with sorafenib to kill NSCLC cells via inhibition of sorafenib-mediated EGFR pathway activation.  Taken together, our findings might partly explain the failure of Phase III trial of sorafenib in improving overall survival of advanced NSCLC patients and bear possible implications for the improvement on the efficacy of sorafenib in treatment of NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRwrkvhyIzugdLIORRPd5lbfW6udTcc2eb3NivbIp_yo7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bhtlKktQ%253D%253D&md5=909f9461c4f4ba112123be59c6adbf91</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1007%2Fs12032-016-0765-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12032-016-0765-5%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DHu%26aufirst%3DP.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DXie%26aufirst%3DC.%26atitle%3DHDAC6-Mediated%2520EGFR%2520Stabilization%2520and%2520Activation%2520Restrict%2520Cell%2520Response%2520to%2520Sorafenib%2520in%2520Non-Small%2520Cell%2520Lung%2520Cancer%2520Cells%26jtitle%3DMed.%2520Oncol.%26date%3D2016%26volume%3D33%26spage%3D50%26doi%3D10.1007%2Fs12032-016-0765-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lienlaf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Villarroel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pabon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahakian, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woan, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smalley, K. S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montecino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinilla-Ibarz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarnaik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotomayor, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villagra, A.</span></span> <span> </span><span class="NLM_article-title">Essential Role of HDAC6 in the Regulation of PD-L1 in Melanoma</span>. <i>Med. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">750</span>, <span class="refDoi"> DOI: 10.1016/j.molonc.2015.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1016%2Fj.molonc.2015.12.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=735-750&author=M.+Lienlafauthor=P.+Perez-Villarroelauthor=T.+Knoxauthor=M.+Pabonauthor=E.+Sahakianauthor=J.+Powersauthor=K.+V.+Woanauthor=C.+Leeauthor=F.+Chengauthor=S.+Dengauthor=K.+S.+M.+Smalleyauthor=M.+Montecinoauthor=A.+Kozikowskiauthor=J.+Pinilla-Ibarzauthor=A.+Sarnaikauthor=E.+Setoauthor=J.+Weberauthor=E.+M.+Sotomayorauthor=A.+Villagra&title=Essential+Role+of+HDAC6+in+the+Regulation+of+PD-L1+in+Melanoma&doi=10.1016%2Fj.molonc.2015.12.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.molonc.2015.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molonc.2015.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DLienlaf%26aufirst%3DM.%26aulast%3DPerez-Villarroel%26aufirst%3DP.%26aulast%3DKnox%26aufirst%3DT.%26aulast%3DPabon%26aufirst%3DM.%26aulast%3DSahakian%26aufirst%3DE.%26aulast%3DPowers%26aufirst%3DJ.%26aulast%3DWoan%26aufirst%3DK.%2BV.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DF.%26aulast%3DDeng%26aufirst%3DS.%26aulast%3DSmalley%26aufirst%3DK.%2BS.%2BM.%26aulast%3DMontecino%26aufirst%3DM.%26aulast%3DKozikowski%26aufirst%3DA.%26aulast%3DPinilla-Ibarz%26aufirst%3DJ.%26aulast%3DSarnaik%26aufirst%3DA.%26aulast%3DSeto%26aufirst%3DE.%26aulast%3DWeber%26aufirst%3DJ.%26aulast%3DSotomayor%26aufirst%3DE.%2BM.%26aulast%3DVillagra%26aufirst%3DA.%26atitle%3DEssential%2520Role%2520of%2520HDAC6%2520in%2520the%2520Regulation%2520of%2520PD-L1%2520in%2520Melanoma%26jtitle%3DMed.%2520Oncol.%26date%3D2016%26volume%3D10%26spage%3D735%26epage%3D750%26doi%3D10.1016%2Fj.molonc.2015.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Houlden, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchby, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyler, S. N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagné, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd-Jones, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Booker-Milburn, K. I.</span></span> <span> </span><span class="NLM_article-title">Room-Temperature Palladium-Catalyzed C-H Activation: Ortho-Carbonylation of Aniline Derivatives</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1830</span>– <span class="NLM_lpage">1833</span>, <span class="refDoi"> DOI: 10.1002/anie.200805842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1002%2Fanie.200805842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjt1OjtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=1830-1833&author=C.+E.+Houldenauthor=M.+Hutchbyauthor=C.+D.+Baileyauthor=J.+G.+Fordauthor=S.+N.+G.+Tylerauthor=M.+R.+Gagn%C3%A9author=G.+C.+Lloyd-Jonesauthor=K.+I.+Booker-Milburn&title=Room-Temperature+Palladium-Catalyzed+C-H+Activation%3A+Ortho-Carbonylation+of+Aniline+Derivatives&doi=10.1002%2Fanie.200805842"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Room-temperature palladium-catalyzed C-H activation: Ortho-carbonylation of aniline derivatives</span></div><div class="casAuthors">Houlden, Chris E.; Hutchby, Marc; Bailey, Chris D.; Ford, J. Gair; Tyler, Simon N. G.; Gagne, Michel R.; Lloyd-Jones, Guy C.; Booker-Milburn, Kevin I.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1830-1833</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The title reaction proceeds efficiently at 18°C under CO (1 atm) with 5% [Pd(OTs)2-(MeCN)2] as precatalyst.  Depending on the solvents used, either anthranilates or cyclic imides can be obtained in high yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkntHdRJvnfrVg90H21EOLACvtfcHk0ljm5-oERFev0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjt1OjtbY%253D&md5=8eafe11603203bc2d644abbfeea471ac</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fanie.200805842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200805842%26sid%3Dliteratum%253Aachs%26aulast%3DHoulden%26aufirst%3DC.%2BE.%26aulast%3DHutchby%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DC.%2BD.%26aulast%3DFord%26aufirst%3DJ.%2BG.%26aulast%3DTyler%26aufirst%3DS.%2BN.%2BG.%26aulast%3DGagn%25C3%25A9%26aufirst%3DM.%2BR.%26aulast%3DLloyd-Jones%26aufirst%3DG.%2BC.%26aulast%3DBooker-Milburn%26aufirst%3DK.%2BI.%26atitle%3DRoom-Temperature%2520Palladium-Catalyzed%2520C-H%2520Activation%253A%2520Ortho-Carbonylation%2520of%2520Aniline%2520Derivatives%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D1830%26epage%3D1833%26doi%3D10.1002%2Fanie.200805842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chern, J.-W.</span></span> <span> </span><span class="NLM_article-title">Efficient Microwave-Assisted Pd-Catalyzed Hydroxylation of Aryl Chlorides in the Presence of Carbonate</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">3688</span>– <span class="NLM_lpage">3691</span>, <span class="refDoi"> DOI: 10.1021/ol301523q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol301523q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BC38Xps1Giurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=3688-3691&author=C.-W.+Yuauthor=G.+S.+Chenauthor=C.-W.+Huangauthor=J.-W.+Chern&title=Efficient+Microwave-Assisted+Pd-Catalyzed+Hydroxylation+of+Aryl+Chlorides+in+the+Presence+of+Carbonate&doi=10.1021%2Fol301523q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient Microwave-Assisted Pd-Catalyzed Hydroxylation of Aryl Chlorides in the Presence of Carbonate</span></div><div class="casAuthors">Yu, Chao-Wu; Chen, Grace S.; Huang, Chen-Wei; Chern, Ji-Wang</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3688-3691</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient microwave-assisted, palladium-catalyzed hydroxylation of aryl chlorides in the presence of a weak base carbonate was developed, which rapidly converts aryl and heteroaryl chlorides to phenols, and can be used when the aryl chloride is functionalized with a ketone, aldehyde, ester, nitrile, or amide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIA1TkYC88vrVg90H21EOLACvtfcHk0lirhDnq9RvQkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xps1Giurk%253D&md5=d613d975b8ea090e95da498d0a8d638c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fol301523q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol301523q%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DC.-W.%26aulast%3DChen%26aufirst%3DG.%2BS.%26aulast%3DHuang%26aufirst%3DC.-W.%26aulast%3DChern%26aufirst%3DJ.-W.%26atitle%3DEfficient%2520Microwave-Assisted%2520Pd-Catalyzed%2520Hydroxylation%2520of%2520Aryl%2520Chlorides%2520in%2520the%2520Presence%2520of%2520Carbonate%26jtitle%3DOrg.%2520Lett.%26date%3D2012%26volume%3D14%26spage%3D3688%26epage%3D3691%26doi%3D10.1021%2Fol301523q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Molander, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gormisky, P. E.</span></span> <span> </span><span class="NLM_article-title">Cross-Coupling of Cyclopropyl- and Cyclobutyltrifluoroborates with Aryl and Heteroaryl Chlorides</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">7481</span>– <span class="NLM_lpage">7485</span>, <span class="refDoi"> DOI: 10.1021/jo801269m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo801269m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOqtLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=7481-7485&author=G.+A.+Molanderauthor=P.+E.+Gormisky&title=Cross-Coupling+of+Cyclopropyl-+and+Cyclobutyltrifluoroborates+with+Aryl+and+Heteroaryl+Chlorides&doi=10.1021%2Fjo801269m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Cross-Coupling of Cyclopropyl- and Cyclobutyltrifluoroborates with Aryl and Heteroaryl Chlorides</span></div><div class="casAuthors">Molander, Gary A.; Gormisky, Paul E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7481-7485</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Suitable conditions were found for the Suzuki-Miyaura cross-coupling reaction of potassium cyclopropyl- and cyclobutyltrifluoroborates with aryl chlorides.  Both of these secondary alkyl trifluoroborates coupled in moderate to excellent yield with electron-rich, electron-poor, and hindered aryl chlorides to give a variety of substituted aryl cyclopropanes and cyclobutanes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6VymYqSga5rVg90H21EOLACvtfcHk0lirhDnq9RvQkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOqtLrF&md5=575a47623b0f8fd598563f41b81e3564</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjo801269m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo801269m%26sid%3Dliteratum%253Aachs%26aulast%3DMolander%26aufirst%3DG.%2BA.%26aulast%3DGormisky%26aufirst%3DP.%2BE.%26atitle%3DCross-Coupling%2520of%2520Cyclopropyl-%2520and%2520Cyclobutyltrifluoroborates%2520with%2520Aryl%2520and%2520Heteroaryl%2520Chlorides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D73%26spage%3D7481%26epage%3D7485%26doi%3D10.1021%2Fjo801269m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Somoza, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skene, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mol, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buggy, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, B.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynands, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leahy, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navre, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knuth, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McRee, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tari, L. W.</span></span> <span> </span><span class="NLM_article-title">Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1325</span>– <span class="NLM_lpage">1334</span>, <span class="refDoi"> DOI: 10.1016/j.str.2004.04.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1016%2Fj.str.2004.04.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=15242608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsFyrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=1325-1334&author=J.+R.+Somozaauthor=R.+J.+Skeneauthor=B.+A.+Katzauthor=C.+Molauthor=J.+D.+Hoauthor=A.+J.+Jenningsauthor=C.+Luongauthor=A.+Arvaiauthor=J.+J.+Buggyauthor=E.+Chiauthor=J.+Tangauthor=B.-C.+Sangauthor=E.+Vernerauthor=R.+Wynandsauthor=E.+M.+Leahyauthor=D.+R.+Douganauthor=G.+Snellauthor=M.+Navreauthor=M.+W.+Knuthauthor=R.+V.+Swansonauthor=D.+E.+McReeauthor=L.+W.+Tari&title=Structural+Snapshots+of+Human+HDAC8+Provide+Insights+into+the+Class+I+Histone+Deacetylases&doi=10.1016%2Fj.str.2004.04.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases</span></div><div class="casAuthors">Somoza, John R.; Skene, Robert J.; Katz, Bradley A.; Mol, Clifford; Ho, Joseph D.; Jennings, Andy J.; Luong, Christine; Arvai, Andrew; Buggy, Joseph J.; Chi, Ellen; Tang, Jie; Sang, Bi-Ching; Verner, Erik; Wynands, Robert; Leahy, Ellen M.; Dougan, Douglas R.; Snell, Gyorgy; Navre, Marc; Knuth, Mark W.; Swanson, Ronald V.; McRee, Duncan E.; Tari, Leslie W.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1325-1334</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Modulation of the acetylation state of histones plays a pivotal role in the regulation of gene expression.  Histone deacetylases (HDACs) catalyze the removal of acetyl groups from lysines near the N termini of histones.  This reaction promotes the condensation of chromatin, leading to repression of transcription.  HDAC deregulation has been linked to several types of cancer, suggesting a potential use for HDAC inhibitors in oncol.  Here we describe the first crystal structures of a human HDAC: the structures of human HDAC8 complexed with four structurally diverse hydroxamate inhibitors.  This work sheds light on the catalytic mechanism of the HDACs, and on differences in substrate specificity across the HDAC family.  The structure also suggests how phosphorylation of Ser39 affects HDAC8 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPLrZup76hGLVg90H21EOLACvtfcHk0lirhDnq9RvQkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsFyrsLc%253D&md5=3f1842802bac2543509a25f5ddbea5f6</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2004.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2004.04.012%26sid%3Dliteratum%253Aachs%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DSkene%26aufirst%3DR.%2BJ.%26aulast%3DKatz%26aufirst%3DB.%2BA.%26aulast%3DMol%26aufirst%3DC.%26aulast%3DHo%26aufirst%3DJ.%2BD.%26aulast%3DJennings%26aufirst%3DA.%2BJ.%26aulast%3DLuong%26aufirst%3DC.%26aulast%3DArvai%26aufirst%3DA.%26aulast%3DBuggy%26aufirst%3DJ.%2BJ.%26aulast%3DChi%26aufirst%3DE.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DSang%26aufirst%3DB.-C.%26aulast%3DVerner%26aufirst%3DE.%26aulast%3DWynands%26aufirst%3DR.%26aulast%3DLeahy%26aufirst%3DE.%2BM.%26aulast%3DDougan%26aufirst%3DD.%2BR.%26aulast%3DSnell%26aufirst%3DG.%26aulast%3DNavre%26aufirst%3DM.%26aulast%3DKnuth%26aufirst%3DM.%2BW.%26aulast%3DSwanson%26aufirst%3DR.%2BV.%26aulast%3DMcRee%26aufirst%3DD.%2BE.%26aulast%3DTari%26aufirst%3DL.%2BW.%26atitle%3DStructural%2520Snapshots%2520of%2520Human%2520HDAC8%2520Provide%2520Insights%2520into%2520the%2520Class%2520I%2520Histone%2520Deacetylases%26jtitle%3DStructure%26date%3D2004%26volume%3D12%26spage%3D1325%26epage%3D1334%26doi%3D10.1016%2Fj.str.2004.04.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navre, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, B.-C.</span></span> <span> </span><span class="NLM_article-title">Characterization of the Two Catalytic Domains in Histone Deacetylase 6</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>341</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2005.12.144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1016%2Fj.bbrc.2005.12.144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=16412385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BD28Xoslygtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2006&pages=45-50&author=H.+Zouauthor=Y.+Wuauthor=M.+Navreauthor=B.-C.+Sang&title=Characterization+of+the+Two+Catalytic+Domains+in+Histone+Deacetylase+6&doi=10.1016%2Fj.bbrc.2005.12.144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the two catalytic domains in histone deacetylase 6</span></div><div class="casAuthors">Zou, Hua; Wu, Yiqin; Navre, Marc; Sang, Bi-Ching</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-50</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Histone deacetylase 6 (HDAC6) is the only known HDAC with two potentially functional catalytic domains, yet the role towards substrate played by these two domains remains ambiguous.  Most studies report HDAC6 activities measured using either immune complexes or in vitro translated products.  Here, we characterize the activity of highly purified recombinant HDAC6, mutants with active site histidine mutations in each domain (H216A and H611A), and individual catalytic domains.  The deacetylase activities of these proteins, as well as their kinetic parameters, were measured using histone, α-tubulin, and fluorogenic acetylated lysine as substrates.  Mutant H216A only slightly lowers the catalytic rate.  However, mutant H611A decreases the catalytic rate more than 5000-fold.  The first domain expressed alone is not catalytically active.  In contrast, the second domain shows only a modest decrease in substrate binding and product formation rate.  Our results indicate that the in vitro deacetylase activity of HDAC6 resides in the C-terminal second catalytic domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-ljQmtqSmN7Vg90H21EOLACvtfcHk0lhrydWqlFVK5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xoslygtg%253D%253D&md5=160f566a8fdd2756e398869647e54fe7</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2005.12.144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2005.12.144%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DNavre%26aufirst%3DM.%26aulast%3DSang%26aufirst%3DB.-C.%26atitle%3DCharacterization%2520of%2520the%2520Two%2520Catalytic%2520Domains%2520in%2520Histone%2520Deacetylase%25206%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2006%26volume%3D341%26spage%3D45%26epage%3D50%26doi%3D10.1016%2Fj.bbrc.2005.12.144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, S. H.</span></span> <span> </span><span class="NLM_article-title">Histone Deacetylase 6 Plays a Role as a Distinct Regulator of Diverse Cellular Processes</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">775</span>– <span class="NLM_lpage">793</span>, <span class="refDoi"> DOI: 10.1111/febs.12079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1111%2Ffebs.12079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=23181831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVKrs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2013&pages=775-793&author=Y.+Liauthor=D.+Shinauthor=S.+H.+Kwon&title=Histone+Deacetylase+6+Plays+a+Role+as+a+Distinct+Regulator+of+Diverse+Cellular+Processes&doi=10.1111%2Ffebs.12079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase 6 plays a role as a distinct regulator of diverse cellular processes</span></div><div class="casAuthors">Li, Yingxiu; Shin, Donghee; Kwon, So Hee</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">775-793</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase (HDAC) 6 is the best-characterized class IIb deacetylase that regulates many important biol. processes via the formation of complexes with its partner proteins.  HDAC6 is important both for cytoplasmic and nuclear functions.  Unlike other deacetylases, HDAC6 has unique substrate specificity for nonhistone proteins.  Such diverse functions of HDAC6 suggest that it serves a potential therapeutic target for the treatment of a wide range of diseases.  This therapeutic interest in HDAC6 stems from the observation that HDAC6 may be overexpressed or deregulated in various cancers, neurodegenerative diseases and inflammatory disorders.  Despite extensive efforts, however, very few HDAC6-selective inhibitors have been identified and the precise structural determinants remain undefined.  Future efforts aiming to better define the structure and function of HDAC6 should provide the basis for the discovery of novel effective inhibitors.  In this review, we focus on recent studies that highlight the importance of HDAC6-mediated biol. processes, disease mechanisms and HDAC6-selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrphsn42_IKCLVg90H21EOLACvtfcHk0lhrydWqlFVK5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVKrs78%253D&md5=1343243c2d7ba72ef6b67104ad3749b8</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12079%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DShin%26aufirst%3DD.%26aulast%3DKwon%26aufirst%3DS.%2BH.%26atitle%3DHistone%2520Deacetylase%25206%2520Plays%2520a%2520Role%2520as%2520a%2520Distinct%2520Regulator%2520of%2520Diverse%2520Cellular%2520Processes%26jtitle%3DFEBS%2520J.%26date%3D2013%26volume%3D280%26spage%3D775%26epage%3D793%26doi%3D10.1111%2Ffebs.12079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brent Derry, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copp, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, L.</span></span> <span> </span><span class="NLM_article-title">Mitotic Block Induced in HeLa Cells by Low Concentrations of Paclitaxel (Taxol) Results in Abnormal Mitotic Exit and Apoptotic Cell Death</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">816</span>– <span class="NLM_lpage">825</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=8631019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADyaK28XhtVClsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1996&pages=816-825&author=M.+A.+Jordanauthor=K.+Wendellauthor=S.+Gardinerauthor=W.+Brent+Derryauthor=H.+Coppauthor=L.+Wilson&title=Mitotic+Block+Induced+in+HeLa+Cells+by+Low+Concentrations+of+Paclitaxel+%28Taxol%29+Results+in+Abnormal+Mitotic+Exit+and+Apoptotic+Cell+Death"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exist and apoptotic cell death</span></div><div class="casAuthors">Jordan, Mary Ann; Wendell, Kim; Gardiner, Sara; Derry, W. Brent; Copp, Hillary; Wilson, Leslie</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">816-25</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Paclitaxel at low concns. (10 nm for 20 h) induces ∼90% mitotic block at the metaphase/anaphase transition in HeLa cells, apparently by suppressing dynamics of spindle microtubules.  It is not known, however, whether inhibition of mitosis by such low paclitaxel concns. results in cell death.  In the present work, we found that after removal of paclitaxel (10 nm-1 μm), blocked cells did not resume proliferation.  Instead, cells exited mitosis abnormally within 24 h.  They did not progress through anaphase or cytokinesis but entered an interphase-like state (chromatin decondensed, and an interphase-like microtubule array and nuclear membranes reformed).  Many cells (≥55%) contained multiple nuclei.  Addnl. DNA synthesis and polyploidy did not occur.  DNA degrdn. into nucleosome-sized fragments characteristic of apoptosis began during drug incubation and increased after drug removal.  Cells died within 48-72 h.  Incubation with paclitaxel (10 nm for 20 h) resulted in high intracellular drug accumulation (8.3 μm) and little efflux after paclitaxel removal; intracellular retention of paclitaxel may contribute to its efficacy.  The results support the hypothesis that the most potent chemotherapeutic mechanism of paclitaxel is kinetic stabilization of spindle microtubule dynamics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdfuHo0TTnJrVg90H21EOLACvtfcHk0lhrydWqlFVK5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhtVClsbo%253D&md5=5114e564fbf8b8ed0b45df06dbfd5286</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DM.%2BA.%26aulast%3DWendell%26aufirst%3DK.%26aulast%3DGardiner%26aufirst%3DS.%26aulast%3DBrent%2BDerry%26aufirst%3DW.%26aulast%3DCopp%26aufirst%3DH.%26aulast%3DWilson%26aufirst%3DL.%26atitle%3DMitotic%2520Block%2520Induced%2520in%2520HeLa%2520Cells%2520by%2520Low%2520Concentrations%2520of%2520Paclitaxel%2520%2528Taxol%2529%2520Results%2520in%2520Abnormal%2520Mitotic%2520Exit%2520and%2520Apoptotic%2520Cell%2520Death%26jtitle%3DCancer%2520Res.%26date%3D1996%26volume%3D56%26spage%3D816%26epage%3D825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamanishi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abiko, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murat, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horikawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konishi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandai, M.</span></span> <span> </span><span class="NLM_article-title">Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-ΚB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">5034</span>– <span class="NLM_lpage">5045</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-14-3098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1158%2F0008-5472.can-14-3098" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=5034-5045&author=J.+Pengauthor=J.+Hamanishiauthor=N.+Matsumuraauthor=K.+Abikoauthor=K.+Muratauthor=T.+Babaauthor=K.+Yamaguchiauthor=N.+Horikawaauthor=Y.+Hosoeauthor=S.+K.+Murphyauthor=I.+Konishiauthor=M.+Mandai&title=Chemotherapy+Induces+Programmed+Cell+Death-Ligand+1+Overexpression+via+the+Nuclear+Factor-%CE%9AB+to+Foster+an+Immunosuppressive+Tumor+Microenvironment+in+Ovarian+Cancer&doi=10.1158%2F0008-5472.can-14-3098"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.can-14-3098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.can-14-3098%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DHamanishi%26aufirst%3DJ.%26aulast%3DMatsumura%26aufirst%3DN.%26aulast%3DAbiko%26aufirst%3DK.%26aulast%3DMurat%26aufirst%3DK.%26aulast%3DBaba%26aufirst%3DT.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DHorikawa%26aufirst%3DN.%26aulast%3DHosoe%26aufirst%3DY.%26aulast%3DMurphy%26aufirst%3DS.%2BK.%26aulast%3DKonishi%26aufirst%3DI.%26aulast%3DMandai%26aufirst%3DM.%26atitle%3DChemotherapy%2520Induces%2520Programmed%2520Cell%2520Death-Ligand%25201%2520Overexpression%2520via%2520the%2520Nuclear%2520Factor-%25CE%259AB%2520to%2520Foster%2520an%2520Immunosuppressive%2520Tumor%2520Microenvironment%2520in%2520Ovarian%2520Cancer%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D5034%26epage%3D5045%26doi%3D10.1158%2F0008-5472.can-14-3098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramalingam, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parise, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramananthan, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagattuta, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musguire, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoller, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argiris, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwiebel, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egorin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belani, C. P.</span></span> <span> </span><span class="NLM_article-title">Phae I and Pharmacokinetic Study of Vorinostat, A Histone Deacetylase Inhibitor, in Combination with Carboplatin and Paclitaxel for Advanced Solid Malignancies</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">3605</span>– <span class="NLM_lpage">3610</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.ccr-07-0162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=10.1158%2F1078-0432.ccr-07-0162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=17510206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFCqur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=3605-3610&author=S.+S.+Ramalingamauthor=R.+A.+Pariseauthor=R.+K.+Ramananthanauthor=T.+F.+Lagattutaauthor=L.+A.+Musguireauthor=R.+G.+Stollerauthor=D.+M.+Potterauthor=A.+E.+Argirisauthor=J.+A.+Zwiebelauthor=M.+J.+Egorinauthor=C.+P.+Belani&title=Phae+I+and+Pharmacokinetic+Study+of+Vorinostat%2C+A+Histone+Deacetylase+Inhibitor%2C+in+Combination+with+Carboplatin+and+Paclitaxel+for+Advanced+Solid+Malignancies&doi=10.1158%2F1078-0432.ccr-07-0162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I and Pharmacokinetic Study of Vorinostat, A Histone Deacetylase Inhibitor, in Combination with Carboplatin and Paclitaxel for Advanced Solid Malignancies</span></div><div class="casAuthors">Ramalingam, Suresh S.; Parise, Robert A.; Ramananthan, Ramesh K.; Lagattuta, Theodore F.; Musguire, Lori A.; Stoller, Ronald G.; Potter, Douglas M.; Argiris, Athanassios E.; Zwiebel, James A.; Egorin, Merrill J.; Belani, Chandra P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3605-3610</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The primary objective of this study was to det. the recommended phase II doses of the novel histone deacetylase inhibitor vorinostat when administered in combination with carboplatin and paclitaxel.  Exptl. DESIGN: Patients (N = 28) with advanced solid malignancies were treated with vorinostat, administered orally once daily for 2 wk or twice daily for 1 wk, every 3 wk.  Carboplatin and paclitaxel were administered i.v. once every 3 wk.  Doses of vorinostat and paclitaxel were escalated in sequential cohorts of three patients.  The pharmacokinetics of vorinostat, its metabolites, and paclitaxel were characterized.  RESULTS: Vorinostat was administered safely up to 400 mg qd or 300 mg bd with carboplatin and paclitaxel.  Two of 12 patients at the 400 mg qd schedule experienced dose-limiting toxicities of grade 3 emesis and grade 4 neutropenia with fever.  Non-dose-limiting toxicity included nausea, diarrhea, fatigue, neuropathy, thrombocytopenia, and anemia.  Of 25 patients evaluable for response, partial responses occurred in 11 (10 non-small cell lung cancer and 1 head and neck cancer) and stable disease occurred in 7.  Vorinostat pharmacokinetics were linear over the dose range studied.  Vorinostat area under the concn. vs. time curve and half-life increased when vorinostat was coadministered with carboplatin and paclitaxel, but vorinostat did not alter paclitaxel pharmacokinetics.  CONCLUSIONS: Both schedules of vorinostat (400 mg oral qd x 14 days or 300 mg bd x 7 days) were tolerated well in combination with carboplatin (area under the concn. vs. time curve = 6 mg/mL x min) and paclitaxel (200 mg/m2).  Encouraging anticancer activity was noted in patients with previously untreated non-small cell lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE_xqO3LrE6LVg90H21EOLACvtfcHk0lhBEHHPQFUQiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFCqur8%253D&md5=393c48c8bd6bc8e809f5eff929884cd2</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.ccr-07-0162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.ccr-07-0162%26sid%3Dliteratum%253Aachs%26aulast%3DRamalingam%26aufirst%3DS.%2BS.%26aulast%3DParise%26aufirst%3DR.%2BA.%26aulast%3DRamananthan%26aufirst%3DR.%2BK.%26aulast%3DLagattuta%26aufirst%3DT.%2BF.%26aulast%3DMusguire%26aufirst%3DL.%2BA.%26aulast%3DStoller%26aufirst%3DR.%2BG.%26aulast%3DPotter%26aufirst%3DD.%2BM.%26aulast%3DArgiris%26aufirst%3DA.%2BE.%26aulast%3DZwiebel%26aufirst%3DJ.%2BA.%26aulast%3DEgorin%26aufirst%3DM.%2BJ.%26aulast%3DBelani%26aufirst%3DC.%2BP.%26atitle%3DPhae%2520I%2520and%2520Pharmacokinetic%2520Study%2520of%2520Vorinostat%252C%2520A%2520Histone%2520Deacetylase%2520Inhibitor%252C%2520in%2520Combination%2520with%2520Carboplatin%2520and%2520Paclitaxel%2520for%2520Advanced%2520Solid%2520Malignancies%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D3605%26epage%3D3610%26doi%3D10.1158%2F1078-0432.ccr-07-0162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i90"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01590">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_30720"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01590">10.1021/acs.jmedchem.8b01590</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">SMILES (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01590/suppl_file/jm8b01590_si_001.csv">CSV</a>)</p></li><li><p class="inline">HPLC purity results, <sup>1</sup>H, <sup>13</sup>C NMR spectra, and enzyme inhibition curves of target compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01590/suppl_file/jm8b01590_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01590/suppl_file/jm8b01590_si_001.csv">jm8b01590_si_001.csv (1.39 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01590/suppl_file/jm8b01590_si_002.pdf">jm8b01590_si_002.pdf (3.93 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01590&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-2%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01590%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01590" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677affb16ab332b5","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
